,date,information,related
0,2022-09-23,"Headline: Henry Ford Health First in Michigan to Offer Multi-Cancer Early Detection Blood Test, source:Finnhub, summary: DETROIT and MENLO PARK, Calif. - Henry Ford Health, one of the nation's leading academic medical centers recognized for excellence in clinical care, research and education, and GRAIL, LLC, a... | September 23, 2022, Headline: SVB Securities biotech analysts to hold an analyst/industry conference call, source:Thefly.com, summary: SVB Securities Biotech An... ILMN, Headline: Invitae Busted Business Model Offers A Tactical Opportunity, source:SeekingAlpha, summary: Invitae's business model remains untested, having spent a decade building a precarious market position with low pricing strategies. Read why I'm avoiding NVTA stock., Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 1.61% to $190.38 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: Healthcare Learned a Lot From Covid. 12 Ways to Invest Now., source:MarketWatch, summary: From biotech to managed care, companies are tackling new challenges in science and business. Our healthcare roundtable experts pick 12 stocks that could win., Headline: How Comprehensive Genomic Profiling Is Helping Cancer Patients Today, source:Yahoo, summary: The European Society of Medical Oncology (ESMO) annual congress convened earlier this month in Paris, where, Illumina presented key abstracts demonstrating the clinical utility of comprehensive genomic profiling (CGP)., Headline: Illumina (ILMN) Stock Moves -1.61%: What You Should Know, source:Yahoo, summary: Illumina (ILMN) closed at $190.38 in the latest trading session, marking a -1.61% move from the prior day.",ILMN
1,2022-09-26,"Headline: Myriad: Trying To Find Its Footing In An Evolving Industry, source:SeekingAlpha, summary: Myriad Genetics is a leading provider of genetic testing services and products. See prudent investors might want to pass on MYGN stock.",ILMN
2,2022-09-27,"Headline: Illumina Genomics Forum Sold Out, Announces Opportunity to View Innovation Roadmap Session via Livestream, source:Finnhub, summary: SAN DIEGO - Illumina, Inc. announced that its inaugural Illumina Genomics Forum, being held in San Diego from September 28 through October 1, is sold out.The Illumina Genomics Forum is now sold... | September 27, 2022, Headline: Analystsâ Opinions Are Mixed on These Healthcare Stocks: Illumina (ILMN), LAVA Therapeutics (LVTX) and Design Therapeutics (DSGN), source:TipRanks, summary: Analysts have been eager to weigh in on the Healthcare sector with new ratings on Illumina (<a hr..., Headline: Piper Sandler med care facilities analyst holds analyst/industry conference call, source:Thefly.com, summary: Healthcare Analysts, alon... ILMN, Headline: What You Missed On Wall Street On Wednesday, source:Thefly.com, summary: Five top five lists with the news and calls moving stocks, powered by The Fly. FYBR, DOCU, AAPL, BIIB, ESALY, BTRS, AMZN, NFLX, LMT, ILMN, ETRN, LYFT, TGI, BR, M, TWTR, TSLA, ASTL, SAND, HOLI, CTAS, BB, THO, VFC, PAYX, BCS, BAC, C, CS, DB, MS, JEF, UBS, NMR",ILMN
3,2022-09-28,"Headline: Illumina’s New Gene Sequencers Are Almost Here. What They Need to Deliver., source:Yahoo, summary: The firm's better-than-90% share of a booming market for gene-reading technology sent its stock to $525 last year. It now has an army of rivals., Headline: Illumina upgraded to Outperform from In Line at Evercore ISI, source:Thefly.com, summary: Evercore ISI analyst Vija... ILMN, Headline: Illumina upgraded to Outperform at Evercore ISI ahead of analyst day, source:Thefly.com, summary: As previously reported, E... ILMN, EW, ISRG, Headline: Illumina view downgraded to Mixed from Positive at OTR Global, source:Thefly.com, summary: OTR Global downgraded its... ILMN, Headline: Early notable gainers among liquid option names on September 28th, source:Thefly.com, summary: Notable gainers among liq... BIIB, LLY, ILMN, NEM, EXPE, Headline: What You Missed On Wall Street This Morning, source:Thefly.com, summary: Five top five lists with the news and calls moving stocks, powered by The Fly. AAPL, BIIB, ESALY, BTRS, PATH, MSFT, MAN, NFLX, LMT, ILMN, ETRN, LYFT, TGI, BR, M, GM, FYBR, DOCU, ASTL, SAND, CTAS, BB, THO, VFC, PAYX, BCS, BAC, C, CS, DB, MS, UBS, JEF, NMR, CSX, NSC, Headline: Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations, source:Thefly.com, summary: Netflix upgrade, Lockheed Martin downgrade and Sunrun initiation among today's top calls on Wall Street NFLX, BIIB, ILMN, SHOO, SSB, TFC, LMT, LHX, CSX, ETRN, AVNT, RUN, IE, GNRC, SABR, ENVX, Headline: Stocks making the biggest moves midday: Apple, Netflix, Biogen, Canopy Growth and more, source:CNBC, summary: These are the stocks posting the largest moves in midday trading. , Headline: ETFs: Investing in automation has become the latest 'mega-trend,' expert explains, source:Yahoo, summary: ROBO Global Head of Advisor Relations Lauren Hein joins Yahoo Finance Live to explain how more investors are shifting towards robotics and how increased automation could affect the job market.",ILMN
4,2022-09-29,"Headline: Illumina launches line of high-end DNA sequences, Statnews reports, source:Thefly.com, summary: Illumina is launching the... ILMN, Headline: Illumina unveils NovaSeq X Series sequencers, source:Thefly.com, summary: Illumina announced the la... ILMN, Headline: Piper says Illumina remains a top pick after NovaSeq X unveil, source:Thefly.com, summary: Piper Sandler analyst Dav... ILMN, Headline: Illumina Engages Obama To Push Its Customers' Reimbursement Agenda, source:SeekingAlpha, summary: There is a high chance that the Grail deal would collapse after European regulators decide to block the acquisition. Read more here., Headline: Illumina Launches More Powerful Gene Sequencer, source:Yahoo, summary: Illumina introduced gene-sequencing machines that it says can more-than-double capacity and slash the cost of sequencing, as it faces competition and price pressures., Headline: Illumina launches next-generation DNA sequencers, source:Reuters, summary: Illumina Inc, the top maker of DNA sequencers used to speed drug development and other research, on Thursday announced the launch of its next-generation NovaSeq X systems, which it said can generate more than 20,000 whole genomes per year, or 2.5 times that of prior sequencers..., Headline: Illumina’s New Gene-Sequencing Products Pressure Challengers, source:Yahoo, summary: Illumina, a leading maker of gene-sequencing systems, announced faster, cheaper gene-readers Thursday., Headline: Illumina Aims to Push Genetics Beyond the Lab With $200 Genome, source:Yahoo, summary: (Bloomberg) -- Illumina Inc. says it can read a person’s entire genetic code for as little as $200 with its new sequencing machine, bringing the company within reach of its long-promised goal of the $100 genome.Most Read from BloombergMacKenzie Scott Files for Divorce From Science Teacher HusbandMeta to Cut Headcount for First Time, Slash Budgets Across TeamsStocks Plummet to 22-Month Low as Fed Hawks Circle: Markets WrapTrump Refuses to Delay Florida Deposition in Phone-Fraud Case Despite Hurri, Headline: 3 Biotech Stocks to Sell in October, source:Yahoo, summary: This year will probably go down as the roughest year for investors since the financial recession in 2008. The S&P 500 has shed more than 20% of its value year-to-date as inflation and interest rates weigh down the equities market. Hence, investors are scrambling to streamline their portfolios. In doing so, they might want to think about some biotech stocks to sell. Biotech stocks have typically been among the most risky investments. These firms spend a ton of money on research and development an, Headline: Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced multiple breakthrough sequencing innovations at its inaugural Illumina Genomics Forum:, Headline: Illumina Introduces Faster, Cheaper Model of Genome-Sequencing Machine, source:Yahoo, summary: The era of rapid and cheap genome sequencing is now here. Illumina, which has long lived at the cutting edge of the genome-sequencing race,...",ILMN
5,2022-09-30,"Headline: Illumina price target raised to $175 from $130 at Barclays, source:Thefly.com, summary: Barclays analyst Luke Ser... ILMN, Headline: 12 Best Medical Technology Stocks to Buy, source:Yahoo, summary: In this article, we discuss 12 best medical technology stocks to buy. If you want to read about some more medical technology stocks, go directly to 5 Best Medical Technology Stocks to Buy. The medical technology industry can finally start to put the COVID-19 virus behind it after United States President Joe Biden admitted in […], Headline: Illumina Unveils Revolutionary NovaSeq X Series To Rapidly Accelerate Genomic Discoveries and Improve Human Health, source:Yahoo, summary: llumina, Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, announced the launch of the NovaSeq™ X Series (NovaSeq X and NovaSeq X Plus), new production-scale sequencers that will push the limits of what is possible with genomic medicine, enabling faster, more powerful, and more sustainable sequencing., Headline: What’s Going On With Illumina (ILMN)?, source:Yahoo, summary: Harding Loevner, an asset management company, released its “Global Equity” second quarter 2022 investor letter. A copy of the same can be downloaded here. In the second quarter, the fund returned -20.63% net of fees compared to a return of -15.53% for the MSCI All Country World Index and a return of -16.05% for the […], Headline: ILLUMINA, INC. : Change in Directors or Principal Officers (form 8-K), source:Finnhub, summary: Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.On September 29,... | September 30, 2022, Headline: Bill Gates Says Genomics Shouldn’t Help Just Rich People, source:Yahoo, summary: Bill Gates told an audience that his foundation targets infectious diseases such as malaria, polio, HIV, and Covid, which hit poor nations hard. Gene sequencing is a starting point for many of these battles., Headline: Illumina (ILMN) Dips More Than Broader Markets: What You Should Know, source:Yahoo, summary: In the latest trading session, Illumina (ILMN) closed at $190.79, marking a -1.56% move from the previous day.",ILMN
6,2022-10-01,"Headline: Stocks To Watch: Investors Look For Edges Amid Inflation, Rates, Earnings Challenges, source:SeekingAlpha, summary: Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week",ILMN
7,2022-10-02,"Headline: Illumina to host investor day, source:Thefly.com, summary: Investor Day to be held i... ILMN, Headline: Jobs Report, Constellation Brands Stock, Illumina, and More to Watch This Week, source:Yahoo, summary: September jobs numbers will be released on Friday, plus earnings from Lamb Weston, Conagra, McCormick, and Constellation. Also, September PMIs and August JOLTS., Headline: Illumina sees giving detailed FY23 guidance in February, source:Thefly.com, summary: Guidance comments made du... ILMN, Headline: Illumina says retooling R&D has weighed on margins, source:Thefly.com, summary: Illumina executives are s... ILMN, Headline: Illumina to treat Grail strategic review, appeals process as 'parallel paths', source:Thefly.com, summary: Illumina executives conti... ILMN, Headline: What You Missed On Wall Street On Monday, source:Thefly.com, summary: Five top five lists with the news and calls moving stocks, powered by The Fly. TSLA, GM, STLA, VWAGY, VSAT, LHX, HOOD, DIS, DISH, WFC, C, DOCU, BOX, RBLX, ENFN, NKE, FRPT, AAPL, UAL, QCOM, TCEHY, MRNA, MYOV, VRT, RIG, LTHM, APLS, IDCC, DUOT, APRN, VERO, ILMN",ILMN
8,2022-10-03,"Headline: Illumina to host investor day, source:Thefly.com, summary: Investor Day to be held i... ILMN, Headline: Illumina sees long-term revenue growth in 'mid-teens', source:Thefly.com, summary: Shares of Illumina are do... ILMN, Headline: Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum, source:Yahoo, summary: Illumina, Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, announced multiple breakthrough sequencing innovations at its inaugural Illumina Genomics Forum:, Headline: Piper Sandler med care facilities analyst holds analyst/industry conference call, source:Thefly.com, summary: Healthcare Analysts, alon... ILMN",ILMN
9,2022-10-04,"Headline: Illumina long-term outlook in line with expectations, says Citi, source:Thefly.com, summary: Citi analyst Patrick Donn... ILMN, Headline: U.S. keeps losing antitrust court battles but few expect pullback, source:Finnhub, summary: The U.S. government has been hit with four painful losses at antitrust trials recently but legal experts do not expect the Biden administration's regulators to slow efforts to make American... | October 4, 2022, Headline: Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (ILMN), Adaptimmune Therapeutics (ADAP) and RegenXBio (RGNX), source:TipRanks, summary: Analysts have been eager to weigh in on the Healthcare sector with new ratings on Illumina (<a hr..., Headline: Illumina upgraded to Outperform from Market Perform at SVB Securities, source:Thefly.com, summary: SVB Securities analyst Pu... ILMN, Headline: Early notable gainers among liquid option names on October 4th, source:Thefly.com, summary: Notable gainers among liq... ILMN, NCLH, CCL, DAL, CZR, Headline: Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations, source:Thefly.com, summary: Domino's Pizza upgrade, Paramount downgrade and TD Synnex initiation among today's top calls on Wall Street GILD, DPZ, ILMN, COMM, BK, PARA, SRAD, MCG, MTB, WLK, AGTC, SNX, GKOS, DHX, LFG, Headline: Stocks making the biggest moves midday: Twitter, Poshmark, Rivian and more, source:CNBC, summary: These are the stocks posting the largest moves in midday trading. ",ILMN
10,2022-10-05,"Headline: Analysts are Upgrading These 10 Stocks, source:Yahoo, summary: In this article, we will take a look at the 10 stocks recently upgraded by analysts. If you want to see some more stocks on the list, go directly to Analysts are Upgrading These 5 Stocks. U.S. stocks turned red on Wednesday morning after staying in positive territory during the last two trading sessions. Meanwhile, […]",ILMN
11,2022-10-06,"Headline: ILMN November 25th Options Begin Trading, source:Stock Options Channel, summary: Staff article entitled ILMN November 25th Options Begin Trading, about stock options, from Stock Options Channel., Headline: Technical Trouble Haunts This Medtech Name, source:Yahoo, summary: A historically bearish signal could keep a lid on shares, Headline: Illumina to Announce Third Quarter 2022 Financial Results on Thursday, November 3, 2022, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2022 following the close of market on Thursday, November 3, 2022.",ILMN
12,2022-10-07,"Headline: Illumina Lowers the Cost of Gene Sequencing. Buy the Stock Before It Drives Higher., source:Yahoo, summary: Illumina CEO Francis deSouza told analysts that the company can cut sequencing’s cost without crimping its 60%-plus gross margins., Headline: Cancer-Detecting Blood Tests Behind Illumina’s $7.1 Billion Antitrust Battle Gain Ground, source:Yahoo, summary: Tests from Grail and others aim to help clinicians diagnose more cancers earlier, though data are limited., Headline: How Illumina's Newest Employee Resource Group, iLatinx, Supports Employees and Advocates for Diversity in Life Science, source:Yahoo, summary: Many corporations and companies have adopted employee resource groups, or ERGs, into their work cultures to help employees from minority and marginalized backgrounds feel welcome and to provide career support and development. These groups are completely voluntary and employee-led, and unite employees around a common cause or shared life experiences.",ILMN
13,2022-10-08,"Headline: Home - The Fly, source:Thefly.com, summary: The Fly is a leading digital publisher of real-time financial news. The Fly team scours all sources of company news and delivers short-form stories consisting of only market moving content., Headline: Illumina should be bought before stock drives higher, Barron's says, source:Thefly.com, summary: Newly announced gene sequ... ILMN",ILMN
14,2022-10-09,"Headline: Fly Intel: Top five weekend stock stories, source:Thefly.com, summary: Catch up on the weekend&#... TSLA, LMT, ILMN, PARA, MSGS, CFG, FITB, HBAN, MTB, Headline: Big-Cap S&P Stocks Will Soon Provide Tech-Like Returns, I Explain, source:SeekingAlpha, summary: Learn more about an opportunity to acquire well-known big-cap names in the S&P 500 that, at this point, could provide ""tech-like"" returns., Headline: Illumina remains top pick after analyst day at Piper Sandler, source:Thefly.com, summary: Piper Sandler analyst Dav... ILMN",ILMN
15,2022-10-10,"Headline: Buy Illumina Stock. The Biotech Is Lowering the Cost of Gene Sequencing., source:Yahoo, summary: Illumina CEO Francis deSouza told analysts that the company can cut sequencing’s cost without crimping its 60%-plus gross margins.",ILMN
16,2022-10-11,"Headline: Top 5 3rd Quarter Trades of No - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by insider and the topic is about: , Headline: Illumina launches strategic research collaboration with AstraZeneca, source:Thefly.com, summary: Illumina (ILMN) announced... ILMN, AZN, Headline: Illumina price target lowered to $250 from $300 at Argus, source:Thefly.com, summary: Argus analyst Jasper Hell... ILMN, Headline: UC San Diego Students Cross Borders and Explore New Fields in STEM, source:Yahoo, summary: Growing up in Tijuana, Mexico, Olivia Graeve was interested in pursuing the sciences but didn't quite know how to make a career of it. To her knowledge, no cross-border student exchange programs for scientific research were available to her. She was able to attend college and graduate school in the US and eventually joined the University of California San Diego as a professor in the Department of Mechanical and Aerospace Engineering in 2012., Headline: Illumina Inks AI Pact With AstraZeneca To Accelerate Drug Target Discovery, source:Yahoo, summary: Illumina Inc (NASDAQ: ILMN) entered a strategic research collaboration with AstraZeneca plc (NASDAQ: AZN) on drug target discovery. Financial and other details of the partnership were not disclosed. Under the terms of the agreement, the firms will join forces on artificial intelligence-based genome interpretation and genomic analysis and evaluate whether a combined framework can increase the yield of and confidence in target discovery. AstraZeneca's Center for Genomics Research will use the comb, Headline: Illumina collaborates with AstraZeneca on AI-focused research, source:Alliance News, summary: No summary",ILMN
17,2022-10-12,"Headline: Illumina Launches Strategic Research Collaboration With AstraZeneca To Accelerate Drug Target Discovery, source:Yahoo, summary: Illumina Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, announced a strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by combining their strengths in artificial intelligence (AI) based genome interpretation and genomic analysis techniques along with industry expertise., Headline: Illumina Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. dropped 0.45% to $198.27 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",ILMN
18,2022-10-13,"Headline: General Electric Proves Once Again It's A Deep Value Play With Latest Spin-Off News, source:SeekingAlpha, summary: General Electric filed some valuable information regarding the upcoming spinoff of its healthcare operations. See why this presents tremendous upside potential., Headline: GRAIL and Carrum Health Partner to Include Galleri® as Part of Comprehensive Cancer Care Offering to Employers, source:Business Wire, summary: No summary, Headline: ILMN December 2nd Options Begin Trading, source:Stock Options Channel, summary: Staff article entitled ILMN December 2nd Options Begin Trading, about stock options, from Stock Options Channel., Headline: Illumina Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. rose 2.20% to $202.64 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",ILMN
19,2022-10-14,"Headline: In Our DNA: Suzanne Rohrback, Senior Staff Bioinformatics Scientist at Illumina, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / October 14, 2022 / Illumina: As a scientist on Illumina's Assay Research team in San Diego, Suzanne Rohrback works with colleagues to come up with new ways next-generation sequencing (NGS) can maximize insights from ..., Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 1.64% to $199.32 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index..., Headline: Illumina (ILMN) Stock Moves -1.64%: What You Should Know, source:Yahoo, summary: In the latest trading session, Illumina (ILMN) closed at $199.32, marking a -1.64% move from the previous day.",ILMN
20,2022-10-15,"Headline: Guardant: Saving Lives One Blood Test At A Time, source:SeekingAlpha, summary: Guardant Health specializes in cancer diagnoses and genetic analysis. Read why GH stock appears well-positioned to gain some market share.",ILMN
21,2022-10-17,"Headline: Boosting STEM Education in Bangladesh, source:Yahoo, summary: Illumina and the Illumina Corporate Foundation have provided a grant to the Child Health Research Foundation (CHRF), a Bangladeshi nonprofit that promotes public health and STEM education., Headline: Illumina Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. advanced 3.91% to $207.11 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500..., Headline: Illumina to Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN) today announced that it will host its second annual virtual Environment, Social and Corporate Governance (ESG) focused investor event at 9:30 am Pacific Time (12:30 pm Eastern Time), Friday, October 28, 2022., Headline: Ensemble Capital Third Quarter 2022 Investor Letter, source:SeekingAlpha, summary: Ensemble Capital investment strategy began to rebound this quarter vs. S&P 500, declining an estimated 2.6%. Click here to read the full fund letter.",ILMN
22,2022-10-18,"Headline: Illumina enters partnership with GenoScreen  in effort to end tuberculosis, source:Thefly.com, summary: Illumina and GenoScreen a... ILMN, Headline: Illumina and GenoScreen Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics company, today announced a partnership to accelerate progress to end tuberculosis (TB) worldwide. The partnership will expand capabilities for countries most impacted by tuberculosis to more effectively detect and combat multidrug-resistant TB (MDR-TB). This alliance will enable global access to a package combining Illumina sequencing products and the GenoScreen De, Headline: This Growth Stock Rose Last Week. Is It Still a Buy?, source:Yahoo, summary: Shares of Illumina (NASDAQ: ILMN) rose 8% last week and added another 4% on Monday, reaching the stock's highest point since mid-August, on news that the company has developed a speedier gene-sequencing machine.  Illumina stock is still down more than 45% this year and the company has had its share of headaches, but I see it as a great long-term bargain right now.  Shares of Illumina trade for roughly 40 times earnings and have a price-to-sales ratio of 6.6, both of which may seem high, until you consider that the biotech has huge growth potential and has increased revenue by 4,526% over the past 10 years., Headline: Illumina Inc. stock rises Tuesday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.76% higher to $208.68 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P..., Headline: Tracking COVID-19 With Dust at the Ohio State University, source:Yahoo, summary: When COVID-19 hit, most of The Ohio State University-home of the Buckeyes in the state capital of Columbus-shut down.",ILMN
23,2022-10-19,"Headline: Illumina and GenoScreen Partner To Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis, source:Yahoo, summary: Illumina Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics company, announced a partnership to accelerate progress to end tuberculosis (TB) worldwide. The partnership will expand capabilities for countries most impacted by tuberculosis to more effectively detect and combat multidrug-resistant TB (MDR-TB)., Headline: Illumina Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slipped 1.89% to $204.73 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...",ILMN
24,2022-10-20,"Headline: HQH: A Dividend Paymaster That Fails To Register Price Growth, source:SeekingAlpha, summary: Tekla Healthcare Investors is able to generate steady yield and currently trades at a good discount to its NAV. Read more to see why HQH is a Buy., Headline: Australia Begins a Big Push To Sequence Underserved Populations, source:Yahoo, summary: Australia's Centre for Population Genomics (CPG), a collaboration between the Garvan Institute of Medical Research and the Murdoch Children's Research Institute, has launched a new initiative to engage diverse communities in genomic research., Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rallied 1.91% to $208.64 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",ILMN
25,2022-10-21,"Headline: Illumina Is Critically Underva - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by Margaret Moran and the topic is about: A technological breakthrough could turn a multitude of issues from bane to boon for investors, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rose 5.45% to $220.01 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",ILMN
26,2022-10-24,"Headline: Illumina To Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022, source:Yahoo, summary: Illumina, Inc. (NASDAQ:ILMN) announced that it will host its second annual virtual Environment, Social and Corporate Governance (ESG) focused investor event at 9:30 am Pacific Time (12:30 pm Eastern Time), Friday, October 28, 2022., Headline: PacBio's (PACB) Latest Offering to Enhance Genome Sequencing, source:Yahoo, summary: PacBio's (PACB) latest sequencing panels are expected to simplify the study of the difficult-to-sequence or accurately map genomes, thereby aiding researchers., Headline: Illumina (ILMN) Gains But Lags Market: What You Should Know, source:Yahoo, summary: In the latest trading session, Illumina (ILMN) closed at $220.57, marking a +0.25% move from the previous day.",ILMN
27,2022-10-25,"Headline: What's in the Cards for Illumina (ILMN) in Q3 Earnings?, source:Yahoo, summary: The extended lockdown issues in limited geographies, including Greater China, where Illumina (ILMN) has extensive business, are expected to have adversely impacted its top line during the third quarter., Headline: Illumina Inc. stock rises Tuesday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. advanced 4.33% to $230.12 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: Francis deSouza Recognized as 3BL Media's Responsible CEO of the Year for Innovation and ESG Integration, source:Yahoo, summary: Illumina CEO, Francis deSouza received the award for 3BL Media's 2022 Responsible CEO of the Year: Innovation and ESG Integration. 3BL Media presents Responsible CEO of the Year awards to corporate executives who embody leadership in delivering on their environmental, social, and governance (ESG) commitments., Headline: PacBio to launch new gene-sequencing systems, source:Yahoo, summary: Gene-sequencing company Pacific BioSciences of California Inc on Tuesday announced the launch of a new, more affordable, higher-throughput ""long-read"" sequencer as well as customer testing of its first ""short-read"" sequencer aimed at emerging markets such as multi-cancer early detection.  The Menlo, California-based company said its new Revio long-read sequencing system, with a list price of $779,000, offers a 15-fold increase in throughput, enabling customers to sequence up to 1,300 human whole genomes per year for less than $1,000 per genome.  PacBio said its trademark HiFi technology – used for large studies in human genetics, cancer research, agricultural genomics, and more – looks at 20,000 base pairs of DNA at a time.",ILMN
28,2022-10-26,"Headline: Illumina Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. rallied 3.14% to $237.34 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones..., Headline: Pacific Bio Pushes Back at Illumina With New No-Compromise Gene Readers, source:Yahoo, summary: PacBio says its latest technology will halve the cost of sequencing using its products, which could expand its market., Headline: Pacific Biosciences Of California: Leveraging On Scale And Product Development, source:SeekingAlpha, summary: PACB's management believes that it is the only sequencing technology company offering HiFi reads with a 99.9% accuracy. Why is the stock a Hold?",ILMN
29,2022-10-27,"Headline: Can Genomics Stop the World's Leading Cause of Death?, source:Yahoo, summary: For decades, cardiovascular disease has remained the number-one cause of death. In 2019 alone, nearly 18 million people around the world died from cardiovascular diseases (CVDs), which include disorders such as coronary heart disease, heart failure, and cerebrovascular disease., Headline: Illumina (ILMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?, source:Yahoo, summary: Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations., Headline: Illumina Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slipped 0.20% to $236.87 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones..., Headline: Do You Think Illumina (ILMN) is Undervalued?, source:Yahoo, summary: Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2022 investor letter. A copy of the same can be downloaded here. The fund returned -5.47% net in the third quarter compared to -3.60% return for the Russell 1000 Growth Index and -4.88% return for the S&P 500 Index. Inflation and interest rate […]",ILMN
30,2022-10-28,"Headline: Global company events calendar - next 7 days, source:Alliance News, summary: No summary, Headline: Illumina to hold an investor event, source:Thefly.com, summary: President & CEO deSou... ILMN, Headline: Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest, source:Yahoo, summary: It’s true that the troika of Microsoft (NASDAQ:MSFT), Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL), and Meta (NASDAQ:META), much loved by the Street for the decade that ended in mid-2021, reported disappointing third-quarter results. Once viewed as beyond reproach by most, those three stocks are now being shunned and scorned by the “smart money.” But the Street is finally starting to realize, just because much of “Big Tech” is struggling doesn’t mean that there are no good tech stocks to buy. On the con, Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. shed 1.63% to $233.00 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: Empowering the Disability Community at Illumina, source:Yahoo, summary: ""The Spoon Theory,"" a personal story by patient advocate Christine Miserandino, imagines ""spoons"" as a measurement of one's daily energy to illustrate what it's like to ration that energy., Headline: EU renews order for Illumina to keep Grail as separate entity, source:Reuters, summary: EU antitrust regulators on Friday renewed interim measures ordering U.S. life sciences company Illumina to keep Grail as a separate entity pending an order to unwind the takeover completed before the deal had been approved.",ILMN
31,2022-10-30,"Headline: Veracyte: The FDA Is Stepping In, source:SeekingAlpha, summary: Veracyte's products are marketed as LDTs and are not approved by the FDA. Click here to read more to know the reasons why VCYT stock has a Hold rating.",ILMN
32,2022-10-31,"Headline: Tracking Baillie Gifford's 13F Portfolio - Q3 2022 Update, source:SeekingAlpha, summary: Baillie Giffordâs 13F portfolio value decreased from ~$97.51B to ~$96.99B this quarter. Click here to find out the Q3 2022 portfolio update., Headline: Illumina Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slid 1.79% to $228.82 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",ILMN
33,2022-11-01,"Headline: Top 5 3rd Quarter Trades of AL - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by insider and the topic is about: , Headline: Top 5 3rd Quarter Trades of Mc - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by insider and the topic is about: , Headline: Video: Nasdaq 100 Movers: ILMN, IDXX, source:Market News Video, summary: In early trading on Tuesday, shares of Idexx Laboratories, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 10.0% - Year to date, Idexx Laboratories, has lost about 39.9% of its value - ILMN,IDXX,MSFT,JD., Headline: IGB Gene Drive Aims To Broaden Science Accessibility, source:Yahoo, summary: Advances in genomic studies have now permeated all aspects of our lives from agriculture to health and wellness. It is therefore becoming increasingly important to help the community understand these innovations so that they can navigate the increasingly complex realm of genomics. To this end, the outreach team at the Carl R., Headline: Clene Inc. (CLNN) Expected to Beat Earnings Estimates: Should You Buy?, source:Yahoo, summary: Clene Inc. (CLNN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations., Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 4.23% to $219.13 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",ILMN
34,2022-11-02,"Headline: Twist Bioscience and Illumina team on robust exome panel for research, source:Thefly.com, summary: Twist Bioscience (TWST) a... TWST, ILMN, Headline: Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research, source:Business Wire, summary: No summary, Headline: Sicart Associates LLC Buys 2,  - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by insider and the topic is about: , Headline: Global company events calendar - next 7 days, source:Alliance News, summary: No summary, Headline: Why Investors Need to Take Advantage of These 2 Medical Stocks Now, source:Yahoo, summary: Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP., Headline: Should You Buy Illumina (ILMN) Ahead of Earnings?, source:Yahoo, summary: Illumina (ILMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season., Headline: ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS, source:Yahoo, summary: Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing, recently announced the election of three new outside members to its Board of Directors, Bryan Crane, PhD, Arthur Kirsch, and David Vied., Headline: Illumina Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slipped 3.72% to $210.98 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500..., Headline: GLOBAL BRIEFING: BoE to unveil biggest interest rate rise since 1980s, source:Alliance News, summary: No summary, Headline: Illumina reports Q3 adjusted EPS 34c, consensus 30c, source:Thefly.com, summary: Reports Q3 revenue $1.115... ILMN, Headline: Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78, source:Thefly.com, summary: For fiscal 2022, the comp... ILMN",ILMN
35,2022-11-03,"Headline: Notable companies reporting after market close, source:Thefly.com, summary: Notable companies reporti... AMGN, SBUX, PYPL, CTVA, MNST, ILMN, MCHP, SQ, WBD, LYV, DASH, NET, EXPE, COIN, SWKS, BILL, RKT, TWLO, PCTY, DBX, DXC, CVNA, SPCE, Headline: Illumina: Q3 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: Illumina cuts revenue guidance, swings to loss on Grail hit, source:Alliance News, summary: No summary, Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.45% higher to $211.93 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P..., Headline: Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States, source:Yahoo, summary: Illumina, Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, announced a new research test for genitourinary pathogen and antimicrobial resistance (AMR) identification., Headline: Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022, source:Yahoo, summary: Illumina, Inc. (Nasdaq: ILMN) today announced its financial results for the third quarter of fiscal year 2022, which include consolidated financial results for GRAIL., Headline: Illumina Pummeled On Light Earnings Guidance Despite Quarterly Beat, source:Yahoo, summary: Illumina stock crumbled late Thursday after the company offered a lighter-than-expected outlook for full-year earnings., Headline: Illumina (ILMN) Surpasses Q3 Earnings and Revenue Estimates, source:Yahoo, summary: Illumina (ILMN) delivered earnings and revenue surprises of 17.24% and 1.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?, Headline: Illumina, Inc. (ILMN) Q3 2022 Earnings Call Transcript, source:SeekingAlpha, summary: Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Q3 2022 Earnings Conference Call November 3, 2022 17:00 ET Company Participants Salli Schwartz - Vice President of Investor Relations Francis deSouza -...",ILMN
36,2022-11-04,"Headline: Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), Illumina (ILMN) and Regeneron (REGN), source:TipRanks, summary: Analysts have been eager to weigh in on the Healthcare sector with new ratings on Avadel Pharmaceuticals (<span class='tr-stock-ticker' style='color:blue; font-weig..., Headline: Illumina's Q3 Profits Hit By Impairment Of Almost $4B, Cuts Annual Guidance, source:Yahoo, summary: Illumina Inc (NASDAQ: ILMN) posted Q2 revenue of $1.12 billion, up 1% Y/Y and up 3% on a constant currency basis, almost in line with the consensus. Non-GAAP diluted earnings per share of $0.34 compared to $1.45 a year ago, beating the consensus of $0.30. ""Our second quarter results did not meet our expectations as challenges in a complex macroeconomic environment more than offset the growth we continue to see in sequencing runs on our platforms,"" said Francis deSouza, CEO. During the quarter, G, Headline: Illumina (ILMN) Q3 Earnings Beat Estimates, '22 View Slashed, source:Yahoo, summary: Delays in instruments and consumables purchases, negative foreign exchange impact and consumables inventory deleveraging are expected to impede growth in the rest of 2022 for Illumina (ILMN)., Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rallied 5.87% to $224.36 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: Illumina Reverses Pitfall After Light Earnings Guidance On Quarterly Beat, source:Yahoo, summary: Illumina stock surged Friday, reversing an after-hours decline Thursday, after the biggest genomics company issued a light earnings guide.",ILMN
37,2022-11-05,"Headline: POLEN CAPITAL MANAGEMENT LLC B - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by insider and the topic is about: ",ILMN
38,2022-11-06,"Headline: SVB Securities Remains a Buy on Illumina (ILMN), source:TipRanks, summary: In a report released on November 4, Puneet Souda from SVB Securities reiterated a Buy rating on Illumina (ILMN &#8211; Research Report), with a price target of $270...",ILMN
39,2022-11-07,"Headline: Rarebase Is on the Hunt for Therapeutic Opportunities, source:Yahoo, summary: San Francisco Bay Area residents Jainu and Shruti Jogani had their newborn daughter, Reyna, at home for nearly three weeks when they noticed her exhibiting seizure-like symptoms-episodes so quick they weren't able to capture them on video. Standard blood work, MRI scans, and EKGs all came back normal, except for a gene panel for epilepsy., Headline: Illumina Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 3.20% to $217.19 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",ILMN
40,2022-11-08,"Headline: RNA Sequencing Critical to Identifying Key Fusions for Oncology Patients, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Illumina: At the Phoenix Convention Center in Arizona, representatives from Illumina, a global leader in DNA sequencing and array-based technologies, joined approximately 2000 molecular diagnostic ..., Headline: Illumina Inc. stock rises Tuesday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.39% higher to $218.04 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the..., Headline: New Virtual Lab for Students Opens Access to Next-Generation Sequencing, source:Yahoo, summary: While visiting her grandparents in Florida, 17-year-old Kate frequented a pond near their house and spent time observing the various species of fish living there.",ILMN
41,2022-11-09,"Headline: Illumina Third Quarter 2022 Earnings: EPS Misses Expectations, source:Yahoo, summary: Illumina ( NASDAQ:ILMN ) Third Quarter 2022 Results Key Financial Results Revenue: US$1.12b (flat on 3Q 2021). Net..., Headline: Illumina Inc. stock falls Wednesday, still outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. shed 1.00% to $215.85 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",ILMN
42,2022-11-10,"Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. jumped 11.23% to $240.09 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...",ILMN
43,2022-11-11,"Headline: Twist Bioscience: Cash Burn Continues To Be The Issue, source:SeekingAlpha, summary: TWST is delivering stellar sales growth. It continues to have significant cash burn issues despite a rock solid balance sheet. Read more on TWST stock here., Headline: Illumina Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. advanced 1.10% to $242.74 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",ILMN
44,2022-11-13,"Headline: Illumina price target lowered to $300 from $320 at Piper Sandler, source:Thefly.com, summary: Piper Sandler analyst Dav... ILMN",ILMN
45,2022-11-14,"Headline: Illumina participates in a conference call with JPMorgan, source:Thefly.com, summary: Life Science Tools Analys... ILMN, Headline: Greenwood Genetic Center: Answering the Unanswered, source:Yahoo, summary: Before next-generation sequencing (NGS) came along, children and families with rare and undiagnosed genetic diseases often faced years-long diagnostic odysseys., Headline: Illumina Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. shed 3.37% to $234.57 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index..., Headline: Shares of Illumina Have Been Bottoming, source:Yahoo, summary: Illumina  is a developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function.  The shares are down sharply from its 2021 zenith but the charts have improved in recent months., Headline: Illumina cuts 5% of its workforce , source:Reuters, summary: Illumina Inc said on Monday it was cutting 5% of its global workforce to realign its operating expenses amid macro-economic challenges. (Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva), Headline: UPDATE 1-Illumina cuts 5% of its workforce, source:Yahoo, summary: Illumina Inc said on Monday it was cutting 5% of its global workforce to realign its operating expenses as stubborn inflation and a strong dollar weigh on the genetic sequencing equipment maker's business.  The company, which is in the process of launching its next-generation NovaSeq X DNA sequencing systems, has over 9,100 employees globally, according to its website., Headline: Illumina cuts 5% of its workforce, source:Reuters, summary: Illumina Inc said on Monday it was cutting 5% of its global workforce to realign its operating expenses as stubborn inflation and a strong dollar weigh on the genetic sequencing equipment maker's business., Headline: IN BRIEF: Illumina anticipates restructuring charge in fourth quarter, source:Alliance News, summary: No summary, Headline: Alyeska Investment Group, L.P. - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by insider and the topic is about: ",ILMN
46,2022-11-15,"Headline: Mettler-Toledo International: Recent Performance Doesn't Change My Stance, source:SeekingAlpha, summary: Mettler-Toledo has done really well for itself lately, with sales, profits, and cash flows coming in strong. Read why I still am rating MTD stock a hold., Headline: Illumina Slashes 5% Of Its Workforce, source:Yahoo, summary: Illumina Inc (NASDAQ: ILMN) is cutting 5% of its global workforce to realign its operating expenses to reflect the current macroeconomic environment. The company expects to take a restructuring charge, including expenses associated with optimizing facilities, in the fourth quarter of 2022 This charge will be excluded from non-GAAP financial metrics, the company said in its SEC filing. Illumina posted Q2 revenue of $1.12 billion, up 1% Y/Y and up 3% on a constant currency basis, almost in line wi, Headline: Illumina To Webcast Upcoming Investor Conferences, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences:",ILMN
47,2022-11-17,"Headline: Illumina Supports Next Generation Scientists at Genspace, source:Yahoo, summary: Access to cutting edge genomics technology is expanding beyond the walls of industry and the conventional classroom. Illumina and The Illumina Corporate Foundation have granted Genspace in-kind product donations and a cash grant totalling over $100,000 to build capacity for authentic genomics research and project-based learning for New York City youth., Headline: Alphabet Inc (GOOGL) Investment Portfolio: Top 15 Companies, source:Yahoo, summary: In this article, we discuss the top 15 companies in Alphabet Inc (GOOGL)’s investment portfolio. If you want to see more names in this portfolio, check out Alphabet Inc (GOOGL) Investment Portfolio: Top 5 Companies. GV, previously named Google Ventures, is the venture capital investment arm of Alphabet Inc. (NASDAQ:GOOG), which was founded in 2009 […], Headline: GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection, source:Yahoo, summary: MENLO PARK, Calif., November 17, 2022--GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced findings from a fundamental substudy of the Circulating Cell-free Genome Atlas (CCGA; NCT02889978) study, demonstrating that methylation had the most promising combination of cancer detection and prediction of cancer signal origin when compared with other evaluated approaches. This is the first rigorous and systematic comparison of various genomic",ILMN
48,2022-11-18,"Headline: Q&A With the CTO: Storing Growing Data While Reducing Environmental Impact, source:Yahoo, summary: As the UN Climate Change Conference (COP27) convenes this month in Sharm el-Sheikh, Egypt, Sharon Vidal, global head of Corporate Social Responsibility at Illumina, talks to the company's chief technology officer, Alex Aravanis, about achieving a sustainable future with intelligent data storage solutions that reduce Illumina's environmental footprint.",ILMN
49,2022-11-21,"Headline: Addressing the Shortage of Genetic Counselors With Software, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / November 21, 2022 / Illumina: Nearly everyone is a carrier for some kind of genetic disorder.1 (Probably even you.) Being a carrier means you inherited an abnormal copy of a gene from one parent, but you show no symptoms ..., Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. advanced 1.75% to $224.42 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...",ILMN
50,2022-11-22,"Headline: Illumina Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. shed 1.00% to $222.17 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",ILMN
51,2022-11-23,"Headline: Illumina Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slipped 0.04% to $222.08 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...",ILMN
52,2022-11-25,"Headline: 10 Best Biotech Stocks To Buy According To Hedge Funds, source:Yahoo, summary: In this article, we discuss 10 best biotech stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Best Biotech Stocks To Buy According To Hedge Funds. In 2023, digitalization will increase in the biotech industry as the possibility of online and remote assessment, diagnosis, […]",ILMN
53,2022-11-28,"Headline: Illumina Inc. stock falls Monday, still outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slipped 0.95% to $216.91 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",ILMN
54,2022-11-29,"Headline: Illumina, Inc. (ILMN) Presents at Evercore ISI HealthCONx Conference (Transcript), source:SeekingAlpha, summary: Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Evercore ISI HealthCONx Conference November 29, 2022 11:20 AM ET Company Participants Dr., Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 3.84% to $208.57 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones..., Headline: Video: Increasing Genomic Capability in the United Arab Emirates, source:Yahoo, summary: Emirati scientists, clinicians, and dignitaries attended the opening of the Illumina Solutions Center in Dubai on November 8.",ILMN
55,2022-11-30,"Headline: Illumina, Inc. (ILMN) Presents at Piper Sandler 34th Annual Healthcare Conference (Transcript), source:SeekingAlpha, summary: Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Piper Sandler 34th Annual Healthcare Conference November 30, 2022 09:00 AM ET Company Participants Francis deSouza - President &amp; Chief Executive...",ILMN
56,2022-12-01,"Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rose 1.27% to $220.86 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500..., Headline: RingCentral and Illumina are cutting dozens of Bay Area jobs, source:Yahoo, summary: The business communications company and the biotechnology business said they are responding to ""challenging"" economic conditions.",ILMN
57,2022-12-02,"Headline: Tech layoffs send visa holders on frantic search for employment to avoid deportation, source:CNBC, summary: The spike in tech layoffs is creating a particularly stressful holiday season for employees on work visa programs who have a short window to find a new job., Headline: BBH: Portfolio Of Large-Cap Biotechnology Stocks Has Delivered Strong Returns, source:SeekingAlpha, summary: BBH has an asset base of $520 million, posted strong growth over the past 6 months, and is trading much higher than its pre-pandemic price range. Click here to learn more., Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 0.95% to $218.76 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",ILMN
58,2022-12-04,"Headline: Tracking Al Gore`s Generation Investment Management Portfolio - Q3 2022 Update, source:Seeking Alpha, summary: No summary, Headline: Tracking Al Gore's Generation Investment Management Portfolio - Q3 2022 Update, source:SeekingAlpha, summary: Al Gore's 13F portfolio value decreased from $18.35B to $16.86B this quarter. Find out Generation Investment Management's holdings and trades for Q2 2022.",ILMN
59,2022-12-05,"Headline: European Commission says Illumina has to unwind Grail acquisition, source:Thefly.com, summary: No summary, Headline: European Commission Informs Illumina of Restorative Measures Over Grail Acquisition, source:MarketWatch, summary: By Kim Mackrael BRUSSELS--The European Union on Monday set out the details of an order requiring Illumina Inc. to unwind its $7.1 billion acquisition of..., Headline: EC divesture statement `notably positive` for Illumina, says Piper, source:Thefly.com, summary: No summary, Headline: Illumina gets EU antitrust charge sheet to unwind Grail acquisition swiftly, source:Yahoo, summary: EU antitrust regulators on Monday sent a charge sheet to U.S. life sciences company Illumina outlining proposed measures to unwind its acquisition of Grail, three months after they blocked the deal on concerns that it would hurt competition.  Illumina completed the deal in August last year without first waiting for EU regulatory approval.  The European Commission in its September decision said the company failed to offer adequate remedies to allay its worries., Headline: UPDATE 1-EU charge sheet tells Illumina to swiftly unwind Grail deal, source:Yahoo, summary: EU antitrust regulators on Monday proposed measures for U.S. life sciences company Illumina to unwind its acquisition of biotech firm Grail , three months after blocking the deal on concerns that it would hurt competition.  Illumina completed the takeover of Grail in August 2021, without securing European Union regulatory approval.  The European Commission said in a September veto decision that the company failed to offer adequate remedies to allay its worries and opened a separate case to force Illumina to unravel the deal., Headline: EU charge sheet tells Illumina to swiftly unwind Grail deal, source:Reuters, summary: EU antitrust regulators on Monday proposed measures for U.S. life sciences company Illumina to unwind its acquisition of biotech firm Grail, three months after blocking the deal on concerns that it would hurt competition., Headline: Illumina Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 2.24% to $213.86 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index..., Headline: EU Tells Illumina How to Unwind Deal to Buy Cancer-Test Developer Grail, source:Yahoo, summary: The European Commission said Illumina will have to restore Grail’s independence and return it to the same level that existed before the acquisition., Headline: General Electric: Latest Developments Underscore Tremendous Upside Potential, source:SeekingAlpha, summary: General Electric's management team has made some interesting moves regarding its impending spinoff of its healthcare operations. Read why I rate GE stock a Buy., Headline: Illumina initiated with an Outperform at RBC Capital, source:Thefly.com, summary: No summary, Headline: Illumina Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: No summary",ILMN
60,2022-12-06,"Headline: Illumina divestment for GRAIL buy worth the wait, says Canaccord, source:Thefly.com, summary: No summary, Headline: SVB Securities Sticks to Their Buy Rating for Illumina (ILMN), source:TipRanks, summary: No summary, Headline: European regulator leans on Illumina to break off Grail, its $8 billion early cancer detection company, source:Yahoo, summary: The European Commission amped up its calls for Illumina Inc. to unwind early cancer detection company Grail Inc., which the giant life sciences tools maker bought with antitrust regulators' approval more than a year ago for a potential $8 billion.  It is the latest salvo in a long battle between San Diego-based Illumina (NASDAQ: ILMN), which has major operations in Foster City, and regulators on both sides of the Atlantic.  Grail and Illumina can formally respond to the EC's ""statement of objections,"" but the commission could make the ""transitional measures"" binding early next year.",ILMN
61,2022-12-07,"Headline: GLOBAL BROKER RATINGS: UBS cuts Kering; RBC likes Thermo Fisher, source:Alliance News, summary: No summary, Headline: Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations, source:Thefly.com, summary: No summary, Headline: Let's Shine Another Light on Dimming Illumina, source:Yahoo, summary: The stock of the provider of genetic analysis products is pulling back more than expected, so here's what may be next.",ILMN
62,2022-12-08,"Headline: January 2023 Options Now Available For Illumina (ILMN), source:Stock Options Channel, summary: No summary, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.91% higher to $210.42 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the..., Headline: The Next Frontier in Carbon Capture Is a Hungry Bacterium, source:Yahoo, summary: Emissions from industrial plants worldwide have been driving global warming for decades. Waste and gases from facilities like steel mills are rich in carbon and constitute about 21% of humanity's carbon footprint.",ILMN
63,2022-12-09,"Headline: Bionano Genomics: Still Waiting For Genome Mapping Market To Reveal Itself, source:SeekingAlpha, summary: Bionano Genomics is an engaging company operating in the genome mapping space. Check out what makes BNGO a lukewarm buy opportunity at best for the time being., Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 2.28% to $205.62 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500..., Headline: Illumina: Strong EPS Growth Expected, But Shares Richly Valued In A Risky Space, source:SeekingAlpha, summary: For Illumina investors, with an impairment charge in the rearview mirror, all eyes are on a future earnings rebound. Read what's expected for ILMN's earnings.",ILMN
64,2022-12-12,"Headline: Illumina downgraded to Sell from Neutral at Citi, source:Thefly.com, summary: No summary, Headline: Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations, source:Thefly.com, summary: No summary, Headline: Illumina Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. advanced 1.41% to $208.52 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",ILMN
65,2022-12-13,"Headline: Illumina Inc. stock rises Tuesday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. rose 1.07% to $210.76 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index..., Headline: Illumina defends $7.1 bln Grail buy to fend off antitrust regulators, source:Yahoo, summary: U.S. life sciences company Illumina Inc on Tuesday defended its $7.1 billion acquisition of biotech firm Grail Inc , pledging to keep selling its DNA sequencing services to other firms, as it seeks to head off a potential vote by U.S. antitrust regulators to kill the deal.  The Federal Trade Commission, which enforces antitrust law, filed a complaint in March 2021 to stop Illumina's bid for its former subsidiary Grail.  The agency cited concerns that Illumina, the dominant provider of DNA sequencing for multi-cancer early detection tests, might raise prices or refuse to keep selling to rivals of Grail, which is seeking to market a powerful test to diagnose many kinds of cancer from a single blood test., Headline: Illumina defends $7.1 billion Grail buy to fend off antitrust regulators, source:Yahoo, summary: U.S. life sciences company Illumina Inc on Tuesday defended its $7.1 billion acquisition of biotech firm Grail Inc , pledging to keep selling its DNA sequencing services to other firms, as it seeks to head off a potential vote by U.S. antitrust regulators to kill the deal.  The Federal Trade Commission, which enforces antitrust law, filed a complaint in March 2021 to stop Illumina's bid for its former subsidiary Grail.  The agency cited concerns that Illumina, the dominant provider of DNA sequencing for multi-cancer early detection tests, might raise prices or refuse to keep selling to rivals of Grail, which is seeking to market a powerful test to diagnose many kinds of cancer from a single blood test.",ILMN
66,2022-12-14,"Headline: Is Illumina Cheap or Expensive?, source:Yahoo, summary: Investors use a lot of different multiples to figure out if a stock is cheap or expensive. Sometimes that can just create confusion. Take Illumina (NASDAQ: ILMN), for example. The stock is down 60% from its peak to just above $200 per share -- a level it first reached in early 2018., Headline: Illumina Ranks Among Top Scores on Dow Jones Sustainability Index and CDP, source:Yahoo, summary: Illumina, Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, today announced its achievement of the highest score out of 72 companies in its industry in the S&P Global Corporate Sustainability Assessment, also known as the Dow Jones Sustainability Index (DJSI)., Headline: Invitae Likely Hasn`t Reached The Bottom Yet, source:Seeking Alpha, summary: No summary",ILMN
67,2022-12-15,"Headline: Point32Health and GRAIL Expand Galleri® Multi-Cancer Early Detection Blood Test Pilot to Harvard Pilgrim Health Care Members on the Maine Health Insurance Marketplace, source:Business Wire, summary: No summary, Headline: SVB Securities Sticks to Its Buy Rating for Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Invitae Likely Hasn't Reached The Bottom Yet, source:SeekingAlpha, summary: Invitaeâs restructuring plan is riddled with uncertainty and carries serious risks. See why I believe NVTA stock has yet to reach the bottom., Headline: Illumina Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slipped 1.20% to $207.46 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500..., Headline: Guardant Claimed Success for Its Colon Cancer Blood Test. The Stock Slumped., source:MarketWatch, summary: “We just launched a rocket and got it to the moon,” said co-CEO Helmy Eltoukhy. “It's illogical, irrational, and people don't understand the science.”",ILMN
68,2022-12-16,"Headline: Guardant Health Drops 30% as Cancer Test Disappoints, source:GuruFocus, summary: No summary, Headline: FOCUS-Cancer researchers question antitrust arguments against Illumina-Grail deal, source:Yahoo, summary: U.S. and European antitrust enforcers want to unwind gene sequencing leader Illumina Inc's purchase of cancer test company Grail, saying the two would stifle competition in a critical area of medicine, but some cancer researchers say it's far too early to make that assessment.  Illumina is the leading maker of high-speed genomic sequencing systems that can examine fragments of DNA found in blood or other samples for use in everything from solving crimes to drug research.  Antitrust regulators argue that Illumina, whose sequencers are being used by companies, hospitals and research centers, could unfairly prioritize Grail in the race to create tests for the early detection of multiple types of cancer., Headline: RPT-FOCUS-Cancer researchers question antitrust arguments against Illumina-Grail deal, source:Yahoo, summary: U.S. and European antitrust enforcers want to unwind gene sequencing leader Illumina Inc's purchase of cancer test company Grail, saying the two would stifle competition in a critical area of medicine, but some cancer researchers say it's far too early to make that assessment.  Illumina is the leading maker of high-speed genomic sequencing systems that can examine fragments of DNA found in blood or other samples for use in everything from solving crimes to drug research.  Antitrust regulators argue that Illumina, whose sequencers are being used by companies, hospitals and research centers, could unfairly prioritize Grail in the race to create tests for the early detection of multiple types of cancer., Headline: Cancer researchers question antitrust arguments against Illumina-Grail deal, source:Reuters, summary: U.S. and European antitrust enforcers want to unwind gene sequencing leader Illumina Inc's purchase of cancer test company Grail, saying the two would stifle competition in a critical area of medicine, but some cancer researchers say it's far too early to make that assessment..., Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. shed 3.82% to $199.54 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",ILMN
69,2022-12-17,"Headline: Buy/Sell: Wall Street`s top 10 stock calls this week, source:Thefly.com, summary: No summary",ILMN
70,2022-12-18,"Headline: IBBQ: Healthcare Dashboard For December, source:SeekingAlpha, summary: The pharmaceuticals/biotechnology subsector has good value and quality scores. Click here to read more about IBBQ ETF., Headline: mRNA-based cancer vaccines have limits, pioneer of the technology says, source:Seeking Alpha, summary: No summary",ILMN
71,2022-12-19,"Headline: Interesting ILMN Put And Call Options For February 2023, source:Stock Options Channel, summary: No summary, Headline: Illumina Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 3.98% to $191.59 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: Illumina To Webcast Upcoming Investor Conference, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:",ILMN
72,2022-12-20,"Headline: Illumina view upgraded to Positive from Mixed at OTR Global, source:Thefly.com, summary: No summary, Headline: Illumina Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slid 0.07% to $191.46 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL) and Illumina (ILMN), source:TipRanks, summary: No summary",ILMN
73,2022-12-21,"Headline: Nurturing the Next Generation of Life Sciences and Genomic Experts, source:Yahoo, summary: When Gloucester Marine Genomics Institute (GMGI) was founded in 2013, it already had an Illumina connection-it was created with help from Illumina co-founder David Walt., Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. advanced 3.13% to $197.46 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...",ILMN
74,2022-12-22,"Headline: ILMN February 2023 Options Begin Trading, source:Stock Options Channel, summary: No summary, Headline: Illumina Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. sank 0.85% to $195.78 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",ILMN
75,2022-12-23,"Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 2.32% to $191.24 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",ILMN
76,2022-12-27,"Headline: 12 Blue Chip Stocks to Buy That Are Down Over 30% YTD, source:Yahoo, summary: In this article, we take a look at 12 blue chip stocks to buy that are down over 30% YTD. If you want to see more blue chip stocks to buy that are down over 30% YTD, go directly to 5 Blue Chip Stocks to Buy That Are Down Over 30% YTD. Many stocks are […], Headline: Illumina Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. shed 1.29% to $188.77 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones..., Headline: Wednesday Sector Leaders: Healthcare, Financial, source:Market News Video, summary: No summary",ILMN
77,2022-12-28,"Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rallied 1.08% to $190.81 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...",ILMN
78,2022-12-29,"Headline: Illumina Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. rallied 5.68% to $201.64 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...",ILMN
79,2022-12-30,"Headline: Are Options Traders Betting on a Big Move in Illumina (ILMN) Stock?, source:Yahoo, summary: Investors need to pay close attention to Illumina (ILMN) stock based on the movements in the options market lately., Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.28% higher to $202.20 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...",ILMN
80,2023-01-03,"Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. sank 0.66% to $200.87 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index..., Headline: Illumina initiated with a Sector Perform at Scotiabank, source:Thefly.com, summary: No summary",ILMN
81,2023-01-04,"Headline: Illumina: A Growth Stock in Waiting, source:Yahoo, summary: Undervalued and in limbo because of an acquisition, the genome sequencing company offers strong fundamentals at a low price, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.87% higher to $202.61 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P..., Headline: GE And GE HealthCare Technologies: Separation Paves Way For Tremendous Value Creation, source:SeekingAlpha, summary: GE successfully spun off GE HealthCare, resulting in two publicly-traded companies. Read why this move is a positive for shareholders in both GE and GEHC., Headline: Illumina Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: No summary",ILMN
82,2023-01-05,"Headline: Illumina initiated with Sector Perform on Grail uncertainty Scotiabank, source:Thefly.com, summary: No summary, Headline: Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations, source:Thefly.com, summary: No summary, Headline: Top 5 4th Quarter Trades of Norman Fields, Gottscho Capital Management, LLC, source:GuruFocus, summary: No summary, Headline: This Long-Term Investor Is Sticking With Tesla and Cloud Stocks. Here’s Why. , source:MarketWatch, summary: Dave Bujnowski, a portfolio manager for a century-old Scottish investment firm, says the key to stock market success is to patiently bet on companies..., Headline: ILMN, CARA and ADMA are among after hour movers, source:Seeking Alpha, summary: No summary",ILMN
83,2023-01-06,"Headline: Video: Nasdaq 100 Movers: ILMN, COST, source:Market News Video, summary: No summary, Headline: Is Illumina, Inc. (NASDAQ:ILMN) Trading At A 25% Discount?, source:Yahoo, summary: In this article we are going to estimate the intrinsic value of Illumina, Inc. ( NASDAQ:ILMN ) by estimating the..., Headline: Does Your Dog Have Nine Lives, Too? This DNA Test Can Tell You, source:Yahoo, summary: Originally published on Illumina News Center, Headline: Healthcare Stocks Sell Off Friday, source:Yahoo, summary: Most sectors are rallying on Friday, but healthcare is a glaring exception. Health stocks dominate the list of biggest laggards in the S 500. Baxter International shares fell 6% after the hospital products supplier announced it plans to spin off its kidney-care business. Lab equipment maker Thermo Fisher Scientific was down about 5%, on pace for its worst day since 2020. Waters Corp. and Danaher were down 8% and 3%, respectively., Headline: Twist And Short, source:SeekingAlpha, summary: Twist operates in a trendy space, with good growth, but profits are not in the companyâs DNA, so losses are likely to continue. Find out why I'm shorting TWST stock., Headline: Illumina Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.36% higher to $201.87 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P..., Headline: Jim Cramer says these 5 Nasdaq losers could rebound in 2023, source:CNBC, summary: Cramer offered investors a list of Nasdaq stocks he believes could make a comeback this year.",ILMN
84,2023-01-09,"Headline: Illumina Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. advanced 2.69% to $207.31 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500..., Headline: Illumina and Nashville Biosciences Announce Sequencing Agreement With Amgen, source:Yahoo, summary: Illumina Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, and Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.",ILMN
85,2023-01-10,"Headline: S&P 500 Futures Drop in Premarket Trading; Oak Street Health, Corteva Lead, source:MarketWatch, summary: With U.S. stock markets set to open in two hours, (OSH) was up 35.1% in pre-market trading, and (CTVA) was up 3.0%. (GXO), (ROK), and (EIX) were all posting..., Headline: Stocks making the biggest moves midday: Bed Bath & Beyond, Coinbase, Virgin Orbit and more, source:CNBC, summary: These are the stocks posting the largest moves midday., Headline: UPDATE 1-Illumina challenges EU order to keep Grail separate, source:Yahoo, summary: U.S. life sciences company Illumina on Tuesday challenged an EU antitrust order to keep biotech firm Grail separate, ratcheting up its fight against EU regulators which blocked a merger deal last year.  Following its veto, the European Union competition enforcer renewed an interim measure last October requiring Illumina to keep Grail as a separate entity so the company can unwind a takeover it had completed without waiting for the deal to get EU approval.  ""Today, we appealed the European Commission's interim measures order to hold separate Illumina and Grail,"" Illumina said in a statement., Headline: Illumina Slumps as 2023 Profit Outlook Disappoints Street, source:Yahoo, summary: (Bloomberg) -- Illumina Inc. shares tumbled after the gene-sequencing equipment maker said 2023 profit will be lower than analysts expected.Most Read from BloombergUS Safety Agency to Consider Ban on Gas Stoves Amid Health FearsRental Housing Is Suddenly Headed Toward a Hard LandingBrady, Gisele, Patriots’ Bob Kraft Among FTX Shareholders Facing WipeoutMicrosoft Considers $10 Billion Investment in ChatGPT CreatorStocks Bounce Back With Brewing Optimism Over CPI: Markets WrapThe company expects t, Headline: Illumina’s stock falls 10% on ‘more cautious outlook’ for 2023, source:Yahoo, summary: Shares of Illumina Inc.  (ILMN)  tumbled about 10% in premarket trading on Tuesday, the day after the company said it expects lower-than-expected earnings per share of of $1.25 to $1.50 in 2023.  Illumina also said it expects revenue growth of 7% to 10% this year., Headline: Biotech's Illumina stock tumbles on weaker-than-expected profit outlook, source:Yahoo, summary: Yahoo Finance Live anchors discuss the decline in stock for Illumina after the company issued weaker-than-expected guidance for 2023., Headline: Oak Street Health Jumps, CVS Slips After News of Deal Talks, source:Yahoo, summary: Health stocks are making big moves in both directions. January is typically a busy month for the sector, as firms contemplate large acquisitions and [share their business outlooks](https://www.wsj.com/livecoverage/stock-market-news-today-01-09-2023/card/inflation-banks-biotech-what-s-on-tap-for-this-week-SwgbGitBuQOyISoLL9Mx) with Wall Street. Shares of Oak Street Health, which runs primary care facilities for Medicare patients, were up 27% Tuesday after Bloomberg News reported that CVS Health i, Headline: Illumina (ILMN), Nashville Biosciences Partner With Amgen, source:Yahoo, summary: Illumina (ILMN) is currently keeping well with its goals to strengthen its foothold in the multi-billion gene sequencing market globally., Headline: Illumina challenges EU order to keep Grail separate, source:Reuters, summary: U.S. life sciences company Illumina on Tuesday challenged an EU antitrust order to keep biotech firm Grail separate, ratcheting up its fight against EU regulators which blocked a merger deal last year., Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 6.20% to $194.45 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: Why Illumina Has Grown Cautious and What It Means for the Gene-Sequencing Stock, source:Yahoo, summary: The gene-sequencing company grew sensationally during the pandemic, but sales moderated in the second half of 2022. Now it expects a further slowdown., Headline: Illumina's Disappointing 2023 Guidance Sends Shares Lower, source:Yahoo, summary: Illumina  provides ""sequencing and array-based solutions for genetic and genomic analysis.""  In this daily bar chart of ILMN, below, I can see that prices suffered a big decline in early 2022 followed by a sideways trend from June.  ILMN made a recovery rally into August but the On-Balance-Volume (OBV) line declined throughout the advance telling me that sellers were more aggressive than buyers and the rally was likely to fail., Headline: Illumina to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023, source:Yahoo, summary: Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the fourth quarter and full year 2022 following the close of market on Tuesday, February 7, 2023., Headline: Illumina's Woes Mount As Guidance Lags And Grail Controversy Continues, source:Yahoo, summary: Illumina stock plunged to its lowest point in three months Tuesday after the gene-sequencing giant issued a disappointing outlook for 2023.",ILMN
86,2023-01-11,"Headline: 5 big earnings reports: Bed Bath & Beyond, Illumina, source:Yahoo, summary: In case you missed it, here are yesterday's 5 biggest earnings announcements.  Q3 EPS came in at ($3.65), significantly worse than the consensus estimate of ($2.38).  Revenue fell 33% year-over-year to $1.26 billion, missing the consensus estimate of $1.33 billion., Headline: Illumina to face EU fine of 10% of turnover due to Grail deal, Reuter says, source:Thefly.com, summary: No summary, Headline: Illumina Selected as One of America's Most JUST Companies, source:Yahoo, summary: Illumina has been named one of America's Most JUST Companies by JUST Capital and CNBC, for the fourth consecutive year., Headline: Illumina expects revenue to grow by up to 10% in 2023, source:Alliance News, summary: No summary, Headline: Illumina Remains A Sell After 2023 Guidance, source:SeekingAlpha, summary: Illumina fell 6.2% on Tuesday, January 10 after lowering guidance. Growth in Q3 2022 was only 1% y/y. Find out what investors need to know about ILMN stock., Headline: NEW YORK MARKET CLOSE: Stocks higher with focus on US inflation data, source:Alliance News, summary: No summary, Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rallied 4.94% to $204.05 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P..., Headline: Exclusive-Illumina to face EU fine of 10% of turnover over Grail deal -sources, source:Reuters, summary: U.S. life sciences company Illumina is likely to face a fine of 10% of its global annual turnover, the maximum penalty, for closing its takeover of Grail without waiting for EU antitrust approval, people familiar with the matter said., Headline: Thursday Sector Laggards: Healthcare, Utilities, source:Market News Video, summary: No summary",ILMN
87,2023-01-12,"Headline: IBB: A History Of Outperformance During Recessions, source:SeekingAlpha, summary: iShares Biotechnology has outperformed the S&P 500 during all 3 recessions in the U.S. since inception in early 2001. See why I'm bullish about IBB ETF now., Headline: Illumina Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 5.05% to $193.75 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P..., Headline: Friday Sector Leaders: Healthcare, Services, source:Market News Video, summary: No summary",ILMN
88,2023-01-13,"Headline: Illumina Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. rose 3.80% to $201.11 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: Ensemble Capital 2022 Annual Investor Letter, source:SeekingAlpha, summary: Ensemble Capital recently published its annual letter. Who were the detractors and contributors to total return? Click here to find out.",ILMN
89,2023-01-16,"Headline: Should You Hold Illumina (ILMN)?, source:Yahoo, summary: Ensemble Capital Management, an investment management company, released its 2022 annual investor letter. A copy of the same can be downloaded here. For the fiscal year ended October 31, 2022, the fund returned -29.33% compared to a total return of -14.61% for the benchmark S&P 500 Index for the same period. In addition, please check the […]",ILMN
90,2023-01-17,"Headline: Illumina price target lowered to $300 from $330 at Canaccord, source:Thefly.com, summary: No summary, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. advanced 2.65% to $206.44 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500..., Headline: Illumina Inc. stock falls Wednesday, still outperforms market, source:MarketWatch, summary: No summary",ILMN
91,2023-01-18,"Headline: NIH outlays fall, US govt healthcare grants grow but Biopharma financings decline Y/Y, source:Seeking Alpha, summary: No summary, Headline: Analysts Are Cutting Price Targets of These 10 Stocks, source:Yahoo, summary: In this article, we will discuss the 10 stocks whose price targets were recently trimmed by analysts. If you want to see more such stocks on the list, go directly to Analysts Are Cutting Price Targets of These 10 Stocks. U.S. stocks inched higher on Wednesday morning after the latest wholesale prices data indicated a […], Headline: Bruker Corp.: My Top Ranked Holding In Laboratory Analytical Instruments, source:SeekingAlpha, summary: Bruker offers a range of advantages over peers: profitability, value, growth, and more. See why I'm bullish on BRKR stock at the current valuation., Headline: Illumina Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: No summary",ILMN
92,2023-01-19,"Headline: Illumina CEO: Genomics in children's hospitals will be the biggest part of the market, source:CNBC, summary: Francis Desouza, Illumina CEO and Disney board member, joins 'Squawk Box' to discuss the future of gene sequencing and what Illumina is doing, the promise behind Illumina's GRAIL and more., Headline: Top 5 4th Quarter Trades of Amazon com Inc, source:GuruFocus, summary: No summary, Headline: These 4 Toxic Stocks May Bring Bad Luck to Your Portfolio, source:Yahoo, summary: Consider dumping toxic stocks like BALY, OMCL, ILMN and AY from your portfolio to avoid huge losses.",ILMN
93,2023-01-20,"Headline: Illumina (ILMN) Presents At 41st Annual Healthcare Conference - Slideshow, source:SeekingAlpha, summary: The following slide deck was published by Illumina, Inc., Headline: Sequencing the Sustainable Secrets of Seaweed, source:Yahoo, summary: Originally published on Illumina News Center",ILMN
94,2023-01-22,"Headline: Illumina Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: No summary",ILMN
95,2023-01-23,"Headline: Healthcare Sector Is Lagging As We Enter 2022 Earnings Season, source:TalkMarkets, summary: No summary, Headline: Illumina Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: No summary",ILMN
96,2023-01-24,"Headline: Illumina Ventures Announces Strategic New Additions to its Investment Team, source:Business Wire, summary: No summary, Headline: Illumina Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: No summary",ILMN
97,2023-01-25,"Headline: Baillie Gifford Slashes Meta, Boosts Nvidia, source:GuruFocus, summary: No summary, Headline: Illumina downgraded to Hold from Buy at Argus, source:Thefly.com, summary: No summary, Headline: Illumina downgraded to Hold at Argus on valuation, deteriorating outlook, source:Thefly.com, summary: No summary, Headline: Illumina downgraded to hold at Argus on poor near-term outlook, source:Seeking Alpha, summary: No summary, Headline: Illumina Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: No summary",ILMN
98,2023-01-26,"Headline: ILMN March 10th Options Begin Trading, source:Stock Options Channel, summary: No summary, Headline: What's in the Cards for Illumina (ILMN) in Q4 Earnings?, source:Yahoo, summary: Negative foreign exchange impact and consumables inventory deleveraging are expected to have affected Illumina's (ILMN) top line during the fourth quarter., Headline: Investors in Illumina (NASDAQ:ILMN) from a year ago are still down 35%, even after 7.5% gain this past week, source:Yahoo, summary: Illumina, Inc. ( NASDAQ:ILMN ) shareholders should be happy to see the share price up 12% in the last month. But in..., Headline: Illumina price target lowered to $290 from $300 at Piper Sandler, source:Thefly.com, summary: No summary, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: No summary",ILMN
99,2023-01-27,"Headline: Health-Care Stocks Have Outperformed; Here Are a Few Undervalued., source:Yahoo, summary: The S&P 500 Healthcare index gained 4.8% during the past 12 months, versus a 6% dip for the S&P 500 as a whole.",ILMN
100,2023-01-29,"Headline: Tracking Baillie Gifford`s 13F Portfolio - Q4 2022 Update, source:Seeking Alpha, summary: No summary, Headline: Has Illumina taken the wrong path in its Grail quest?, source:Yahoo, summary: DNA sequencing expert’s investors question acquisition of cancer testing group that has also angered EU regulators, Headline: Tracking Baillie Gifford's 13F Portfolio - Q4 2022 Update, source:SeekingAlpha, summary: Baillie Giffordâs 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. Click here for a detailed analysis., Headline: Illumina Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: No summary",ILMN
101,2023-01-30,"Headline: Bionano`s Balance Sheet Challenges: History Repeating Itself, source:Seeking Alpha, summary: No summary, Headline: Bionano's Balance Sheet Challenges: History Repeating Itself, source:SeekingAlpha, summary: Aggressive expansion into capital-intensive markets will likely put significant pressure on BNGO's balance sheet. Click here to read my analysis of Bionano., Headline: Illumina Inc. stock rises Tuesday, outperforms market, source:MarketWatch, summary: No summary",ILMN
102,2023-01-31,"Headline: GE HealthCare Technologies: Still Significantly Undervalued, source:Seeking Alpha, summary: No summary, Headline: Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for, source:Yahoo, summary: Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations., Headline: Video: UK Festival of Genomics & Biodata Inspires and Connects Genomics Leaders, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / January 31, 2023 / Illumina Originally published on Illumina News Center The Festival of Genomics & Biodata 2023, held in London in January, is the largest event in the UK's genomics events calendar. More than 4000 ..., Headline: Illumina Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: No summary",ILMN
103,2023-02-01,"Headline: Illumina appoints Joydeep Goswami as CFO, source:Thefly.com, summary: No summary, Headline: Joydeep Goswami is the new finance chief of Illumina, source:Seeking Alpha, summary: No summary, Headline: Ensemble Capital Fourth Quarter 2022 Investor Letter, source:SeekingAlpha, summary: Ensemble Capital Management, LLC is based in Burlingame, California, midway between Silicon Valley and San Francisco., Headline: Illumina appoints new chief financial officer, effective immediately, source:Alliance News, summary: No summary, Headline: Illumina Appoints Joydeep Goswami Chief Financial Officer, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Joydeep Goswami has been appointed Chief Financial Officer, effective immediately. Goswami previously served as Illumina's Chief Strategy and Corporate Development Officer and interim Chief Financial Officer. As CFO, Goswami will be responsible for the Company's financial planning and analysis, accounting, investor relations, internal audit, tax, and treasury functions. He will also con, Headline: Illumina Makes Its Interim CFO Permanent, source:Yahoo, summary: Joydeep Goswami, Illumina’s interim finance chief since July, will take over the role on a permanent basis., Headline: Top 25 Smartest Companies To Buy According To Hedge Funds, source:Yahoo, summary: In this piece, we will take a look at the top 25 smartest companies to buy according to hedge funds. For more companies, head on over to Top 5 Smartest Companies To Buy According To Hedge Funds. Surviving in the modern day corporate world is not for the faint of heart. Business is a ruthless […], Headline: Illumina Named to Bloomberg Gender Equality Index for Fifth Consecutive Year, source:Yahoo, summary: Illumina has been included in the 2023 Bloomberg Gender-Equality Index for the fifth consecutive year., Headline: Illumina Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: No summary, Headline: RBC Capital Sticks to Their Buy Rating for Illumina (ILMN), source:TipRanks, summary: No summary",ILMN
104,2023-02-02,"Headline: Guardant Health `pleased` with ruling in Illumina case, source:Thefly.com, summary: No summary, Headline: Interesting ILMN Put And Call Options For March 24th, source:Stock Options Channel, summary: No summary, Headline: Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?, source:Yahoo, summary: Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",ILMN
105,2023-02-03,"Headline: Notable Two Hundred Day Moving Average Cross - ILMN, source:Market News Video, summary: No summary, Headline: How Organizations Around the World Are Closing the Cancer Care Gap, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / February 3, 2023 / Illumina Originally published on Illumina News Center According to the World Health Organization, half the world's population does not have access to essential health services. At a time when advances ...",ILMN
106,2023-02-05,"Headline: Illumina, Pacific Biosciences, And Oxford Nanopore Market Position Comparison, source:SeekingAlpha, summary: The gene sequencing market is ripe for disruption. Click here for a complete analysis of Illumina, Pacific Biosciences, And Oxford Nanopore., Headline: Illumina Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: No summary",ILMN
107,2023-02-06,"Headline: Global company events calendar - next 7 days, source:Alliance News, summary: No summary, Headline: GLOBAL BRIEFING: Australia lifts interest rates by 25 basis points, source:Alliance News, summary: No summary, Headline: Illumina options imply 6.4% move in share price post-earnings, source:Thefly.com, summary: No summary, Headline: Illumina  reports Q4 adjusted EPS 14c, consensus 10c, source:Thefly.com, summary: No summary, Headline: Illumina  sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98, source:Thefly.com, summary: No summary, Headline: Illumina Non-GAAP EPS of $0.14 misses by $0.05, revenue of $1.08B beats by $10M, source:Seeking Alpha, summary: No summary, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: No summary",ILMN
108,2023-02-07,"Headline: Illumina boosts spending on US lobbying amid opposition to Grail acquisition, source:Yahoo, summary: Illumina sharply increased its spending on lobbying over the past two years as it tried to build support against antitrust regulators in the US and Europe that have attempted to block its $8bn acquisition of cancer testing company Grail.  The world’s biggest genome sequencing company and its subsidiary Grail spent a combined $14.6mn in 2021 and 2022 on federal lobbying in the US, more than five times the $2.72mn combined they spent in the previous two years, according to public disclosures.  Illumina was the fourth-largest spender on lobbying among biotech and pharma companies in 2022 at $9.4mn, behind only Pfizer, Roche and Amgen, which are much larger companies, according to an analysis by OpenSecrets, a transparency group., Headline: Fly Intel: After-Hours Movers, source:Thefly.com, summary: No summary, Headline: Illumina faces low-cost rival as BGI touts sub $100 gene sequencing, source:Seeking Alpha, summary: No summary, Headline: SECTOR GAMMA AS Buys 3, Sells 2 in 4th Quarter, source:GuruFocus, summary: No summary, Headline: Notable companies reporting after market close, source:Thefly.com, summary: No summary, Headline: Illumina Attracts Challengers for DNA Sequencing Ahead of Earnings, source:Yahoo, summary: Illumina competitors are out in force this week at the sequencing industry's annual gathering. The company reports fourth-quarter and year earnings after Tuesday's close., Headline: Illumina: Q4 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: Cramer's lightning round: Parker-Hannifin is a buy, source:CNBC, summary: ""Mad Money"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed., Headline: Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022, source:Yahoo, summary: Illumina, Inc. (Nasdaq: ILMN) today announced its financial results for the fourth quarter and fiscal year 2022, which include consolidated financial results for GRAIL., Headline: Illumina, Inc. (ILMN) Q4 2022 Earnings Call Transcript, source:SeekingAlpha, summary: Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Q4 2022 Earnings Conference Call February 7, 2023 5:00 PM ETCompany ParticipantsSallilyn Schwartz - VP, IRJoydeep Goswami - CFO, Chief Strategy &..., Headline: DNA-Reading Giant Illumina Topples On Wide Profit Miss, source:Yahoo, summary: Illumina beat sales estimates, but profit came in light during the fourth quarter. That led ILMN stock to fall in late action Tuesday., Headline: Illumina (ILMN) Misses Q4 Earnings Estimates, source:Yahoo, summary: Illumina (ILMN) delivered earnings and revenue surprises of -26.32% and 1.54%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?, Headline: Top 5 4th Quarter Trades of SECTOR GAMMA AS, source:GuruFocus, summary: No summary, Headline: Illumina swings to net loss in 2022; fourth quarter revenue drops 10%, source:Alliance News, summary: No summary, Headline: Illumina Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: No summary, Headline: Illumina price target lowered to $150 from $160 at Barclays, source:Thefly.com, summary: No summary",ILMN
109,2023-02-08,"Headline: The Brazilian billionaires embroiled in a $3.9bn scandal, source:Yahoo, summary: Plus, Illumina turns to lobbyists to back its Grail takeover and DD looks at Abu Dhabi’s stock market darling, Headline: Analysts` Opinions Are Mixed on These Healthcare Stocks: Cigna (CI), Illumina (ILMN) and Vertex Pharmaceuticals (VRTX), source:TipRanks, summary: No summary, Headline: Illumina price target raised to $230 from $210 at BofA, source:Thefly.com, summary: No summary, Headline: Illumina price target raised to $303 from $284 at RBC Capital, source:Thefly.com, summary: No summary, Headline: Illumina (ILMN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates, source:Yahoo, summary: While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values., Headline: Illumina price target lowered to $235 from $285 at Stifel, source:Thefly.com, summary: No summary, Headline: Stocks making the biggest moves premarket: Uber, Chipotle, Microsoft, Lumen and more, source:CNBC, summary: These are some of the stocks posting the largest moves before the stock market's opening bell., Headline: J.P. Morgan Reaffirms Their Hold Rating on Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Vertex Pharmaceuticals (VRTX) and Inspire Medical Systems (INSP), source:TipRanks, summary: No summary, Headline: Illumina in EU hearing to fight order to divest GRAIL, source:Seeking Alpha, summary: No summary, Headline: Oxford Nanopore: Illumina`s Formidable Challenger, source:Seeking Alpha, summary: No summary, Headline: Illumina (ILMN) Q4 Earnings Miss Estimates, Gross Margin Down, source:Yahoo, summary: Delays in recruitment for some large research projects in the Americas and Europe, the impact of COVID disruptions in China and foreign exchange woes hurt Illumina's (ILMN) Q4 revenues., Headline: NEW YORK MARKET CLOSE: Stocks red as markets mull Powell remarks, source:Alliance News, summary: No summary, Headline: Illumina fights EU order to divest Grail, source:Reuters, summary: U.S. life science company Illumina on Wednesday took its case to senior EU and national antitrust officials at a closed hearing to argue against an EU antitrust order that it divests cancer detection test maker Grail Inc., Headline: Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first NovaSeq X Plus system was recently delivered to the Broad Institute. Alex Aravanis, PhD, chief technology officer of Illumina, made the announcement today in a presentation at the Advances in Genome Biology and Technology (AGBT) conference in Hollywood, Florida. Aravanis also announced much anticipated updates on Illumina's innovation roadmap including Illumina Complete Lo, Headline: The Wild Card That Keeps Haunting DNA-Reading Giant Illumina, source:Yahoo, summary: Illumina beat sales estimates, but profit came in light during the fourth quarter. That led ILMN stock to fall Wednesday., Headline: Illumina Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: No summary",ILMN
110,2023-02-09,"Headline: A New Era for Discoveries at Admera Health, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / February 9, 2023 / Illumina Originally published on Illumina News Center What role does RNA play in regulating fat deposits? Which transcription factors affect insulin resistance and halt cancer progression? What ..., Headline: Illumina, Inc. (NASDAQ:ILMN) Q4 2022 Earnings Call Transcript, source:Yahoo, summary: Illumina, Inc. (NASDAQ:ILMN) Q4 2022 Earnings Call Transcript February 7, 2023 Operator: Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2022 Illumina Earnings Conference Call. . I would now like to hand the conference over to Salli Schwartz, Vice President of Investor Relations. Sallilyn Schwartz: Hello, everyone, and welcome to our earnings […], Headline: Illumina Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: No summary",ILMN
111,2023-02-10,"Headline: Illumina Receives Highest Distinction in the 2023 S&P Global Sustainability Yearbook, source:Yahoo, summary: Illumina has been included in the 2023 S&P Global Sustainability Yearbook for the fourth consecutive year.",ILMN
112,2023-02-12,"Headline: 7 Stocks to Buy and Hold for the Next 20 Years, source:Yahoo, summary: When looking for stocks to buy and hold for the next 20 years, it’s essential to find ones with economic moat. After all, when it comes to picking stocks, they should strong competitive advantages that are in durable sectors. Some of the top stocks to buy and hold, include: MGM MGM. $43.83 GM General Motors $41.35 NOW ServiceNow $458.36 ILMN Illumina $196.58 BKNG Booking Holdings $2,348.37 FTNT Fortinet $59.61 PYPL PayPal $80.80 Stocks to Buy and Hold: MGM (MGM) Source: ImageFlow/Shutterstock.co",ILMN
113,2023-02-13,"Headline: Early notable gainers among liquid option names on February 13th, source:Thefly.com, summary: No summary, Headline: Stocks making the biggest moves midday: Zillow, Microsoft, Meta, Fidelity National and more, source:CNBC, summary: These are the stocks posting the largest moves midday., Headline: NEW YORK MARKET CLOSE: Shares rise ahead of key US inflation data, source:Alliance News, summary: No summary, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. advanced 9.85% to $215.94 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",ILMN
114,2023-02-14,"Headline: Illumina price target lowered to $240 from $255 at UBS, source:Thefly.com, summary: No summary, Headline: Illumina Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slid 1.44% to $212.83 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index..., Headline: Illumina Faces Rival Gene Sequencers and Price Competition, source:Yahoo, summary: An Illumina competitor with a less-expensive price point unveiled new technology at a recent genome biology conference.",ILMN
115,2023-02-15,"Headline: Using Whole-Genome Sequencing To Study Early-Onset Parkinson`s Disease, source:Accesswire, summary: No summary, Headline: Singular Genomics: Betting On Expanding Genomics Systems Market, source:SeekingAlpha, summary: Singular Genomics is a unique opportunity to invest in a commercially-viable startup at the forefront of a rapidly expanding field. See why OMIC stock is a Buy., Headline: Using Whole-Genome Sequencing To Study Early-Onset Parkinson’s Disease, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / February 15, 2023 / Illumina: Originally published on Illumina News Center The Norwegian term for virgin snow, ""nysnø"", seemed the appropriate inspiration to name Jennifer Johnston's company, NysnoBio, as it underscores ..., Headline: Illumina Inc. stock underperforms Wednesday when compared to competitors despite daily gains, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.57% higher to $214.05 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the..., Headline: Top 5 4th Quarter Trades of MayTech Global Investments, LLC, source:GuruFocus, summary: No summary",ILMN
116,2023-02-16,"Headline: Continue To Avoid Illumina Inc, source:SeekingAlpha, summary: Illumina's most recent financial results were bad. Click here to find out why I recommend avoiding ILMN stock., Headline: Illumina Inc. stock falls Thursday, still outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slid 1.04% to $211.82 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: Startups Take On Illumina in Race for Cheaper DNA Sequencing, source:Yahoo, summary: Startups are challenging market leader  Illumina  in the race to lower the cost of DNA sequencing and expand use of the technology throughout research and medicine.  DNA sequencing lets scientists read the individual bases, or letters, of genetic code.  San Diego-based Illumina, whose market capitalization is over $33 billion, has dominated the sector by launching instruments that have whittled the cost of sequencing the complete set of genetic material in cells, the genome, to $600.",ILMN
117,2023-02-17,"Headline: 10 Sectors Likely To Generate Good Returns In The Next Decade, source:Seeking Alpha, summary: No summary, Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.00% higher to $211.83 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",ILMN
118,2023-02-21,"Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 4.24% to $202.84 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...",ILMN
119,2023-02-22,"Headline: GRAIL Teams Up with Professional Golfers David Duval and Juli Inkster to Raise Awareness of Multi-Cancer Early Detection, source:Business Wire, summary: No summary, Headline: Illumina Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slid 0.56% to $201.71 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",ILMN
120,2023-02-23,"Headline: Interesting ILMN Put And Call Options For April 6th, source:Stock Options Channel, summary: No summary, Headline: John Hancock expands access to Galleri®, GRAIL's breakthrough cancer screening technology, source:Yahoo, summary: Today, John Hancock, a unit of Manulife (NYSE: MFC), announced it will expand access to GRAIL's Galleri® multi-cancer early detection test to eligible life insurance customers participating in the John Hancock Vitality PLUS program, a significant milestone in John Hancock's ongoing efforts to help customers live longer, healthier, better lives. The expanded access comes after John Hancock became the first life insurance carrier to make the breakthrough screening technology available to a pilot g, Headline: Illumina Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.24% higher to $202.20 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...",ILMN
121,2023-02-24,"Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 2.77% to $196.59 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",ILMN
122,2023-02-25,"Headline: No Longer A Momentum Play, Pacific Biosciences Looking To Reaccelerate Growth In 2023, source:SeekingAlpha, summary: PacBio's fourth quarter numbers were ugly, but that was expected as the company prepares for the launch of its next generation of long-read sequencers and its entry into short-read...",ILMN
123,2023-02-27,"Headline: Illumina Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.16% higher to $196.90 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P..., Headline: Illumina To Webcast Upcoming Investor Conference, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:",ILMN
124,2023-02-28,"Headline: 11 Most Promising Cancer Stocks According to Analysts, source:Yahoo, summary: In this article, we discuss 11 most promising cancer stocks according to analysts. If you want to see more stocks in this selection, check out 5 Most Promising Cancer Stocks According to Analysts. The market for community oncology services worldwide is projected to experience substantial growth, with an estimated increase from $47.95 billion in 2022 […], Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rallied 1.17% to $199.20 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500..., Headline: Working To Solve Rare Disease and Support Patients, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / February 28, 2023 / Illumina Originally published on Illumina News Center Every year on the last day of February, Rare Disease Day is celebrated worldwide in a collective effort to raise awareness and funding for ..., Headline: It takes an average of 8 years for a rare disease patient to get diagnosed. Why is it so hard to get life-altering genetic testing in the U.S.?, source:Yahoo, summary: An increasingly inexpensive genetic test stands in the way of a diagnosis for many rare disease patients, who are as common as one in 10 worldwide.",ILMN
125,2023-03-01,"Headline: 23andMe Looking Promising For The Long Term, source:Seeking Alpha, summary: No summary, Headline: Illumina Inc. stock falls Wednesday, still outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slid 0.33% to $198.54 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",ILMN
126,2023-03-02,"Headline: Illumina and Myriad Genetics partner for HRD testing in the U.S., source:Thefly.com, summary: No summary, Headline: Myriad Genetics, Illumina expand partnership for HRD testing access, source:Thefly.com, summary: No summary, Headline: Illumina, Myriad Genetics expand partnership to broaden access to HRD testing in U.S., source:Seeking Alpha, summary: No summary, Headline: April 14th Options Now Available For Illumina (ILMN), source:Stock Options Channel, summary: No summary, Headline: Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States, source:Yahoo, summary: Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industrySALT LAKE CITY, March 02, 2023 (GLOBE NEWSWIRE) -- Myriad Genetic, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the expansion of a strategic partnership to broaden access to and availability of oncology homologous rec, Headline: A New Genomic Atlas Could Help Save Endangered Elephants, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / March 2, 2023 / Illumina: Originally published on Illumina News Center Herds of woolly mammoth once roamed the span of the Northern Hemisphere, from the British Isles across the Bering land bridge to the eastern ..., Headline: Illumina Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. rose 4.02% to $206.52 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",ILMN
127,2023-03-03,"Headline: Illumina Breaks Above 200-Day Moving Average - Bullish for ILMN, source:Market News Video, summary: No summary, Headline: Myriad Genetics' (MYGN) New Pact to Extend HRD Testing Access, source:Yahoo, summary: Myriad Genetics (MYGN), together with Illumina, will seek joint HRD companion diagnostics partnerships with pharmaceutical companies globally., Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. advanced 7.11% to $221.21 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",ILMN
128,2023-03-04,"Headline: Wall Street Breakfast: What Moved Markets, source:SeekingAlpha, summary: Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.",ILMN
129,2023-03-06,"Headline: Illumina Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slipped 2.52% to $215.63 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",ILMN
130,2023-03-07,"Headline: Illumina, Inc. (ILMN) Presents at 43rd Annual TD Cowen Health Care Conference (Transcript), source:SeekingAlpha, summary: Illumina, Inc. (NASDAQ:NASDAQ:ILMN) 43rd Annual TD Cowen Health Care Conference March 7, 2023 9:50 AM ETCompany ParticipantsJoydeep Goswami - Chief Financial Officer & Chief Executive..., Headline: Illumina Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slipped 3.33% to $208.46 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...",ILMN
131,2023-03-08,"Headline: Illumina Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. shed 0.21% to $208.03 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...",ILMN
132,2023-03-09,"Headline: Final Trades: Illumina, JPMorgan & more, source:CNBC, summary: The ""Halftime Report"" traders give their top picks to watch for the second half., Headline: Illumina Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. shed 2.62% to $202.59 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",ILMN
133,2023-03-10,"Headline: Children`s Mercy Kansas City Tackles the Unique Complexity of Pediatric Cancer, source:Accesswire, summary: No summary, Headline: Children’s Mercy Kansas City Tackles the Unique Complexity of Pediatric Cancer, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / March 10, 2023 / Illumina Originally published on Illumina News Center ""Pediatricians like to say children are not little adults, and accordingly, pediatric cancer is not just the miniature form of adult cancer,"" ..., Headline: Illumina Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slid 4.24% to $194.01 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",ILMN
134,2023-03-12,"Headline: Illumina jumps 20%  as Carl Icahn starts proxy battle over Grail deal  (update), source:Seeking Alpha, summary: No summary, Headline: Illumina: It`s not in the ���best interests` of shareholders to support Carl Icahn`s nominees to the board, source:MarketWatch, summary: No summary, Headline: UPDATE 1-Carl Icahn prepares for proxy fight at Illumina - WSJ, source:Yahoo, summary: Activist investor Carl Icahn is preparing a proxy fight at Illumina Inc, arguing that the life science maker's acquisition of Grail Inc cost its shareholders roughly $50 billion, the Wall Street Journal reported on Sunday.  Illumina completed a takeover of cancer-detection test maker Grail in August 2021, without securing regulatory approval from the European Union., Headline: Carl Icahn prepares for proxy fight at Illumina - WSJ, source:Yahoo, summary: Illumina completed a takeover of cancer-detection test maker Grail in August 2021, without securing regulatory approval from the European Union.  The European Commission ordered Illumina in December to unwind the deal, three months after it had blocked the merger on concerns the deal would stifle innovation., Headline: Carl Icahn Prepares for Proxy Fight at Illumina, source:Yahoo, summary: The billionaire activist is arguing the biotechnology company cost its shareholders roughly $50 billion by plowing ahead with a risky acquisition despite opposition from regulators., Headline: Carl Icahn Pens Open Letter to Illumina Shareholders, source:GuruFocus, summary: No summary, Headline: What You Missed On Wall Street On Monday, source:Thefly.com, summary: No summary",ILMN
135,2023-03-13,"Headline: These Stocks Are Moving the Most Today: First Republic, Provention Bio, Roku, Illumina, Boeing, and More Market Movers, source:MarketWatch, summary: First Republic shares are sinking Monday even as it received funding from JPMorgan Chase and the Federal Reserve, Provention Bio soars after agreeing to be..., Headline: Icahn planning proxy fight at Illumina, WSJ reports, source:Thefly.com, summary: No summary, Headline: Billionaire Carl Icahn Could Lock Horns with Illumina (NASDAQ:ILMN), source:TipRanks, summary: No summary, Headline: Piper agrees with Icahn, says Illumina base business undervalued, source:Thefly.com, summary: No summary, Headline: S&P 500 Futures Climb in Premarket Trading; First Republic Bank, Western Alliance Bancorp Lag, source:MarketWatch, summary: With U.S. stock markets set to open in two hours, (SGEN) was up 19.3% in pre-market trading, and (ILMN) was up 7.2%. (XM), (PODD), and (BILL) were all..., Headline: Hedge funds and C-suites: Illumina pops on Icahn news | Pro Recap, source:Yahoo, summary: Here is your Pro Recap of the biggest news out of hedge funds and company top brass you may have missed in the past week.  Illumina (NASDAQ:ILMN) shares rose sharply on word Carl Icahn is preparing to launch a proxy fight there, seeking three board seats, according to the Wall Street Journal.  According to Icahn, the biotech company's acquisition of Grail costed shareholders $50 billion and is now costing the company $800 million annually., Headline: MSTR, HIVE and FSM among pre market gainers, source:Seeking Alpha, summary: No summary, Headline: Fly Intel: Pre-market Movers, source:Thefly.com, summary: No summary, Headline: Stocks making the biggest moves premarket: Illumina, First Republic, Seagen and more, source:CNBC, summary: Bank lenders saw major losses in early morning trading, stinging from the closure of Silicon Valley Bank and Signature Bank. , Headline: Early notable gainers among liquid option names on March 13th, source:Thefly.com, summary: No summary, Headline: ILMN Stock Alert: What to Know as Carl Icahn Prepares for Proxy Fight With Illumina, source:InvestorPlace, summary: No summary, Headline: Why Is ROKU Stock Down Today?, source:InvestorPlace, summary: No summary, Headline: Carl Icahn issues open letter to Illumina shareholders, source:Thefly.com, summary: No summary, Headline: Icahn nominates three people to Illumina`s board of directors, source:Thefly.com, summary: No summary, Headline: Icahn: Nominees to bring `badly needed dose of sanity` to Illumina`s boardroom, source:Thefly.com, summary: No summary, Headline: Illumina jumps as Carl Icahn starts proxy battle over Grail deal  (update), source:Seeking Alpha, summary: No summary, Headline: What You Missed On Wall Street This Morning, source:Thefly.com, summary: No summary, Headline: Stocks Rally As Investors Bet On Rate-Hike Pause, source:TalkMarkets, summary: No summary, Headline: HUT, NMTR and BYSI among mid-day movers, source:Seeking Alpha, summary: No summary, Headline: WSJ: Carl Icahn says Grail deal cost Illumina shareholders $50 billion, source:Yahoo, summary: MARKET PULSE Shares of Illumina Inc. (ILMN) were up about 8% in premarket trading on Monday after the Wall Street Journal reported Sunday that Carl Icahn is planning a proxy fight. The billionaire activist reportedly believes that the company’s $7., Headline: Illumina board recommends shareholders not support Icahn nominees, source:Thefly.com, summary: No summary, Headline: These Stocks Are Moving the Most Today: First Republic, Seagen, Provention Bio, Illumina, Qualtrics, and More Market Movers, source:Yahoo, summary: First Republic shares are sinking Monday even as it received funding from JPMorgan Chase and the Federal Reserve, Pfizer announces it will acquire Seagen for $43 billion, and Provention Bio soars after agreeing to be acquired by France's Sanofi in a $2.9 billion deal., Headline: Stocks making the biggest moves midday: First Republic Bank, Moderna, Newmont, Illumina and more, source:CNBC, summary: These are the stocks posting the largest moves midday., Headline: Midday movers: First Republic, Illumina, Seagen and more, source:Yahoo, summary: By Liz Moyer, Headline: Activist investor Icahn to nominate three people to Illumina's board, source:Reuters, summary: Activist investor Carl Icahn on Monday launched a proxy battle at Illumina Inc, citing that the company's takeover of Grail Inc has cost shareholders about $50 billion since the closing of the deal., Headline: UPDATE 1-Activist investor Icahn launches proxy battle at Illumina, source:Yahoo, summary: Activist investor Carl Icahn on Monday launched a proxy fight at Illumina Inc, arguing the company's takeover of Grail Inc had cost shareholders about $50 billion since the closing of the deal.  Shares of Illumina jumped 18% to $228.97 in morning trade.  Icahn plans to nominate three people to Illumina's board at the company's upcoming shareholder meeting, he said in a letter sent to the life sciences company's shareholders., Headline: Why Illumina Shares Are Soaring Today?, source:Yahoo, summary: Billionaire activist Carl Icahn is preparing a proxy fight at Illumina Inc (NASDAQ: ILMN), saying the company went ahead with the controversial acquisition of Grail Inc despite opposition from regulators, costing shareholders $50 billion. According to the letter viewed by Wall Street Journal, the activist plans to nominate three people to the company's board. Mr. Icahn accuses Illumina of overpaying for a business that made ""exactly zero dollars in revenue,"" then closing the deal despite regulat, Headline: Activist investor Icahn launches proxy fight at Illumina, source:Reuters, summary: Activist investor Carl Icahn on Monday launched a proxy fight at Illumina Inc, saying the life sciences company's takeover of Grail Inc had cost shareholders about $50 billion since the closing of the deal., Headline: KeyCorp, Philips 66 fall; Seagen, Insulet rise, source:Associated Press, The, summary: No summary, Headline: Illumina Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. climbed 16.97% to $226.94 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500..., Headline: Carl Icahn Takes Aim at Illumina Over Grail Deal, source:Yahoo, summary: Carl Icahn said in a letter to Illumina shareholders that he plans to nominate three people to the biotech's board., Headline: Illumina Responds to Icahn Partners' Nomination of Directors, source:Yahoo, summary: Illumina, Inc. (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies, confirmed today that it has received notice from Icahn Partners LP and certain of its affiliates of their intention to nominate three candidates—two current Icahn employees, Jesse Lynn and Andrew Teno, and one former Icahn employee, Vincent Intrieri—for election to the Board of Directors at Illumina's 2023 Annual Meeting of Shareholders., Headline: Illumina: It’s not in the ‘best interests’ of shareholders to support Carl Icahn’s nominees to the board, source:Yahoo, summary: Illumina Inc.  (ILMN)  said Monday it received notice from Icahn Partners that the organization plans to nominate three candidates to to the board over concerns about the company’s $7.1 billion acquisition of Grail.  Jesse Lynn and Andrew Teno are current Icahn employees and Vincent Intrieri is a former Icahn employee.  Icahn reportedly told Illumina that the acquisition, which has faced regulatory scrutiny, cost shareholders $50 billion, according to the Wall Street Journal., Headline: Carl Icahn takes aim at genome sequencer Illumina over Grail deal, source:Yahoo, summary: Shares in Illumina surged more than 20 per cent on Monday following a decision by activist investor Carl Icahn to launch a proxy battle over what he described as the company’s “reckless” acquisition of cancer-screening start-up Grail.  Icahn sent a letter to Illumina shareholders alleging that its management team and the board of directors had wiped out $50bn of value at the world’s biggest genome sequencing company through the “ill-advised” purchase of Grail for $8bn in 2021.  The proxy battle follows a tumultuous 18 months for Illumina, whose market capitalisation has slumped from $75bn in August 2021 when it acquired Grail to just over $30bn last month., Headline: Illumina Surges As Activist Carl Icahn Reportedly Steps In Over Grail, source:Yahoo, summary: Activist investor Carl Icahn could press Illumina to divest its controversial Grail asset, analysts said Monday as ILMN stock surged., Headline: Icahn launches proxy fight at Illumina, seeks board seats, source:Reuters, summary: Billionaire investor Carl Icahn is pushing for three board seats at Illumina, criticizing the biotechnology company's acquisition of a cancer test developer that cost investors $50 billion., Headline: Illumina should spin off Grail, activist Carl Icahn says, source:Seeking Alpha, summary: No summary",ILMN
136,2023-03-14,"Headline: Analysts` Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Illumina (ILMN) and Arcutis Biotherapeutics (ARQT), source:TipRanks, summary: No summary, Headline: SVB May Be a Failure of Supervision. What It Means for Other Banks., source:Yahoo, summary: Pfizer bets $43 billion on Seagen, United Airlines projects loss on reduced demand, March Madness to draw $15.5 billion in wagers, and other news to start your day., Headline: Company News for Mar 14, 2023, source:Yahoo, summary: Companies In The News Are: SGEN, PFE, PODD, SIVB, ILMN, PNC., Headline: Illumina Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. shed 0.47% to $225.88 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: BRIEF-Carl Icahn Says We Own More Illumina Stock Than All Their Board Members Combined-CNBC Interview, source:Reuters, summary: * CARL ICAHN SAYS POWELL HAS TO INCREASE INTEREST RATES SOONER OR LATER-CNBC INTERVIEW, Headline: Illumina launches its first product enabling long- and short-read sequencing on one instrument, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Illumina Complete Long Read technology is now available to order. The high-performance, long-read, human whole-genome sequencing (WGS) assay – Illumina Complete Long Read Prep, Human – is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. For the first time ever, it offers users access to both long- and short",ILMN
137,2023-03-15,"Headline: Illumina: Promising Technology But Overvalued Company, source:SeekingAlpha, summary: Illumina is the market leader in the DNA sequencing industry. See why I think ILMN stock is highly overvalued at today's prices., Headline: Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Illumina (ILMN) and Tandem Diabetes Care (TNDM), source:TipRanks, summary: No summary, Headline: Icahn Reacts Audaciously To Illumina`s Audacity, source:Seeking Alpha, summary: No summary, Headline: Icahn Reacts Audaciously To Illumina's Audacity, source:SeekingAlpha, summary: Carl Icahn wants three board seats at Illumina after it overpaid for Grail and took on too much regulatory risk. Find out more here., Headline: ChatGPT Says These 7 Stocks Could Be the Next Trillion-Dollar Companies, source:InvestorPlace, summary: No summary, Headline: Icahn says `only path forward` for Illumina is to divest GRAIL, source:Thefly.com, summary: No summary, Headline: TD Cowen life science/diagnostic analyst holds analyst/industry conference call, source:Thefly.com, summary: No summary, Headline: Illumina Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. rose 1.00% to $228.15 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500..., Headline: Illumina (ILMN) Unveils Complete Long Reads Technology, source:Yahoo, summary: Illumina's (ILMN) Complete Long Read Prep combines Illumina sequencing by synthesis chemistry with DRAGEN secondary analysis to provide WGS with more accuracy., Headline: Icahn urges Illumina to unwind Grail deal, pushes ahead on proxy fight, source:Reuters, summary: Billionaire investor Carl Icahn is urging life sciences company Illumina Inc to divest cancer test developer Grail Inc and said on Wednesday that his director candidates will be best placed to pursue this goal.",ILMN
138,2023-03-16,"Headline: Carl Icahn Responds to Illumina in Open Letter, source:GuruFocus, summary: No summary, Headline: Buy This Magnificent Growth Stock Before It's Too Late, source:Yahoo, summary: Bionano Genomics (NASDAQ: BNGO) appears to be in just that place -- at the start of its growth journey -- and it could be a great way to give your portfolio some additional upside potential.  Bionano's claim to fame is its laboratory analyzer device for optical genome mapping, which it calls the Saphyr., Headline: Illumina Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 1.40% to $224.95 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",ILMN
139,2023-03-17,"Headline: Carl Icahn urges Fed to keep fighting inflation ‘disease’ after SVB collapse, source:Yahoo, summary: Activist investor Carl Icahn has urged the Federal Reserve to stay the course in the fight against the “disease of inflation” despite the failure of Silicon Valley Bank and two other banks last week.  “I think you have to stamp out the disease of inflation,” Icahn told the Financial Times.  Icahn’s comments come ahead of the Fed’s rate-setting meeting next week, with economists actively debating whether it will raise interest rates by 0.25 percentage points or take a pause following the SVB implosion., Headline: UPDATE 1-Carl Icahn urges Fed to keep fighting inflation after SVB collapse - FT, source:Yahoo, summary: Activist investor Carl Icahn has urged the U.S. Federal Reserve to stay the course in the fight against the ""disease of inflation"" despite the failure of Silicon Valley Bank and two other banks last week, the Financial Times reported on Friday.  ""I think you have to stamp out the disease of inflation,"" Icahn told FT, ahead of Fed's rate-setting meeting next week in which the U.S. central bank is expected to raise its benchmark by 25 basis points.  The activist investor also warned of stress beyond the financial sector, saying that many companies had wasted billions of dollars on flawed acquisitions and become over indebted in the process, the report said., Headline: Why Is Seattle Genetics (SGEN) Up 24.6% Since Last Earnings Report?, source:Yahoo, summary: Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues., Headline: Illumina Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slipped 0.18% to $224.55 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500..., Headline: Illumina Should Heed Carl Icahn, Give Up on Grail, source:Yahoo, summary: Many of  Illumina  shareholders have grown increasingly frustrated with Chief Executive  Francis deSouza’s  pursuit of Grail.  The decision to close the $7.1 billion acquisition in August 2021 despite regulators’ objections baffled many investors and is largely to blame for cutting the company’s market capitalization in half.  Grail, which makes cancer-detection tests, lost about $600 million last year, cutting into Illumina’s profit.",ILMN
140,2023-03-18,"Headline: Wall Street Breakfast: What Moved Markets, source:Seeking Alpha, summary: No summary, Headline: Icahn proposes three candidates for Illumina’s board — Here’s what could be next in the battle, source:CNBC, summary: A fight has broken out between veteran activist Carl Icahn and biotech company Illumina as the investor nominates three candidates to the board., Headline: 3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time, source:Yahoo, summary: Healthcare costs in America and the world are set to rise in the foreseeable future. All thanks to an aging population, and the expectation that healthcare companies will be able to cure more of our diseases. The companies that can break into new markets by curing new diseases are set to profit the most from the coming healthcare boom. All of which is great news for healthcare stocks. In fact, companies like CRISPR Therapeutics (NASDAQ:CRSP) need to show that their new technology is safe, effect",ILMN
141,2023-03-20,"Headline: Illumina says Icahn`s nominees `lack relevant skills and experience`, source:Thefly.com, summary: No summary, Headline: Illumina Underscores Commitment to Shareholder Value and Responds to Carl Icahn's Statements, source:Yahoo, summary: Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued the following response to Carl Icahn's public statements and letters to Illumina's shareholders dated March 13 and March 15, 2023:, Headline: Illumina says Icahn board nominees will damage core business, source:Seeking Alpha, summary: No summary, Headline: Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal, source:CNBC, summary: Illumina pushed back against Carl Icahn's proxy fight over the Grail deal, saying it's committed to maximizing shareholder value as it works with regulators. , Headline: Illumina backs Grail deal and strategy after Icahn hits out, source:Alliance News, summary: No summary, Headline: Illumina Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 2.13% to $219.77 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: S&P 500 Losers: First Republic Crashes; Dow Giant Microsoft Slides, source:Yahoo, summary: First Republic is the new bank crisis epicenter, with FRC stock easily the S&P 500's biggest loser Monday. Microsoft fell below a buy point.",ILMN
142,2023-03-21,"Headline: Illumina Inc. stock rises Tuesday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.84% higher to $221.61 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P...",ILMN
143,2023-03-22,"Headline: Bank of America Securities Remains a Hold on Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Illumina Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slid 2.00% to $217.18 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",ILMN
144,2023-03-23,"Headline: Illumina Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. dropped 0.11% to $216.95 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P..., Headline: Oxford Nanopore: Attractive Long-Term Growth, Possible Buyout Scenario, source:Seeking Alpha, summary: No summary, Headline: Illumina says Icahn nominees `lack relevant skills and experience`, source:Thefly.com, summary: No summary",ILMN
145,2023-03-24,"Headline: Illumina responds to latest salvo from Carl Icahn, source:Seeking Alpha, summary: No summary, Headline: Carl Icahn says Illumina directors demanded extra insurance for Grail deal, source:Yahoo, summary: Carl Icahn has alleged Illumina directors demanded the company buy them extra personal liability insurance before they agreed to close its $8bn purchase of cancer screening company Grail against the wishes of regulators.  Icahn has engaged in a proxy battle with the company over what he describes as its “disastrous” acquisition of Grail in August 2021.  EU authorities raised objections with Illumina over its proposed acquisition of Grail in September 2020 and were investigating the deal when the company took the unusual step of closing the transaction., Headline: Carl Icahn claims Illumina directors sought extra insurance for Grail deal ��� FT, source:Seeking Alpha, summary: No summary, Headline: Icahn claims Illumina directors got insurance to close Grail deal -FT, source:Yahoo, summary: Carl Icahn has alleged that Illumina Inc's directors demanded extra personal liability insurance before they agreed to sign off on the life sciences company's $7.1 billion purchase of Grail in 2021, the Financial Times reported on Friday.  The billionaire investor's claims, made in a letter to Illumina's shareholder that the FT saw, come as he continues his push for board seats on the world's largest genome sequencing company and for it to unwind the Grail acquisition.  Illumina completed the takeover of Grail, which develops cancer detection tests, in August 2021, without winning U.S. or European regulatory approval, although it has since won U.S. clearance and is currently fighting for European approval., Headline: Icahn claims Illumina directors asked for insurance for Grail deal approval, source:Yahoo, summary: In response to Icahn's claims, Illumina said insurance agreements with its directors were standard and it regularly reviews them to reflect appropriate coverage.  Activist investor Icahn, who owns 1.4% of Illumina, launched a proxy battle against the company earlier this month seeking divestment of cancer test developer Grail as the $7.1-billion acquisition cost investors billions of dollars.  The deal also faces antitrust opposition from the European Union, but that did not stop Illumina from going ahead and closing it., Headline: Icahn to investigate `massive value destruction` by Illumina, source:Thefly.com, summary: No summary, Headline: Carl Icahn claims Illumina directors sought extra insurance for Grail deal, source:Seeking Alpha, summary: No summary, Headline: Carl Icahn claims Illumina directors got extra insurance to close 'disastrous' $7.1 billion Grail deal, source:CNBC, summary: Carl Icahn claims Illumina directors demanded extra personal liability insurance before the biotech company signed off on a $7.1 billion acquisition of Grail, Headline: UPDATE 2-Icahn claims Illumina directors asked for insurance for Grail deal approval, source:Yahoo, summary: Carl Icahn on Friday came down heavily on Illumina Inc, saying its directors demanded extra personal liability insurance against any potential claims related to the acquisition of Grail in 2021 before agreeing to signing off on the deal.  In response to Icahn's claims, Illumina said insurance agreements with its directors were standard and it regularly reviews them to reflect appropriate coverage.  Activist investor Icahn, who owns 1.4% of Illumina, launched a proxy battle against the company earlier this month seeking divestment of cancer test developer Grail as the $7.1-billion acquisition cost investors billions of dollars., Headline: Carl Icahn Steps Up Battle With Illumina, Says Directors Asked Additional Insurance For Grail Deal, source:Yahoo, summary: Activist Carl Icahn reportedly accused Illumina Inc (NASDAQ: ILMN) directors of demanding extra personal liability insurance before agreeing to close the $8 billion purchase of cancer screening company Grail Inc as regulators were against the deal. The claim is contained in the latest salvo of criticisms levied by the activist investor against the genome sequencing company. In a letter to Illumina shareholders, as seen by the Financial Times, Icahn alleges that Illumina directors required a comm, Headline: Binance Suspends Trading, European Bank Trouble, Twitter To Remove Legacy Verified Checkmarks: Today's Top Stories, source:Yahoo, summary: Reuters European Bank Trouble: Deutsche Bank Stock Under Pressure Due To Higher Costs Of Default Insurance Deutsche Bank AG (NYSE: DB) shares came under pressure following a spike in credit default swaps amid persistent concerns regarding the stability of European banks. Deutsche Bank's credit default swaps (CDS) - a form of insurance for bondholders - shot up above 200 basis points (bps) - the most since early 2019 - from 142 bps, based on data from S&P Market Intelligence. SVB's Private Bank U, Headline: Illumina defends director insurance as Carl Icahn proxy battle wages, source:Alliance News, summary: No summary, Headline: Illumina Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. advanced 1.41% to $220.00 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: Illumina Issues Statement in Response to Carl Icahn's Letter, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, issued the following statement in response to a letter from Carl Icahn dated March 24, 2023:",ILMN
146,2023-03-27,"Headline: Hedge funds and C-suites: Trump-linked DWAC fires CEO | Pro Recap, source:Yahoo, summary: Digital World Acquisition  (NASDAQ:DWAC), fired Patrick Orlando from his positions as Chairman and CEO of the company, according to the Wednesday filing.  Orlando, who, together with his other company ARC Global Investments, owns 10% of DWAC, remains a director of the company.  Eric Swider, another director, was appointed to serve as interim chief executive while the board works on executing a final succession plan., Headline: Illumina: What Is Up With The Genes?, source:SeekingAlpha, summary: Illumina has seen continued uncertainty and incurred a lot of losses with GRAIL acquisition while the core business was performing soft. Learn why I'm neutral on ILMN stock., Headline: Illumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the release of Connected Insights, a new cloud-based software enabling tertiary analysis for clinical next-generation sequencing (NGS) data., Headline: Illumina Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. sank 0.99% to $217.82 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",ILMN
147,2023-03-28,"Headline: Illumina Hits Back at Carl Icahn’s Grail Deal Claims and His Board Nominations, source:Fintel, summary: nan, Headline: Illumina Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slid 1.83% to $213.84 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index..., Headline: What You Missed On Wall Street On Wednesday, source:Thefly.com, summary: No summary",ILMN
148,2023-03-29,"Headline: Icahn seeks to bring back Illumina`s former CEO, WSJ reports, source:Thefly.com, summary: No summary, Headline: Carl Icahn seeks to bring Illumina`s former CEO back ��� WSJ, source:Seeking Alpha, summary: No summary, Headline: Carl Icahn tells WSJ he wants old CEO back at Illumina, source:MarketWatch, summary: Illumina Inc. activist shareholder and billionaire Carl Icahn told The Wall Street Journal he’d like to see the return of ex-CEO Jay Flatley to replace the..., Headline: Carl Icahn wants to bring back Illumina's ex-CEO 'immediately' as proxy fight intensifies , source:CNBC, summary: Icahn said Illumina should bring back former CEO Jay Flatley, saying current management is making the mistake of holding onto the $7.1 billion Grail deal.  , Headline: What You Missed On Wall Street This Morning, source:Thefly.com, summary: No summary, Headline: Carl Icahn plans to bring back Illumina's old CEO - WSJ, source:Reuters, summary: Carl Icahn is planning to bring back former Illumina CEO Jay Flatley at the helm of the gene-sequencing machine maker, with whom the activist investor is engaged in a proxy fight, the Wall Street Journal reported on Wednesday. (Reporting by Leroy Leo in Bengaluru; Editing..., Headline: DNA Data Storage Alliance Announces Board Appointments, source:Yahoo, summary: SAN DIEGO, March 29, 2023--The DNA Data Storage Alliance, a SNIA Technology Affiliate, formed in 2020 by Illumina, Inc. (NASDAQ: ILMN), Microsoft (Nasdaq: MSFT), Twist Bioscience Corporation (NASDAQ: TWST) and Western Digital (NASDAQ: WDC) to create and promote an interoperable storage ecosystem based on DNA as a data storage medium, today announced the appointments of CATALOG Technologies and Quantum Corporation to the governing board of the Alliance. David Turek will represent CATALOG and Don, Headline: UPDATE 1-Carl Icahn wants to bring back Illumina's ex-CEO -WSJ, source:Yahoo, summary: Carl Icahn wants former Illumina CEO Jay Flatley back at the U.S. life sciences firm, the Wall Street Journal reported on Wednesday, as the activist investor intensifies his proxy fight that was launched earlier this month.  In an interview with the WSJ, Icahn signaled that Illumina ""should bring Flatley back as CEO immediately"".  Icahn, who owns 1.4% of Illumina, is pushing for Illumina to unwind its buyout of cancer detection test maker Grail and is seeking three board seats after weeks of private discussions failed to yield results., Headline: Carl Icahn wants to bring back Illumina's ex-CEO -WSJ, source:Yahoo, summary: In an interview with the WSJ, Icahn signaled that Illumina ""should bring Flatley back as CEO immediately"".  Icahn, who owns 1.4% of Illumina, is pushing for Illumina to unwind its buyout of cancer detection test maker Grail and is seeking three board seats after weeks of private discussions failed to yield results., Headline: Illumina (ILMN) to Enable Tertiary Analysis With New Launch, source:Yahoo, summary: Illumina's (ILMN) Connected Software is an end-to-end software system that standardizes analysis tools and connects data across the genomics workflow., Headline: What's The Similiarity Between Disney And Illumina? Billionaire Activist Investor Wanted Retired CEO To Come Back, source:Yahoo, summary: After launching a proxy battle against Illumina Inc (NASDAQ: ILMN), activist investor Carl Icahn has clarified that he wants management change with former CEO Jay Flatley to come back and Grail divested. “They should bring Flatley back as CEO immediately,” Mr. Icahn said in an interview, without specifying whether he has contacted the former CEO about the idea. “He obviously knows the company and did a good job with it.” Mr. Flatley, who served as CEO between 1999 and 2016, is credited with tran, Headline: Carl Icahn Wants to Bring Illumina’s Old CEO Back, Disney-Style, source:Yahoo, summary: The activist investor signaled he wants change at the management level, and he has a candidate in mind for the top spot: former CEO Jay Flatley., Headline: Carl Icahn responds to Illumina `obfuscations` in open letter, source:Thefly.com, summary: No summary",ILMN
149,2023-03-30,"Headline: Carl Icahn, Illumina fight continues with dueling statements, source:Seeking Alpha, summary: No summary, Headline: Illumina (NASDAQ:ILMN): Bringing Back Old CEOs Is the Latest Fad, source:TipRanks, summary: No summary, Headline: Illumina urges shareholders to withhold votes for Icahn Group director nominees, source:Thefly.com, summary: No summary, Headline: Illumina Urges Shareholders to Reject Carl Icahn's Board Nominees, source:MarketWatch, summary: By Dean Seal Illumina Inc. is urging shareholders to vote in favor of its proposed board of directors at the next annual meeting and to withhold votes for..., Headline: Illumina urges shareholders to reject Carl Icahn's board nominees as proxy fight heats up , source:CNBC, summary: Illumina told shareholders that Carl Icahn's board nominees would ""threaten the progress"" of the biotech company's core business. , Headline: Illumina Files Preliminary Proxy, Urging Shareholders to Vote for Its Director Nominees and Withhold for Each Icahn Group Nominee, source:Yahoo, summary: Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today filed its preliminary proxy statement with the Securities and Exchange Commission, which contains important information for shareholders., Headline: Illumina chief’s pay nearly doubles ahead of clash with Carl Icahn, source:Yahoo, summary: Francis deSouza was awarded $26.7mn in total pay last year despite drop in genome sequencer’s market value, Headline: Icahn, Illumina discussed settlement before proxy fight - filing, source:Yahoo, summary: Activist investor Carl Icahn and U.S. life sciences firm Illumina failed to reach a settlement during weeks-long private negotiations before he began a proxy fight earlier this month, a regulatory filing showed on Thursday.  Icahn, who owns 1.4% of Illumina, has been pushing for the company to unwind its buyout of cancer detection test maker Grail and is seeking three board seats.  In a preliminary proxy filing, Illumina disclosed that the billionaire had proposed a negotiated settlement on March 8., Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. advanced 1.45% to $225.26 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P..., Headline: Illumina, Icahn Fight Intensifies After Negotiation Failed, source:Yahoo, summary: (Bloomberg) -- Illumina Inc. and activist investor Carl Icahn tried but failed to reach a compromise that would have avoided the public battle over seats on its board, according to a preliminary proxy statement filed by the DNA-sequencing company.Most Read from BloombergTrump Faces Fingerprints, Mug Shots After Historic Indictment$335,000 Pay for ‘AI Whisperer’ Jobs Appears in Red-Hot Market$52 Billion Chipmaking Plan Is Racing Toward FailureNew Yorkers Are Moving to These Three Florida CitiesA, Headline: UPDATE 1-Icahn, Illumina privately discussed settlement before public fight - filing, source:Yahoo, summary: Activist investor Carl Icahn and Illumina Inc had weeks-long private negotiations before he started a proxy fight to push the U.S. life sciences firm to unwind its 2021 buyout of Grail, a regulatory filing showed on Thursday.  The billionaire proposed a negotiated settlement on March 8 that included two board seats for his nominees and one for a mutually agreed candidate, according to the filing from Illumina.  He also suggested a joint statement supporting the divestiture of cancer detection test maker Grail if Illumina's appeal to European regulators, which had ordered it to sell Grail, was not successful., Headline: Icahn, Illumina privately discussed settlement before public fight - filing, source:Reuters, summary: Activist investor Carl Icahn and Illumina Inc had weeks-long private negotiations before he started a proxy fight to push the U.S. life sciences firm to unwind its 2021 buyout of Grail, a regulatory filing showed on Thursday., Headline: Carl Icahn and Illumina Proxy Fight Heats Up, source:Yahoo, summary: Biotech firm Illumina (ILMN) told shareholders not to vote for the board nominees put forward by billionaire activist investor Carl Icahn.",ILMN
150,2023-03-31,"Headline: Carl Icahn blasts Illumina for nearly doubling CEO’s pay despite steep drop in market value , source:CNBC, summary: Activist investor Carl Icahn ramped up his proxy fight against Illumina with a blistering statement. , Headline: 7 Stocks Gearing Up for a Major Breakout, source:Yahoo, summary: The entire stock market is gearing up for a major breakout as investors are becoming convinced that the banking sector has stabilized and that the Federal Reserve is, at the very least, almost done hiking interest rates. Meanwhile, two critical sectors –housing and computer chips — are showing signs of recovery. Many investors are starting to focus on the economy’s strong fundamentals instead of quaking in fear about interest rate hikes. In this environment, there are many potential breakout sto, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rose 3.24% to $232.55 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",ILMN
151,2023-04-02,"Headline: What You Missed On Wall Street On Monday, source:Thefly.com, summary: No summary",ILMN
152,2023-04-03,"Headline: Illumina ordered to divest cancer detection test maker GRAIL by FTC, source:Thefly.com, summary: No summary, Headline: FTC orders Illumina to divest cancer detection test maker GRAIL, source:Thefly.com, summary: No summary, Headline: Illumina ordered by FTC to divest GRAIL over competition concerns, source:Seeking Alpha, summary: No summary, Headline: Illumina to appeal FTC decision in federal court, source:Thefly.com, summary: No summary, Headline: Illumina sees resolution by late 2023, early 2024, source:Thefly.com, summary: No summary, Headline: Illumina to move expeditiously to divest GRAIL if it does not prevail in appeal, source:Thefly.com, summary: No summary, Headline: FTC orders Illumina to divest Grail; Illumina plans to appeal, source:MarketWatch, summary: No summary, Headline: Illumina prepared to divest GRAIL if FTC appeal fails, source:Seeking Alpha, summary: No summary, Headline: FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail, source:CNBC, summary: The decision reverses an administrative judge's ruling that dismissed the FTC's initial challenge of Illumina's $7.1 billion Grail deal. , Headline: TOP NEWS: US regulator orders Illumina to divest newly-bought Grail, source:Alliance News, summary: No summary, Headline: FTC orders Illumina to divest cancer test maker Grail on competition grounds, source:MarketWatch, summary: No summary, Headline: Midday movers: Marathon Oil, McDonald's, Illumina and more, source:Yahoo, summary: By Liz Moyer, Headline: Illumina Will Appeal FTC Decision in Federal Court, Will Seek US Resolution by Late 2023 or Early 2024, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN) today announced that it will appeal the Federal Trade Commission's (""FTC"") decision ordering the unwinding of Illumina's acquisition of GRAIL., Headline: UPDATE 2-US FTC orders Illumina to divest cancer detection test maker Grail, source:Yahoo, summary: The U.S. Federal Trade Commission (FTC) on Monday ordered Illumina to divest cancer diagnostic test maker Grail, finding that its ownership would stifle competition in the U.S. market for cancer tests.  Illumina said it would appeal the decision, and will seek expedited consideration from an appeals court.  Judge Michael Chappell, an administrative law judge at the agency, ruled last year that the $7.1 billion acquisition of Grail would not hurt competition., Headline: US FTC orders Illumina to divest cancer detection test maker Grail, source:Reuters, summary: The U.S. Federal Trade Commission (FTC) on Monday ordered Illumina to divest cancer diagnostic test maker Grail, finding that its ownership would stifle competition in the U.S. market for cancer tests., Headline: US antitrust regulator orders Illumina to unwind $8bn Grail deal, source:Yahoo, summary: The Federal Trade Commission has ordered Illumina to divest cancer screening company Grail, arguing the $8bn acquisition would damage competition in the US market for life-saving cancer tests.  The decision reverses an earlier ruling by an administrative law judge in favour of the deal and marks the latest setback to the San Diego-based company’s efforts to diversify into the nascent market for multi-cancer early detection tests.  The US antitrust regulator issued an opinion and order on Monday, which found Illumina’s decision to buy Grail, a company that it had initially spun out in 2016, would diminish innovation in the domestic market for the oncology tests while increasing prices and decreasing choice and quality of tests., Headline: NEW YORK MARKET CLOSE: Soaring oil price lifts Dow, holds back tech, source:Alliance News, summary: No summary, Headline: Illumina Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. shed 1.09% to $230.02 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: U.S. Orders Illumina to Divest Cancer Tester Grail, source:Yahoo, summary: Chief Executive Francis deSouza had championed the deal to get Illumina into the nascent market for blood tests that can detect early signs of cancers., Headline: FTC orders Illumina to unwind $7B deal for cancer test developer Grail, source:Yahoo, summary: The Federal Trade Commission has rejected Illumina's $7.1 billion acquisition of cancer detection test maker Grail, saying the deal would stifle competition., Headline: FTC Orders Illumina To Divest Grail, Mounts Pressure On Company Amid Proxy Fight With Icahn, source:Yahoo, summary: The Fed­er­al Trade Com­mis­sion has or­dered Il­lu­mi­na Inc (NASDAQ: ILMN) to di­vest Grail Inc, saying that the deal would stifle competition and innovation in the U.S. market for cancer tests. Billionaire activist Carl Icahn is preparing a proxy fight at Illumina, saying the company went ahead with the controversial acquisition of Grail Inc despite opposition from regulators, costing shareholders $50 billion. The Commission found that the acquisition would diminish innovation in the U.S. mar, Headline: FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle, source:Yahoo, summary: The FTC ordered Monday that biotech firm Illumina must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell on the news., Headline: Icahn proxy fight is 'distraction' for Illumina outlook: RBC analyst, source:Yahoo, summary: Illumina is struggling with its latest acquisition, facing regulatory backlash from both the EU and the FTC, as well as a proxy fight with activist investor Carl Icahn., Headline: FTC Rejects Illumina’s $7 Billion Deal for Cancer-Test Developer Grail, source:Yahoo, summary: The agency said the combination would hurt competition for cancer-detection tests while raising prices., Headline: Regulators Tell Illumina to Unwind GRAIL Deal, source:Yahoo, summary: Shares of Ilumina (ILMN) dropped as the Federal Trade Commission (FTC) ordered the biotech firm to unwind its purchase of cancer test provider GRAIL., Headline: FTC Overturns Approval of $7 Billion Illumina-Grail Deal, source:Yahoo, summary: It's probably too late to put the champagne back in the bottle. Some six months after biotech giant Illumina gained regulatory approval for its..., Headline: FTC Orders Illumina (NASDAQ:ILMN) to Unwind $7B Grail Acquisition, source:TipRanks, summary: No summary",ILMN
153,2023-04-04,"Headline: Grail alumni say Illumina battle threatens cancer breakthrough, source:Yahoo, summary: Two of Grail’s founding directors have warned Illumina’s battles with antitrust regulators and activist investor Carl Icahn over its ownership of the cancer screening company threaten to hamper access to potentially life-saving oncology tests.  Jeff Huber, former founding chief executive of Grail, and Meredith Halks-Miller, an Illumina scientist whose discovery led to development of its blood test that detects 50 types of cancer, said political wrangling was causing delays and funding concerns.  “One of the disappointing aspects of the European Union and Federal Trade Commission regulatory issues and now the Icahn proxy battle is that Grail is moving more slowly than it should,” Huber told the Financial Times., Headline: PRESS DIGEST- New York Times business news - April 4, source:Yahoo, summary: The following are the top stories on the New York Times business pages.  - The U.S. Federal Trade Commission on Monday ordered Illumina, the leading maker of gene-sequencing machines, to divest Grail, a cancer-test developer.  - Two workers were killed at Kennedy International Airport in New York City on Monday when they were buried under construction rubble inside a trench while moving utility lines as part of a broader overhaul at the airport., Headline: Carl Icahn Writes Another Letter to Illumina Shareholders, source:GuruFocus, summary: No summary, Headline: Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (ILMN) and Travere Therapeutics (TVTX), source:TipRanks, summary: No summary, Headline: 5 things to know before the stock market opens Tuesday, source:CNBC, summary: Here are the most important news items that investors need to start their trading day., Headline: Virgin Orbit, AMC Entertainment and Ncino fall premarket; Etsy rises, source:Yahoo, summary: By Peter Nurse, Headline: Illumina`s NovaSeq X exceeds 200th order milestone in Q1, source:Thefly.com, summary: No summary, Headline: Illumina gets Street support after probable GRAIL divestment, source:Seeking Alpha, summary: No summary, Headline: Providence and GRAIL Expand Partnership to Increase Access to Galleri® Multi-Cancer Early Detection Screening, source:Business Wire, summary: No summary, Headline: The FTC ordered Illumina to unravel its $7 billion Grail purchase, source:Yahoo, summary: The US Federal Trade Commission (FTC) ordered Illumina, a leading DNA-sequencing firm, to unravel its $7 billion acquisition of Grail, a developer of cancer-screening tests, stating the deal would hurt innovation and competition in the market., Headline: OPEC Makes the Fed’s Job Harder. That May End Up Hurting Investors., source:Yahoo, summary: OPEC production cuts put wind under major oil stocks, AMC common stock falls after ‘APE’ share settlement, Disney CEO Iger Calls Gov. DeSantis’s Actions ‘Anti-Florida,’ and other news to start your day., Headline: Illumina's revolutionary NovaSeq X exceeds 200th order milestone in first quarter 2023, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has already exceeded more than 200 orders for its revolutionary NovaSeq X sequencing system in the first quarter of 2023. The orders represent a diverse customer base spanning research and clinical customer segments in nearly 30 countries, across five continents, all seeking to add NovaSeq X – our fastest, most powerful, most sustainable high-throughput sequencer available., Headline: 25 Greatest Impacts in 25 Years: Illumina and the Evolution of Genomics, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / April 4, 2023 / Illumina Originally published on Illumina News Center This month, Illumina celebrates a quarter century of innovation, research, and passion. As a genomics pioneer founded in San Diego in 1998, we ..., Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.09% higher to $230.22 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P..., Headline: Illumina to Announce First Quarter 2023 Financial Results on Tuesday, April 25, 2023, source:Yahoo, summary: Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the first quarter 2023 following the close of market on Tuesday, April 25, 2023.",ILMN
154,2023-04-05,"Headline: Carl Ican Issues Another Letter to Illumina Shareholders, source:GuruFocus, summary: No summary, Headline: Icahn issues new letter to Illumina holders, calls for deSouza to be dismissed, source:Thefly.com, summary: No summary, Headline: Carl Icahn calls for removal of Illumina CEO Francis deSouza, source:Seeking Alpha, summary: No summary, Headline: ACEGID and Illumina to Increase Africa`s Genomics Capacity through Establishment of a Joint Training Academy, source:Accesswire, summary: No summary, Headline: ACEGID and Illumina to Increase Africa’s Genomics Capacity through Establishment of a Joint Training Academy, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / April 5, 2023 / Illumina Originally published on LinkedIn The African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, announced that it will collaborate with Illumina, a ..., Headline: Illumina celebrates 25 years of innovation, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today begins a monthlong celebration of its 25th anniversary., Headline: Illumina's (ILMN) NovaSeq X Exceeds 200 Order Milestone, source:Yahoo, summary: Illumina's (ILMN) NovaSeq X records the strongest pre-launch demand ever witnessed for any instrument., Headline: Carl Icahn says Illumina’s appeal of FTC order to divest Grail is ‘an almost impossible battle’, source:CNBC, summary: Carl Icahn shares common ground with the FTC, which argued that Illumina's acquisition of cancer test developer Grail would stifle competition and innovation. , Headline: Illumina Inc. stock underperforms Wednesday when compared to competitors despite daily gains, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.30% higher to $230.92 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",ILMN
155,2023-04-06,"Headline: 5 things to know before the stock market opens Thursday, source:CNBC, summary: Here are the most important news items that investors need to start their trading day., Headline: Illumina Rings the Bell at Nasdaq, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / April 6, 2023 / Illumina Originally published on Illumina News Center The Nasdaq closing bell in New York City signifies the end of a full day of trading on the stock market, a day of transactions made to benefit ..., Headline: Illumina (ILMN) to Expand Genomics Capacity With New Pact, source:Yahoo, summary: Illumina's (ILMN) recent collaboration is built on the shared goal of the organizations to expand sequencing capabilities and capacity for all people in Africa., Headline: Illumina Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slipped 0.40% to $229.99 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: The 3 Best Millionaire-Maker Stocks to Buy for April 2023, source:InvestorPlace, summary: No summary",ILMN
156,2023-04-07,"Headline: The Old CEO’s Back, but It Doesn’t Mean Things Will Get Better, source:MarketWatch, summary: Carl Icahn wants Illumina’s former CEO back in the saddle at the life-sciences firm. A returning CEO usually can’t pull off a Steve Jobs, however., Headline: Oil Prices Are Surging, but Futures Are Falling. Why That’s a Bullish Sign., source:MarketWatch, summary: The trading pattern, known as backwardation, looks bearish but is often bullish. The reason: Traders buy cheaper oil and producers balance the market by...",ILMN
157,2023-04-08,"Headline: Is There Any Hope for Illumina Stock?, source:Yahoo, summary: With shares of Illumina (NASDAQ: ILMN) down 37% over the last 12 months and underperforming the market over the last five years, shareholders have had a rough time.  As of April 3, regulators in the U.S. were rebuffing its acquisition of Grail, a cancer-testing company that it originally founded and spun off.  While some competitors make devices that do the same thing as Illumina's products, there's certainly no rising star anywhere in sight that could take its place.",ILMN
158,2023-04-10,"Headline: Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?, source:Yahoo, summary: Illumina, Inc. ( NASDAQ:ILMN ) saw a double-digit share price rise of over 10% in the past couple of months on the..., Headline: Illumina Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slumped 0.12% to $229.71 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",ILMN
159,2023-04-11,"Headline: Illumina partners with Henry Ford Health on genomic testing, source:Thefly.com, summary: No summary, Headline: Illumina, Henry Ford Health partner to study impact of genomic testing in heart disease, source:Seeking Alpha, summary: No summary, Headline: Illumina and Henry Ford Health team up to study impact of comprehensive genomic testing for cardiovascular patients, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Henry Ford Health, a not-for-profit health care organization in the Detroit metro area, today announced the launch of a partnership to assess the impact of comprehensive genomic testing in cardiovascular disease. The first study under this new partnership, CardioSeq, launches today and will include 1500 patients receiving care from the Division of Cardiovascular Medicine at Henry Ford., Headline: S&P 500 Q1 2023 Earnings Preview: Entering An Earnings Recession, source:SeekingAlpha, summary: Q1 is expected to mark the second consecutive quarter of negative y/y earnings growth, which meets the criteria of an earnings recession., Headline: GRAIL Showcases Methylation Platform Performance Across Cancer Continuum With New Data at American Association for Cancer Research (AACR) Annual Meeting, source:Business Wire, summary: No summary, Headline: Local Teachers Spread Passion for STEM with SD2/Illumina Corporate Foundation STEM Educators Award, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / April 11, 2023 / Illumina Originally published on SD2 By Allison Harden The 2022 SD2 and Illumina Corporate Foundation STEM Educator Awards have been awarded to local San Diego educators Hannah Nakamoto, a chemistry ..., Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. sank 0.85% to $227.76 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index..., Headline: Why Healthcare Stocks Are A Prescription For Investors In Q2 2023, source:SeekingAlpha, summary: The recent drop in biopharma stocks presents a buying opportunity for investors. Find out why XLV seems like the best fit.",ILMN
160,2023-04-12,"Headline: Illumina (ILMN) Partners With Henry Ford Health for NGS Test, source:Yahoo, summary: Illumina (ILMN) collaborates with Henry Ford Health to conduct a series of studies that is likely to focus on the genetic drivers of cardiovascular disease., Headline: Illumina's cloud-based informatics programs recognized for robust, international data privacy protections, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has received the international privacy certification of six of its cloud-based informatics programs. The certification, ISO/IEC 27701, recognizes that Illumina implements, and complies with, robust, international data privacy requirements., Headline: Illumina Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slid 0.39% to $226.88 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",ILMN
161,2023-04-13,"Headline: June 2nd Options Now Available For Illumina (ILMN), source:Stock Options Channel, summary: No summary, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. advanced 2.55% to $232.67 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",ILMN
162,2023-04-14,"Headline: RBC Capital Remains a Buy on Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Here's Why You Shouldn't Buy the Dip With Illumina Stock, source:Yahoo, summary: For example, over the last five years, Illumina's (NASDAQ: ILMN) stock is down nearly 5%.  For those who aren't familiar, Illumina is the undisputed king of the gene sequencer hardware market, to where many accept it as a quasi-monopoly.  When healthcare systems or research laboratories need to analyze genetic material, the company's devices are the industry's standard, and it has a product in every segment of the market., Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 2.00% to $228.01 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",ILMN
163,2023-04-16,"Headline: Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market, source:TalkMarkets, summary: No summary",ILMN
164,2023-04-17,"Headline: Profit from the Artificial Intelligence Boom with These 7 AI ETFs, source:InvestorPlace, summary: No summary, Headline: The African Continent Ramps Up Efforts To Crack the Code on Outbreaks, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / April 17, 2023 / Illumina Samuel Oyola, senior scientist and head of genomics at Nairobi's International Livestock Research Institute, near a vat used for long-term storage of specimen samples. Photo by: Sara Jerving ..., Headline: GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research (AACR) Annual Meeting 2023, source:Business Wire, summary: No summary, Headline: Ravgen settles patent fight with Illumina over genetic testing, source:Reuters, summary: Gene-sequencing giant Illumina Inc has settled a patent lawsuit brought by Maryland biotech company Ravgen Inc, which accused Illumina's genetic tests of infringing its patents., Headline: Illumina Inc. stock underperforms Monday when compared to competitors despite daily gains, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.86% higher to $229.97 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P..., Headline: Illumina Singapore continues to climb in Best Employers Award Reaching 7th Overall, source:Yahoo, summary: Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) was honoured today to be ranked 7th overall from 250 companies and 1st in Healthcare Equipment & Services, in Singapore's Best Employers Award.",ILMN
165,2023-04-18,"Headline: Chinese genetics company targets US despite political tensions, source:Yahoo, summary: MGI Tech insists it can succeed even though parts of its former parent BGI Group have been blacklisted, Headline: FirstHealth of the Carolinas to Offer GRAIL’s Galleri®, a Multi-Cancer Early Detection Blood Test, source:Business Wire, summary: No summary, Headline: Tarsus Pharmaceuticals, Inc. (TARS) Soars 8.6%: Is Further Upside Left in the Stock?, source:Yahoo, summary: Tarsus Pharmaceuticals, Inc. (TARS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road., Headline: Illumina Celebrates ""Save the Smile of the Yangtze River"" Charity Walk in China, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / April 18, 2023 / Illumina: From March 23rd to March 29th, a total of 206 Illumina colleagues in Greater China walked to support the recovery of the endangered species, finless porpoise population, and the healthy development ..., Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. sank 0.73% to $228.28 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index..., Headline: Beware: The Singularity Is Almost Here, source:SeekingAlpha, summary: nan, Headline: Illumina (ILMN) Receives a Buy from HSBC, source:TipRanks, summary: No summary",ILMN
166,2023-04-19,"Headline: Singapore`s Best Employers 2023: Illumina Singapore Illustrates a ���Culture of Care`, source:Accesswire, summary: No summary, Headline: GRAIL Presents Positive Analytical Validation Data on its Methylation-Based Post-Diagnostic Cancer Research Solution at American Association for Cancer Research (AACR) Annual Meeting 2023, source:Business Wire, summary: No summary, Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rose 1.46% to $231.61 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index..., Headline: Illumina wins fast-track appeal of FTC order to offload Grail, source:Reuters, summary: A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc's challenge to a federal agency order requiring the biotechnology company to divest cancer diagnostic test maker Grail LLC., Headline: Singapore’s Best Employers 2023: Illumina Singapore Illustrates a ‘Culture of Care’, source:Yahoo, summary: SINGAPORE / ACCESSWIRE / April 19, 2023 / Illumina: Originally published on The Straits Times By Cheow Sue-Ann, Business Correspondent Flexible time off, critical care leave, mentorship programmes and a week-long company-wide shutdown are just ...",ILMN
167,2023-04-20,"Headline: Illumina issues letter to shareholders regarding board nomination vote, source:Thefly.com, summary: No summary, Headline: Illumina Urges Shareholders to Vote the WHITE Proxy Card FOR all Nine of Illumina's Nominees, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today urged shareholders to vote in favor of Illumina's slate of highly qualified director nominees. It also announced that its Annual Meeting will be held virtually on May 25, 2023, at 10:00 am Pacific Time (1:00 pm Eastern Time)., Headline: Illumina Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. shed 2.62% to $225.55 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",ILMN
168,2023-04-21,"Headline: Piper Sandler Sticks to Their Buy Rating for Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Carl Icahn further accuses Illumina board of `obfuscation`, source:Seeking Alpha, summary: No summary, Headline: Illumina Is Poised to Make an Upside Breakout, source:Yahoo, summary: The charts of biotech firm Illumina  have been basing for months and now look ready and able to make an upside breakout.  In this daily bar chart of ILMN, below, I can see a large ascending triangle formation playing out from June.  An ascending triangle has roughly equal highs with rising lows., Headline: Illumina Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.94% higher to $227.68 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...",ILMN
169,2023-04-24,"Headline: Notable earnings after Tuesday`s close, source:Seeking Alpha, summary: No summary, Headline: Icahn issues letter to Illumina, accuses of `attempt to disenfranchise` holders, source:Thefly.com, summary: No summary, Headline: Illumina under the spotlight as Q1 earnings approach, source:Seeking Alpha, summary: No summary, Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.61% higher to $229.07 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P..., Headline: Carl Icahn Writes Another Open Letter to Illumina Shareholders, source:Yahoo, summary: The activist investor responds to company's recent SEC proxy statement, Headline: Sequencing at Sea - Unlocking the Power of the Genome With eDNA and NextSeq(TM) 2000, source:Yahoo, summary: In 2022, Illumina and Minderoo Foundation announced a $40M AUD partnership to leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions., Headline: 2,800 Singapore Students to Benefit from new STEM Partnership, source:Yahoo, summary: Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) today announced an inaugural partnership with the Science Centre Board to inspire 2,800 students through the power of genomics., Headline: Illumina options imply 5.4% move in share price post-earnings, source:Thefly.com, summary: No summary, Headline: Illumina reports Q1 EPS 2c, consensus 2c, source:Thefly.com, summary: No summary, Headline: Illumina sees FY23 non GAAP EPS $1.25-$1.50, consensus $1.41, source:Thefly.com, summary: No summary, Headline: Illumina Non-GAAP EPS of $0.08 beats by $0.05, revenue of $1.09B beats by $20M, source:Seeking Alpha, summary: No summary, Headline: Illumina reports Q1 non-GAAP EPS 8c, consensus 2c, source:Thefly.com, summary: No summary",ILMN
170,2023-04-25,"Headline: Illumina unveils $100M annual cost cutting plan, source:Seeking Alpha, summary: No summary, Headline: Fly Intel: After-Hours Movers, source:Thefly.com, summary: No summary, Headline: Carl Icahn Writes Another Open Letter to Illumina Shareholders, source:GuruFocus, summary: No summary, Headline: Notable companies reporting after market close, source:Thefly.com, summary: No summary, Headline: EXEL or ILMN: Which Is the Better Value Stock Right Now?, source:Yahoo, summary: EXEL vs. ILMN: Which Stock Is the Better Value Option?, Headline: Illumina: Q1 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: Illumina 1Q Profit, Revenue Drops, source:MarketWatch, summary: By Dean Seal Illumina Inc. reported an expected drop in earnings and revenue for the first quarter as its costs rose and margins tightened. The maker of..., Headline: Illumina first quarter profit, revenue fall; expects full year growth, source:Alliance News, summary: No summary, Headline: Illumina Now Expects to Post Per-Share Loss in FY23, source:MarketWatch, summary: By Dean Seal Illumina Inc. now expects to post a per-share loss this year after previously guiding for a profit. The maker of gene-sequencing machines said..., Headline: Illumina Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slipped 4.53% to $218.69 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500..., Headline: Illumina unveils plans to cut costs as it faces shrinking margins, source:CNBC, summary: The plans aim to reduce Illumina's annualized run rate expenses by more than $100 million starting later this year., Headline: Illumina, Inc. 2023 Q1 - Results - Earnings Call Presentation, source:SeekingAlpha, summary: The following slide deck was published by Illumina, Inc., Headline: Illumina Reports Financial Results for First Quarter of Fiscal Year 2023; Announces Commitment to Accelerate Margin Growth, source:Yahoo, summary: Illumina, Inc. (Nasdaq: ILMN) (""Illumina"" or the ""company"") today announced its financial results for the first quarter of fiscal year 2023, which include the consolidated financial results for GRAIL., Headline: Illumina, Inc. (ILMN) Q1 2023 Earnings Call Transcript, source:SeekingAlpha, summary: Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Q1 2023 Earnings Conference Call April 25, 2023 5:00 PM ETCompany ParticipantsSalli Schwartz - Vice President of Investor RelationsFrancis deSouza -..., Headline: Illumina Narrowly Squeaks Out First-Quarter Beat As Grail Battle Continues, source:Yahoo, summary: Illumina narrowly topped first-quarter forecasts Tuesday as its fight to retain its Grail subsidiary continues. ILMN stock dipped., Headline: Illumina (ILMN) Beats Q1 Earnings and Revenue Estimates, source:Yahoo, summary: Illumina (ILMN) delivered earnings and revenue surprises of 300% and 2.42%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?, Headline: Illumina (ILMN) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates, source:Yahoo, summary: While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values., Headline: Barclays Remains a Sell on Illumina (ILMN), source:TipRanks, summary: No summary",ILMN
171,2023-04-26,"Headline: Bank of America Securities Sticks to Its Hold Rating for Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Illumina price target raised to $229 from $224 at Baird, source:Thefly.com, summary: No summary, Headline: Analysts Conflicted on These Healthcare Names: GlaxoSmithKline (GSK), Illumina (ILMN) and USANA Health (USNA), source:TipRanks, summary: No summary, Headline: What You Missed On Wall Street On Wednesday, source:Thefly.com, summary: No summary, Headline: Illumina price target raised to $265 from $235 at Stifel, source:Thefly.com, summary: No summary, Headline: What You Missed On Wall Street This Morning, source:Thefly.com, summary: No summary, Headline: Illumina (ILMN) Shares Cross Below 200 DMA, source:Market News Video, summary: No summary, Headline: Illumina's Q1 Revenue Drop, Dwindling Margins: Outlines Cost Cutting Plans With $100M Savings, source:Yahoo, summary: In its Q1 earnings release, Illumina Inc (NASDAQ: ILMN) unveiled plans to accelerate margin improvement and create flexibility for further investment in high-growth areas. The company aims to reduce its annualized run rate expenses by more than $100 million starting later this year. Q1 Revenue of $1.09 billion was down 11% Y/Y (down 9% on a constant currency basis), beating the consensus of $1.07 billion. Adjusted EPS of $0.08 declined from $1.07 a year ago, beating the consensus of $0.02. Also, Headline: Illumina (ILMN) Q1 Earnings Beat Estimates, Margins Contract, source:Yahoo, summary: Illumina's (ILMN) Q1 revenues decline year over year, reflecting the impact of Covid-19 monitoring headwinds and the transition of its high-throughput customers to NovaSeq X., Headline: Stifel Maintains Illumina (ILMN) Buy Recommendation, source:Fintel, summary: nan, Headline: RBC Capital Maintains Illumina (ILMN) Outperform Recommendation, source:Fintel, summary: nan, Headline: Baird Maintains Illumina (ILMN) Neutral Recommendation, source:Fintel, summary: nan, Headline: Illumina CEO touts Grail’s 100% revenue growth amid proxy fight with Icahn , source:CNBC, summary: CEO Francis deSouza said San Diego-based Illumina can significantly expand the market for Grail's early cancer screening test. , Headline: Illumina Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slipped 3.53% to $210.96 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500..., Headline: Illumina Stock Tumbles As Sales, Profits Decline — Why The First-Quarter Beat Has 'Mixed Implications', source:Yahoo, summary: DNA-sequencing leader Illumina eked out a first-quarter beat, but ILMN stock toppled Wednesday on its cloudy future.",ILMN
172,2023-04-27,"Headline: Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Humana (HUM) and Illumina (ILMN), source:TipRanks, summary: No summary, Headline: SVB Securities Keeps Their Buy Rating on Illumina (ILMN), source:TipRanks, summary: No summary, Headline: June 9th Options Now Available For Illumina (ILMN), source:Stock Options Channel, summary: No summary, Headline: Breeding Better Sugar With Genomics, source:Yahoo, summary: Folk wisdom says that putting sugar in someone's gas tank will ruin their car., Headline: GE Healthcare Technologies: The Dip Offers A Renewed Buying Opportunity, source:SeekingAlpha, summary: GE Healthcare faced some pressure despite posting attractive financial results for the latest quarter. Read why I'm keeping GEHC stock rated strong buy for now., Headline: Lightning Round: Illumina's core business has some problems, source:CNBC, summary: ""Mad Money"" host Jim Cramer weighs in on stocks, including New Fortress, Illumina, Vontier and Peakstone Realty Trust., Headline: Icahn says board nominees to help keep Illumina from `sinking further`, source:Thefly.com, summary: No summary",ILMN
173,2023-04-28,"Headline: 3 Telemedicine Stocks to Watch as Healthcare Goes Digital, source:InvestorPlace, summary: No summary, Headline: Illumina DNA sequencing devices could be vulnerable to hackers - FDA, source:Seeking Alpha, summary: No summary, Headline: Baron Partners Fund Q4 2022 Quarterly Letter, source:Seeking Alpha, summary: No summary, Headline: FDA Warns Cybersecurity Vulnerability For Illumina Sequencers, source:Yahoo, summary: The FDA issued a letter noting that nearly the entire Illumina Inc's (NASDAQ: ILMN) sequencer lineup carries a cybersecurity vulnerability that could impact genomic data results or even result in a data breach. The agency said that the Universal Copy Service software in the Illumina NovaSeq 6000, NextSeq 500, NextSeq 550, NextSeq 550Dx NextSeq 1000/2000, iSeq 100, MiniSeq, MiSeq, and MiSeqDx sequencing instruments could be exploited to let an unauthorized user remotely control, or aAlter setting, Headline: Carl Icahn calls Illumina Q1 results ‘very disappointing,’ slams cost-cutting plan, source:CNBC, summary: Activist investor Carl Icahn accused Illumina CEO Francis deSouza of trying to downplay the company's ""decidedly mediocre"" Q1 2023 results this week. , Headline: Microsoft Strikes Nware Deal to Woo European Officials Over Activision Acquisition, Lyft Lay-offs Over 1K Employees, Big Oil Earnings: Top Stories For Today, source:Yahoo, summary: Benzinga Playing the Regulator Game: Microsoft Strikes Nware Deal to Woo Skeptical European Officials Over Activision Acquisition Microsoft Corp (NASDAQ: MSFT) President Brad Smith tweeted that European cloud gaming platform Nware inked a 10-year agreement to stream PC games built by Xbox on Nware's platform. After the acquisition closes, the deal also includes rights to stream Activision Blizzard, Inc's (NASDAQ: ATVI) titles on Nware's platform. Earlier, Microsoft forged similar deals with Nvid, Headline: Illumina Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.57% higher to $205.56 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...",ILMN
174,2023-04-30,"Headline: Illumina says Icahn`s campaign `spreading false information`, source:Thefly.com, summary: No summary, Headline: Illumina: Icahn`s nominees ���unqualified`, source:MarketWatch, summary: No summary",ILMN
175,2023-05-01,"Headline: Illumina criticises investor Carl Icahn's nominees for directors, source:Alliance News, summary: No summary, Headline: Illumina: Icahn’s nominees ‘unqualified’, source:MarketWatch, summary: Illumina Inc. said Monday that activist investor Carl Icahn’s board nominees are “unqualified,” urging shareholders to reject all three of Icahn’s nominees..., Headline: Illumina Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slid 1.58% to $202.31 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: Illumina Issues Shareholder Letter and Requests Shareholders Vote for the Illumina Director Nominees on the WHITE Proxy Card, source:Yahoo, summary: Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued a shareholder letter providing additional information regarding its plans to create long-term shareholder value, and requesting shareholders to vote for the Illumina director nominees on the WHITE proxy card.",ILMN
176,2023-05-02,"Headline: Illumina, Inc. (NASDAQ:ILMN) Q1 2023 Earnings Call Transcript, source:Yahoo, summary: Illumina, Inc. (NASDAQ:ILMN) Q1 2023 Earnings Call Transcript April 25, 2023 Illumina, Inc. beats earnings expectations. Reported EPS is $0.08, expectations were $0.03. Operator: Good day, ladies and gentlemen, and welcome to the First Quarter 2023 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there […], Headline: Icahn Writes Another Open Letter to Illumina Shareholders, source:GuruFocus, summary: No summary, Headline: Illumina increases equitable access to STEM education, reaching over 1 million learners, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced outcomes from its annual The Future Is Bright campaign, a monthlong global genomic literacy initiative, in which Illumina employees connect with students by hosting career panels, implementing genomics curricula, and leading hands-on experiments., Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. shed 3.53% to $195.16 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",ILMN
177,2023-05-03,"Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: No summary, Headline: 7 Stocks Poised for a Major Breakout in May 2023, source:InvestorPlace, summary: No summary",ILMN
178,2023-05-04,"Headline: Illumina Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: No summary, Headline: Carl Icahn sends open letter to Illumina shareholders, source:Thefly.com, summary: No summary, Headline: Tracking Baillie Gifford`s 13F Portfolio - Q1 2023 Update, source:Seeking Alpha, summary: No summary, Headline: Carl Icahn urges Illumina to divest GRAIL as soon as possible, source:Seeking Alpha, summary: No summary, Headline: Tracking Baillie Gifford's 13F Portfolio - Q1 2023 Update, source:SeekingAlpha, summary: Baillie Giffordâs 13F portfolio value increased from ~$96B to ~$111B this quarter. Click here to see an update on the portfolio for Q1 2023.",ILMN
179,2023-05-05,"Headline: Illumina Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: No summary",ILMN
180,2023-05-06,"Headline: Why Illumina Fell 11.6% in April, source:Yahoo, summary: The gene-sequencing company reported weaker results while the Federal Trade Commission has ordered it to divest its Grail acquisition., Headline: Better Gene Sequencing Stock: Illumina vs. Bionano Genomics, source:Yahoo, summary: Illumina (NASDAQ: ILMN) and Bionano Genomics (NASDAQ: BNGO) might both make gene sequencing devices, but as investments the two couldn't be more different.  Whereas Bionano is a new entrant to the market and still has a lot to prove to its investors as well as the scientific community, Illumina is the top dog that's fighting to maintain its position.  Bulls argue that Illumina is the better gene sequencing stock because in some sequencing markets, it's basically the only option in town, particularly in the all-important market for next generation sequencers (NGS)., Headline: Is Illumina, Inc. (NASDAQ:ILMN) Worth US$200 Based On Its Intrinsic Value?, source:Yahoo, summary: Key Insights Illumina's estimated fair value is US$164 based on 2 Stage Free Cash Flow to Equity Illumina is estimated...",ILMN
181,2023-05-08,"Headline: Illumina urges shareholders to vote the WHITE proxy card, source:Thefly.com, summary: No summary, Headline: Illumina defends ""deeply experienced"" board amid Carl Icahn attacks, source:Alliance News, summary: No summary, Headline: Illumina Sends Letter to Shareholders Highlighting Board Strength, Weakness of Icahn's ""Plan"", source:Yahoo, summary: Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued a shareholder letter highlighting the strength of its Board and noting that Carl Icahn's ""plan"" for Illumina is sloppy and uninformed., Headline: Illumina Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slipped 1.98% to $195.70 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...",ILMN
182,2023-05-09,"Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slumped 0.74% to $194.26 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500..., Headline: IEP Stock Alert: Regulators Request Information From Icahn Enterprises, source:InvestorPlace, summary: No summary, Headline: What You Missed On Wall Street On Wednesday, source:Thefly.com, summary: No summary",ILMN
183,2023-05-10,"Headline: Glass Lewis backs Icahn`s effort to oust Illumina CEO, chair, FT reports, source:Thefly.com, summary: No summary, Headline: Early notable gainers among liquid option names on May 10th, source:Thefly.com, summary: No summary, Headline: Glass Lewis backs Carl Icahn attempt to replace Illumina CEO and chair, source:Seeking Alpha, summary: No summary, Headline: Carl Icahn's company stock falls as much as 20% after prosecutors seek financial information, source:CNBC, summary: Federal investigators contacted Icahn Enterprises last Wednesday seeking information about corporate governance and other materials., Headline: What You Missed On Wall Street This Morning, source:Thefly.com, summary: No summary, Headline: PacBio equal weight at Barclays on tough macro environment, source:Seeking Alpha, summary: No summary, Headline: Glass Lewis backs Icahn's nominees for Illumina , source:Reuters, summary: Proxy adviser Glass Lewis on Wednesday recommended Illumina Inc shareholders support two of Carl Icahn's nominees to the U.S. life sciences firm's board and vote against re-election of the current chief Francis deSouza and chair John Thompson., Headline: UPDATE 2-Glass Lewis backs two of Icahn's nominees for Illumina, source:Yahoo, summary: Proxy adviser Glass Lewis said on Wednesday Illumina Inc shareholders should vote for two of Carl Icahn's nominees to the firm's board, as representatives who can challenge the current board would be beneficial to the company.  Glass Lewis added shareholders should vote against the re-election of the current chief Francis deSouza and chair John Thompson, saying they had enough reasons to advocate for a new chair.  The recommendations come ahead of the company's annual shareholder meeting on May 25, which could bring to an end the two-month long proxy battle between Illumina and billionaire investor Carl Icahn., Headline: Glass Lewis backs two of Icahn's nominees for Illumina, source:Reuters, summary: Proxy adviser Glass Lewis said on Wednesday Illumina Inc shareholders should vote for two of Carl Icahn's nominees to the firm's board, as representatives who can challenge the current board would be beneficial to the company., Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rallied 7.84% to $209.49 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500..., Headline: Glass Lewis backs Carl Icahn’s push to oust Illumina’s chief and chair, source:Yahoo, summary: Influential proxy adviser Glass Lewis has urged investors to vote against the reappointment of the chief executive and chair of Illumina, the world’s largest gene sequencing company, saying the pair have failed to take responsibility for the “value crimping” acquisition of cancer-screening group Grail.  The recommendation that shareholders withdraw their support for chief executive Francis deSouza and chair John Thompson is a boost for activist investor Carl Icahn, who has launched a proxy battle against Illumina’s board over what he describes as its “reckless” purchase of Grail.",ILMN
184,2023-05-11,"Headline: June 30th Options Now Available For Illumina (ILMN), source:Stock Options Channel, summary: No summary, Headline: Carl Icahn sends open letter to Illumina shareholders, source:Thefly.com, summary: No summary, Headline: Illumina (NASDAQ:ILMN) shareholders are up 6.6% this past week, but still in the red over the last three years, source:Yahoo, summary: As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand..., Headline: BRIEF-Icahn Says Agree With Many Of Glass Lewis Points, Most Importantly That Shareholders Vote Against Illumina CEO, Chair , source:Reuters, summary: * CARL C. ICAHN ISSUES OPEN LETTER TO SHAREHOLDERS OF ILLUMINA, INC., Headline: Illumina Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slid 0.61% to $208.21 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",ILMN
185,2023-05-12,"Headline: GSIT, TLS, MHUA and ILMN are among after hour movers, source:Seeking Alpha, summary: No summary, Headline: GSIT, TLS, MHUA and ILMN among after hour movers, source:Seeking Alpha, summary: No summary, Headline: Q1 2023 Somalogic Inc Earnings Call, source:Yahoo, summary: Q1 2023 Somalogic Inc Earnings Call, Headline: Illumina Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.19% higher to $208.60 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500..., Headline: UPDATE 2-Proxy adviser ISS backs one of Icahn's nominees for Illumina board, source:Yahoo, summary: Proxy advisory firm Institutional Shareholder Services (ISS) on Friday backed only one of Carl Icahn's three nominees to Illumina Inc's board, saying that the activist investor's push to remove the company's CEO was too disruptive.  ISS backed Icahn's candidate Andrew Teno and said he could be an adequate replacement for Illumina Chairman John Thompson, but did not support any other Icahn nominee., Headline: Proxy adviser ISS backs one of Icahn's nominees for Illumina board, source:Reuters, summary: Proxy advisory firm Institutional Shareholder Services (ISS) on Friday backed only one of Carl Icahn's three nominees to Illumina Inc's board, saying that the activist investor's push to remove the company's CEO was too disruptive., Headline: Leading Proxy Advisory Firm ISS Recommends Illumina Shareholders Vote ""FOR"" Eight of Illumina's Highly Qualified Director Nominees, source:Yahoo, summary: Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that Institutional Shareholder Services (""ISS""), a leading independent proxy voting and corporate governance advisory firm, recommends Illumina shareholders vote FOR Illumina CEO Francis deSouza and Board member Robert Epstein. Illumina's Annual Meeting is scheduled to be held on May 25, 2023, at 10:00 am Pacific Time (1:00 pm Eastern Time)., Headline: Illumina wins partial victory in Icahn battle as proxy firm ISS backs CEO DeSouza, source:Seeking Alpha, summary: No summary",ILMN
186,2023-05-14,"Headline: Icahn says Illumina shareholders `clearly want more change`, source:Thefly.com, summary: No summary, Headline: Icahn bought Illumina in Q1, sold shares of Herc and Newell, source:Thefly.com, summary: No summary",ILMN
187,2023-05-15,"Headline: Carl Icahn adds Illumina in Q1, cuts stakes in Herc, Newell Brands, source:Seeking Alpha, summary: No summary, Headline: Illumina board urges shareholders to vote the WHITE proxy card, source:Thefly.com, summary: No summary, Headline: RBC Capital Sticks to Its Buy Rating for Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Illumina board tells shareholders to ignore Carl Icahn`s `unfit associates`, source:Seeking Alpha, summary: No summary, Headline: Illumina sends letter to shareholders detailing why Illumina's nominees far outmatch Icahn's slate in skills and experience, source:Yahoo, summary: Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued a shareholder letter outlining the purpose-built mix of skills Illumina's nominees bring to the Board compared to Carl Icahn's unqualified associates, each of whom lack relevant experience and independence., Headline: What Is Illumina, Inc.'s (NASDAQ:ILMN) Share Price Doing?, source:Yahoo, summary: Let's talk about the popular Illumina, Inc. ( NASDAQ:ILMN ). The company's shares received a lot of attention from a..., Headline: Illumina Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 1.80% to $204.85 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",ILMN
188,2023-05-16,"Headline: FTC sues to block Amgen acquisition of Horizon Therapeutics, source:CNBC, summary: Amgen wants to buy Horizon Therapeutics to bolster is drug portfolio as it faces patent expirations. The FTC fears the deal could entrench monopoly positions., Headline: Illumina's genomic technologies enable better pathogen preparedness and response, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today recognized the progress and impact of genomic technologies on pathogen preparedness and response. Following the boost in sequencing infrastructure and capabilities driven by the COVID-19 pandemic, today genomic technologies are enabling public health agencies and health care systems to better prepare for, and respond to, pathogenic threats., Headline: Illumina Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slid 1.43% to $201.92 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",ILMN
189,2023-05-17,"Headline: Quick blood tests to spot cancer: will they help or harm patients?, source:Yahoo, summary: Investors are pouring billions into companies claiming they can analyse DNA to find the disease early. But some scientists question if they really work, Headline: Video: S&P 500 Movers: ILMN, CMA, source:Market News Video, summary: No summary, Headline: Illumina Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 2.20% to $197.48 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: TD Cowen life science/diagnostic analyst holds analyst/industry conference call, source:Thefly.com, summary: No summary",ILMN
190,2023-05-18,"Headline: Carl Icahn and Illumina Square Off Soon. The Stakes Are High., source:Yahoo, summary: Icahn, who's also juggling an attack from a short seller and questions from prosecutors, is going after the CEO of the gene sequencing leader., Headline: Illumina board chair issues letter, urges shareholders to vote for all nominees, source:Thefly.com, summary: No summary, Headline: Illumina call volume above normal and directionally bullish, source:Thefly.com, summary: No summary, Headline: Illumina (ILMN) Progresses in Pathogen Genomic Technologies, source:Yahoo, summary: Illumina's (ILMN) genomic surveillance solutions enable better pathogen preparedness and response., Headline: Illumina Board Chair issues letter to shareholders and urges shareholders to vote the WHITE proxy card FOR all nine of Illumina's nominees, source:Yahoo, summary: Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued a shareholder letter from Board Chair John Thompson., Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rose 1.93% to $201.29 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500..., Headline: Illumina call volume above normal and directionally bullish, source:Thefly.com, summary: No summary",ILMN
191,2023-05-19,"Headline: Carl Icahn’s activist play plays into the hands of Lina Khan and EU regulators, source:Yahoo, summary: Every company with acquisition plans in the U.S. and Europe should be concerned about the FTC partnering with EU regulators to sink the Illumina-Grail deal., Headline: TD Cowen life science/diagnostic analyst holds analyst/industry conference call, source:Thefly.com, summary: No summary, Headline: Does Illumina (NASDAQ:ILMN) Have A Healthy Balance Sheet?, source:Yahoo, summary: Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to..., Headline: 15 Best Stocks to Buy and Hold According to Billionaire Carl Icahn, source:Yahoo, summary: In this article, we discuss 15 best stocks to buy and hold according to billionaire Carl Icahn. If you want to see more stocks in this selection, check out 5 Best Stocks to Buy and Hold According to Billionaire Carl Icahn. Carl Icahn, recognized for his expertise in the financial market, faced another blow on […], Headline: Carl Icahn Dives Into Activist Investment Illumina, source:Yahoo, summary: The guru has launched a proxy battle against the company, Headline: A Wounded Carl Icahn Makes His Play at a Struggling Illumina, source:Yahoo, summary: The legendary activist, whose own company is under attack, has launched a proxy contest for three seats on the gene-sequencing giant’s board, which is mired in a messy acquisition. The stakes are high for both.",ILMN
192,2023-05-20,"Headline: Icahn Is No Saint, but Illumina Can Still Use a Flawed Savior, source:Yahoo, summary: Despite a short seller’s accusations that his company has inflated its asset prices, Carl Icahn’s effort to shake up Illumina’s board is still very much in the interest of shareholders.",ILMN
193,2023-05-22,"Headline: GRAIL to Present New Multi-Cancer Early Detection Data at the 2023 ASCO Annual Meeting, source:Business Wire, summary: No summary, Headline: $100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today, source:Benzinga, summary: No summary, Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rose 1.95% to $208.85 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...",ILMN
194,2023-05-23,"Headline: Here’s Why Baron Partners Fund Exited Illumina (ILMN), source:Yahoo, summary: Baron Funds, an investment management company, released its “Baron Partners Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. Despite the market volatility, the fund performed well and returned 23.41% in the first quarter, which exceeds the Russell Midcap Growth Index’s 9.14% return and the S&P 500 Index’s 7.50% return […], Headline: Illumina Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slipped 2.15% to $204.37 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500..., Headline: Illumina call volume above normal and directionally bullish, source:Thefly.com, summary: No summary, Headline: What You Missed On Wall Street On Wednesday, source:Thefly.com, summary: No summary, Headline: ILMN Makes Bullish Cross Above Critical Moving Average, source:Market News Video, summary: No summary",ILMN
195,2023-05-24,"Headline: Illumina can survive loss of chair and CEO, says board director, source:Yahoo, summary: Illumina is strong enough to survive the loss of its chair John Thompson and chief executive Francis deSouza if shareholders vote them down at an annual meeting on Thursday, a director of the company has said.  Gary Guthart told the Financial Times there is depth on the board and management of the world’s biggest gene sequencing company beyond the two executives, who have been targeted in a proxy battle waged by activist investor Carl Icahn., Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary, Headline: Illumina director says company strong enough to survive loss of CEO, FT reports, source:Thefly.com, summary: No summary, Headline: Icahn nominee gets enough support to win Illumina board seat, Reuters says, source:Thefly.com, summary: No summary, Headline: Illumina director says company prepared if CEO, chairman tossed out - FT, source:Seeking Alpha, summary: No summary, Headline: What You Missed On Wall Street This Morning, source:Thefly.com, summary: No summary, Headline: Alejandro Pliego’s Journey Into STEM, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / May 24, 2023 / Illumina: Originally published on Illumina News Center Alejandro Pliego is attending Princeton, class of 2027. He is smart and poised, but Princeton was hardly a foregone conclusion. The child of immigrants ..., Headline: Pluton Biosciences Raises $16.5M Series A led by Illumina Ventures and RA Capital to discover and deploy microbes that will fight climate change, source:Yahoo, summary: Pluton Biosciences, a startup leveraging the power of microbes to create cost-effective innovative solutions that address sustainability challenges facing agriculture, announces the close of a $16.5 M Series A funding round. The round was co-led by Illumina Ventures and RA Capital, with participation from existing investors Fall Line Capital, The Grantham Foundation, and First In Ventures, as well as new investors Wollemi, Radicle Growth (first investment from their second fund), and iSelect., Headline: EXCLUSIVE-Icahn poised to win at least one seat on Illumina’s board -sources, source:Reuters, summary: Activist investor Carl Icahn is set to win enough Illumina Inc shareholder support to install at least one of his three nominees to the gene sequencing machine maker’s board, two people familiar with the matter said on Wednesday., Headline: Icahn poised to win at least one seat on Illumina's board - sources, source:Yahoo, summary: NEW YORK (Reuters) -Activist investor Carl Icahn is set to win enough Illumina Inc shareholder support to install at least one of his three nominees to the gene sequencing machine maker's board, two people familiar with the matter said on Wednesday., Headline: Exclusive-Icahn poised to win at least one seat on Illumina's board -sources, source:Reuters, summary: Activist investor Carl Icahn is set to win enough Illumina Inc shareholder support to install at least one of his three nominees to the gene sequencing machine maker's board, two people familiar with the matter said on Wednesday., Headline: Illumina confirms Icahn Capital's Andrew Teno elected to board, source:Thefly.com, summary: No summary, Headline: Illumina stock declines as shareholder voting results overdone - Evercore, source:Seeking Alpha, summary: No summary, Headline: Icahn's Teno says activism 'alive and well' after Illumina elects him to board, source:Thefly.com, summary: No summary",ILMN
196,2023-05-25,"Headline: Illumina Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: No summary, Headline: Illumina’s Fight With the FTC Over Blood Testing Could Reshape U.S. Merger Policy, source:Yahoo, summary: The biotech is fighting U.S.and European regulators to save its deal for cancer screener Grail. The Supreme Court may have the last word., Headline: Icahn vs. Illumina: The CEO’s Job—and Icahn’s Reputation—Are on the Line, source:Yahoo, summary: Activist investor Carl Icahn is seeking to unseat Illumina’s chairman and its CEO, and put three of his own people on the company’s board., Headline: Carl Icahn set to win at least one Illumina board seat - report, source:Seeking Alpha, summary: No summary, Headline: July 7th Options Now Available For Illumina (ILMN), source:Stock Options Channel, summary: No summary, Headline: Icahn holdings Illumina, CVR Energy drop amid Icahn Enterprises weakness, source:Seeking Alpha, summary: No summary, Headline: Icahn holdings Illumina, CVR Energy drop amid Icahn Enterprises' weakness, source:Seeking Alpha, summary: No summary, Headline: Illumina investors elect Icahn nominee Andrew Teno to board, Bloomberg reports, source:Thefly.com, summary: No summary, Headline: Check Out What Whales Are Doing With ILMN, source:Benzinga, summary: No summary, Headline: 10 Health Care Stocks With Whale Alerts In Today's Session, source:Benzinga, summary: No summary, Headline: Midday movers: Nvidia, Illumina, American Eagle Outfitters and more, source:Yahoo, summary: Investing.com -- Stocks are mixed on Thursday as tech gets a boost from Nvidia's strong outlook while Dow stocks are weaker on a lack of resolution in the debt ceiling negotiations. Here are the market movers for May 25., Headline: Illumina shareholders oust board chair in Carl Icahn proxy battle, source:CNBC, summary: Carl Icahn has accused Illumina's management and board of poor oversight, particularly with regard to the company's acquisition of cancer test maker Grail. , Headline: Illumina shareholders vote to elect one of Carl Icahn’s candidates to its board after proxy fight, source:MarketWatch, summary: Illumina Inc. shareholders voted Thursday to elect one of activist investor Carl Icahn’s nominees to its board, and voted against the re-election of company..., Headline: Carl Icahn's Power Play at Illumina: Potential Board Changes and Management Overhaul, source:Yahoo, summary: According to undisclosed sources, activist investor Carl Icahn is poised to secure enough shareholder support to place Andrew Teno, an Icahn nominee, to join the board of Illumina Inc (NASDAQ: ILMN). However, it should be noted that the tally has not yet been finalized, and shareholders still have the opportunity to modify their votes before the commencement of the company's annual shareholder meeting on Thursday, Reuters reported. Also Read: Carl Icahn Admits Making A Mistake On Bearish Bet, Sa, Headline: Icahn Wins One Board Seat in Illumina Proxy Fight, source:Yahoo, summary: (Bloomberg) -- Illumina Inc. shareholders voted to elect a board member nominated by activist shareholder Carl Icahn, a much-needed partial victory for the billionaire as his investment firm grapples with an attack by short-seller Hindenburg Research. Andrew Teno, a portfolio manager at Icahn Capital, will join Illumina’s nine-person board as a director, the company said in a statement Thursday. Teno, one of Icahn’s three nominees, replaces Chairman John Thompson, who had been on Illumina’s boar, Headline: Icahn Nominee Elected to Illumina’s Board, source:Yahoo, summary: Shareholders selected one of the activist investor’s picks, who will replace on the board a director who had served as Illumina’s chairman., Headline: Illumina announces preliminary results of annual meeting, source:Yahoo, summary: Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that based on the preliminary results of its 2023 Annual Meeting, Illumina shareholders have voted to elect eight of nine Illumina director nominees – Francis deSouza, Robert Epstein, MD, Frances Arnold, PhD, Caroline Dorsa, Scott Gottlieb, MD, Gary Guthart, PhD, Philip Schiller, and Sue Siegel, as well as Andrew Teno, to the Board of Directors. The Board thanks John Thompson for his board te, Headline: Illumina chair ousted in proxy battle with Carl Icahn, source:Yahoo, summary: Vote to remove John Thompson is the culmination of one of the largest shareholder activism campaigns in years, Headline: Icahn vs. Illumina Is a Split Decision: CEO Survives, Chairman Is Out, source:Yahoo, summary: Activist investor Carl  Icahn  failed to topple the CEO of gene-sequencing giant  Illumina  in a proxy battle that culminated on Thursday afternoon, but succeeded in getting one of his three nominees onto the company’s board, and knocking out its chairman.  The mixed decision represents a rebuke of Illumina (ticker: ILMN) CEO Francis deSouza, though not as severe a punishment as shareholders could have handed him.  Icahn sought to replace deSouza as CEO, and one influential proxy advisor recommended that investors vote against his board nomination., Headline: UPDATE 2-Icahn scores partial Illumina win amid pressure to defend investment acumen, source:Yahoo, summary: Carl Icahn secured a seat on Thursday for one of his three nominees to the board of gene sequencing machine maker Illumina Inc, a partial victory for the activist investor who is struggling to burnish his credentials following a shortseller attack on his company.  Illumina said Icahn nominee Andrew Teno won enough shareholder votes for election, confirming an earlier Reuters report.  Illumina's market value of $30 billion made the fight this year's largest proxy contest to go to a shareholder vote., Headline: U.S. Equities End Mixed on Nvidia News, Debt Ceiling Worries, source:Yahoo, summary: U.S. equities were mixed on Thursday, May 25, 2023 as Nvidia's results and outlook helped send the Nasdaq and S&P 500 higher, while the Dow fell on growing concerns about a possible government default., Headline: Icahn scores partial Illumina win amid pressure to defend investment acumen, source:Reuters, summary: Carl Icahn secured a seat on Thursday for one of his three nominees to the board of gene sequencing machine maker Illumina Inc, a partial victory for the activist investor who is struggling to burnish his credentials following a shortseller attack on his company., Headline: Baillie Gifford Dumps Salesforce, Loads Up on AMD, source:GuruFocus, summary: No summary",ILMN
197,2023-05-26,"Headline: Why Vice’s bankruptcy is a warning on private equity investment, source:Yahoo, summary: Plus, the battle heats up between Icahn and Illumina and Cayman Islands defends itself as a go-to for the super-rich, Headline: Analysts Are Neutral on These Healthcare Stocks: Illumina (ILMN), Pfizer (PFE), source:TipRanks, summary: No summary, Headline: Illumina Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: No summary, Headline: Illumina chair fails to survive board vote amid Carl Icahn proxy fight, source:Alliance News, summary: No summary, Headline: Debt Deal Optimism, AI Rally Can’t Mask Market Fears Ahead of the Weekend, source:Yahoo, summary: High hopes for Memorial Day travel, Illumina CEO survives in split decision for Carl Icahn, and other news to start your day., Headline: 12% Of This Illumina Insider's Holdings Were Sold \, source:Yahoo, summary: Insiders were net sellers of Illumina, Inc.'s ( NASDAQ:ILMN ) stock during the past year. That is, insiders sold more..., Headline: Illumina (NASDAQ:ILMN): A Major Victory for Carl Icahn’s Activism, source:TipRanks, summary: No summary, Headline: The Olive Oil Crisis Spreads as Prices Soar. What’s to Blame. , source:MarketWatch, summary: A record heat wave hit Spain last summer, the world’s largest producer of olive oil, reducing production by half. The culprit may be climate change, which is...",ILMN
198,2023-05-27,"Headline: Illumina accused by Brussels of ‘delay tactics’ on Grail divestiture, source:Yahoo, summary: Brussels has accused Illumina of using “delay tactics” to prevent a speedy ruling on whether the world’s biggest gene sequencing company should be forced to divest cancer test developer Grail.  It follows repeated claims by Illumina that it is moving as “expeditiously as possible” to resolve litigation linked to its $8bn acquisition of Grail, which is the focus of a bruising proxy battle waged by Carl Icahn, the veteran activist investor.  US antitrust regulators also ordered Grail’s divestiture in April, a decision Illumina is appealing against.",ILMN
199,2023-05-29,"Headline: Fly Intel: Top five weekend stock stories, source:Thefly.com, summary: No summary, Headline: Illumina fight with FTC could reshape U.S. merger policy, Barron's says, source:Thefly.com, summary: No summary",ILMN
200,2023-05-30,"Headline: Carl Icahn Buys Activist Target Illumina, Adds to Southwest Gas Stake, source:GuruFocus, summary: No summary, Headline: Real-world study data reveals better outcomes for cancer patients who receive comprehensive genomic testing, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of the latest data on the impact of comprehensive genomic profiling (CGP) for oncology patients, which will be presented at the American Society of Clinical Oncology's Annual Meeting June 2–6 in Chicago. In addition to the real-world study data, Illumina, along with study collaborators, will also present on findings that expose gaps in current standard-of-care and unmet needs for ca, Headline: Illumina Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. shed 0.70% to $194.51 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index..., Headline: CORRECTED-Illumina CEO survived Icahn's challenge by more than 2-to-1 margin, source:Yahoo, summary: Illumina Inc CEO Francis deSouza survived a challenge to his board seat from activist investor Carl Icahn last week by securing more than twice the shareholder votes than the number his challenger received, the company said in a filing on Tuesday.  It gives deSouza legitimacy to carry on after Icahn mustered enough shareholder support to oust Illumina's board chair John Thompson and install one of his board nominees, Andrew Teno., Headline: Illumina CEO survived Icahn's challenge by more than 2-to-1 margin, source:Yahoo, summary: Illumina Inc CEO Francis deSouza survived a challenge to his board seat from activist investor Carl Icahn last week by securing more than twice the shareholder votes than the number his challenger received, the company said in a filing on Tuesday.  It gives deSouza legitimacy to carry on after Icahn mustered enough shareholder support to oust Illumina's board chair John Thompson and install one of his board nominees, Andrew Teno., Headline: Illumina CEO survived Icahn's challenge by more than 2-to-1 margin, source:Reuters, summary: Illumina Inc CEO Francis deSouza survived a challenge to his board seat from activist investor Carl Icahn last week by securing more than twice the shareholder votes than the number his challenger received, the company said in a filing on Tuesday., Headline: First Week of ILMN December 15th Options Trading, source:Stock Options Channel, summary: No summary",ILMN
201,2023-05-31,"Headline: Illumina (ILMN) to Present Real-World CGP Data at ASCO Meet '23, source:Yahoo, summary: At the ASCO meeting, Illumina (ILMN) is set to showcase data that highlights better outcomes for cancer patients who receive comprehensive genomic testing., Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rallied 1.10% to $196.65 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500..., Headline: Illumina to Host Third Annual Virtual ESG Investor Event on Monday, June 12, 2023, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN) announced today that it will host its third annual virtual Environment, Social and Corporate Governance (ESG) focused investor event at 9:00 am Pacific Time (12:00 pm Eastern Time), Monday, June 12, 2023., Headline: Illumina announces AI algorithm that predicts disease-causing genetic mutations, source:Thefly.com, summary: No summary, Headline: Illumina launches AI software to predict disease-causing genetic mutations, source:Seeking Alpha, summary: No summary",ILMN
202,2023-06-01,"Headline: The Market Continues To Underprice Illumina's Stock And Its Genomics Leadership, source:SeekingAlpha, summary: Illumina is undervalued by 23% according to a discounted cash flow analysis, with a fair value of $253.94. Read why ILMN stock is a Buy., Headline: Illumina's GRAIL present on first study of multi-cancer early detection at ASCO, source:Thefly.com, summary: No summary, Headline: Interesting ILMN Put And Call Options For July 14th, source:Stock Options Channel, summary: No summary, Headline: IN BRIEF: Illumina unveils AI software to predict patient mutations, source:Alliance News, summary: No summary, Headline: Why Is Repligen (RGEN) Up 2.7% Since Last Earnings Report?, source:Yahoo, summary: Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues., Headline: Illumina unveils AI software to predict disease-causing genetic mutations in patients, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the new PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts with unprecedented accuracy disease-causing genetic mutations in patients. The results are published in two papers in the June 2 issue of Science (issue 6648), detailing the training of the algorithm and its application to half a million genomes in the UK Biobank cohort. Two accompanying papers on the primate e, Headline: ‘Primate AI algorithm’ predicts genetic health risks, source:Yahoo, summary: Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans, Headline: GRAIL and University of Oxford to Present Results From First Prospective Study of Multi-Cancer Early Detection in a Symptomatic Patient Population at 2023 ASCO Annual Meeting, source:Business Wire, summary: No summary, Headline: Over 400 Grail patients falsely told they may have cancer, FT reports, source:Thefly.com, summary: No summary, Headline: Illumina unit Grail in hot water over erroneous cancer results – FT, source:Seeking Alpha, summary: No summary",ILMN
203,2023-06-02,"Headline: Illumina elects Hologic chair and chief executive to board as chair, source:Alliance News, summary: No summary, Headline: Elon Musk Calls China-Made Tesla's Highest Quality, Exxon Eyes Double Output With New Fracking Tech, Netflix Shareholders Vote Against Fat Exec. Pay: Today's Top Stories, source:Benzinga, summary: No summary, Headline: Elon Musk Praises Quality of Made in China Teslas, Exxon Eyes Double Output With New Fracking Tech, Netflix Shareholders Vote Against Fat Exec. Pay: Today's Top Stories, source:Benzinga, summary: No summary, Headline: Illumina names Hologic CEO as chair, elects Edwards CFO to board, source:Seeking Alpha, summary: No summary, Headline: Illumina's Board of Directors elects two experienced Independent Directors to Board, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of governance changes consistent with the goal of enhancing long-term shareholder value., Headline: Illumina board appoints Hologic CEO as non-exec chairman, source:Reuters, summary: Illumina Inc said on Friday it has elected two new independent board members, including Hologic Inc CEO Stephen MacMillan as the non-executive chairperson, with immediate effect. (Reporting by Leroy Leo in Bengaluru; Editing by Savio D'Souza), Headline: UPDATE 2-Illumina expands board after fight with Icahn, source:Yahoo, summary: Illumina Inc on Friday said it had expanded its board, adding two C-suite executives a week after shareholders voted to replace the gene sequencing company's chairman with activist investor Carl Icahn's nominee.  On Friday it named Stephen MacMillan, CEO of diagnostics products company Hologic Inc, and Scott Ullem, CFO of heart valve systems maker Edwards Lifesciences Corp, as new directors., Headline: Stock Buying Ideas After The Non-Farm Payroll Report, source:SeekingAlpha, summary: The U.S. saw strong job growth in the service super sector, government and healthcare. Read more on investment ideas after the release of the May jobs report., Headline: Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients. PrimateAI-3D utilizes deep neural network architectures similar to ChatGPT and AlphaFold, but is trained on genome sequences rather than human language. After applying the algorithm to half a million genomes in the U.K. Biobank cohort detailing the training, the results showed unprecedented accuracy. The result is a deep neural network that h, Headline: Why Is Horizon Therapeutics (HZNP) Down 9% Since Last Earnings Report?, source:Yahoo, summary: Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues., Headline: Illumina expands board after fight with Icahn, source:Reuters, summary: Illumina Inc on Friday said it had expanded its board, adding two C-suite executives a week after shareholders voted to replace the gene sequencing company's chairman with activist investor Carl Icahn's nominee., Headline: Illumina's (ILMN) New AI Tool to Predict Genomics Disease, source:Yahoo, summary: Illumina's (ILMN) PrimateAI-3D will be made broadly available to the genomics community integrated across Illumina Connected Software., Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. advanced 4.13% to $207.31 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500..., Headline: Grail says over 400 patients incorrectly informed they may have cancer, source:Yahoo, summary: About 400 patients who signed up to take cancer diagnostic test maker Grail's pioneering oncology detection test received erroneous letters suggesting they may have developed cancer, the company said on Friday.  Grail's flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear.  The company, owned by Illumina Inc, said the letters were mistakenly sent by its telemedicine provider PWNHealth due to a software issue and that it ""was in no way related to or caused by an incorrect Galleri test result""., Headline: UPDATE 1-Grail says about 400 patients incorrectly informed they may have cancer, source:Yahoo, summary: Cancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer.  Grail's flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear.  The company, owned by Illumina Inc, said the letters were mistakenly sent by PWNHealth due to a software issue and that it ""was in no way related to or caused by an incorrect Galleri test result""., Headline: Grail says about 400 patients incorrectly informed they may have cancer, source:Reuters, summary: Cancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer.",ILMN
204,2023-06-03,"Headline: GRAIL Presents Real-World Experience With The Galleri® Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting, source:Business Wire, summary: No summary, Headline: New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing, source:Business Wire, summary: No summary, Headline: Blood-Test Customers Mistakenly Told They May Have Cancer, source:Yahoo, summary: Grail said its telemedicine vendor sent the inaccurate forms to 400 people because of a software glitch.",ILMN
205,2023-06-05,"Headline: Tracking Carl Icahn's Portfolio - Q1 2023 Update, source:SeekingAlpha, summary: Carl Icahn's 13F portfolio value increased from $21.75B to $22.03B, with the number of holdings rising from 16 to 17. Click here for a detailed discussion., Headline: Illumina releases 2022 CSR report, source:Thefly.com, summary: No summary, Headline: Early notable gainers among liquid option names on June 5th, source:Thefly.com, summary: No summary, Headline: Illumina releases 2022 Corporate Social Responsibility Report, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its annual Corporate Social Responsibility (CSR) Report, highlighting the company's commitment to human health, and the progress made by its environmental, social, and governance (ESG) program in 2022., Headline: Software Configuration Error at Grail Causes Cancer Misdiagnosis Scare; Could It Impact Illumina's Acquisition Plans?, source:Yahoo, summary: Illumina Inc's (NASDAQ: ILMN) Grail Inc acquisition is reportedly in more hot water when Grail mistakenly sent form letters to 400 patients, suggesting they may have developed cancer. Galleri, the company's primary blood test for cancer diagnosis, is designed to detect more than 50 different malignancies even before symptoms appear. Related: FTC Orders Illumina To Divest Grail, Mounts Pressure On Company Amid Proxy Fight With Icahn. Grail sells Galleri at about $950 per test and markets it to in, Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. advanced 1.57% to $210.56 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500..., Headline: Tuesday Sector Laggards: Healthcare, Consumer Products, source:Market News Video, summary: No summary, Headline: Illumina asks appeals court to undo FTC ruling that it must sell subsidiary, source:Reuters, summary: Illumina Inc filed an appeal late on Monday against an order by the U.S. Federal Trade Commission, which is demanding that the company divest cancer diagnostic test maker Grail Inc because of concern that its ownership would stifle competition in the U.S. market for cancer..., Headline: UPDATE 2-Illumina appeals FTC order to divest cancer test maker Grail, source:Yahoo, summary: Illumina on Monday filed an appeal against a Federal Trade Commission (FTC) order, demanding that it divest cancer diagnostic test maker Grail over competition concerns in the U.S. market for cancer tests.  San Diego-based Illumina is arguing that the FTC ""violated due process by depriving Illumina and Grail of a fair proceeding before an impartial tribunal,"" according to the filing in the U.S. Fifth Circuit Court of Appeals.  The FTC in April ruled for a second time that Illumina's 2021 acquisition of its formerly part-owned subsidiary should be undone.",ILMN
206,2023-06-06,"Headline: Illumina appeals FTC order to divest cancer test maker Grail, source:Reuters, summary: Illumina on Monday filed an appeal against a Federal Trade Commission (FTC) order, demanding that it divest cancer diagnostic test maker Grail over competition concerns in the U.S. market for cancer tests., Headline: $100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today, source:Benzinga, summary: No summary, Headline: S&P 500 struggles for direction as regional banks rebound, but health care weighs, source:Yahoo, summary: Investing.com -- The S&P 500 slipped between gains and losses Tuesday as investors digested a slip in health care stocks and renewed investor appetite for regional banking stocks., Headline: LGND or ILMN: Which Is the Better Value Stock Right Now?, source:Yahoo, summary: LGND vs. ILMN: Which Stock Is the Better Value Option?, Headline: Stock market today: Dow cuts losses to eke out win as regional banks flex muscles, source:Yahoo, summary: Investing.com -- The Dow ended the day above the flatline Tuesday after cutting gains into the close as renewed investor appetite for regional banking stocks and a climb in tech helped offset losses in health care stocks., Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 3.56% to $203.07 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index..., Headline: TIMELINE-Rocky history of Illumina's Grail deal, source:Yahoo, summary: Gene-sequencing machine maker Illumina Inc has filed an appeal against an order from the U.S. Federal Trade Commission (FTC) that demands it divest cancer diagnostic test maker Grail Inc due to competition concerns.  Illumina spun off Grail in 2016 but retained a 12% stake., Headline: Rocky history of Illumina's Grail deal, source:Reuters, summary: Gene-sequencing machine maker Illumina Inc has filed an appeal against an order from the U.S. Federal Trade Commission (FTC) that demands it divest cancer diagnostic test maker Grail Inc on competition concerns.",ILMN
207,2023-06-07,"Headline: SVB Securities Sticks to Its Buy Rating for Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Illumina Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. shed 0.36% to $202.33 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",ILMN
208,2023-06-08,"Headline: House Republicans seek information from FTC over Illumina's Grail takeover, source:Seeking Alpha, summary: No summary, Headline: House Republicans seek information from FTC over Illumina's Grail deal, source:Seeking Alpha, summary: No summary, Headline: US House Republicans press FTC about fight against Illumina's Grail buy, source:Yahoo, summary: The chair of the House Judiciary Committee, Jim Jordan, and two other Republicans wrote to the U.S. Federal Trade Commission on Thursday to demand information about the agency's battle to oppose Illumina's purchase of former subsidiary Grail.  Jordan, along with Representatives Darrell Issa and Thomas Massie, expressed concern that the agency inappropriately worked with European regulators to get the $7.1 billion deal scrapped.  Massie is chair of the panel's antitrust subcommittee., Headline: Illumina Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.19% higher to $202.72 Thursday, on what proved to be an all-around positive trading session for the stock market, with the...",ILMN
209,2023-06-09,"Headline: Illumina (ILMN) Sequencing Arm Grows, Margin Woes Linger, source:Yahoo, summary: Illumina's (ILMN) total sequencing activity on connected high- and mid-throughput instruments are growing strongly., Headline: Illumina Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slid 1.08% to $200.53 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",ILMN
210,2023-06-11,"Headline: Illumina CEO is said to have resigned, source:Seeking Alpha, summary: No summary, Headline: Illumina CEO Francis deSouza leaving, Charles Dadswell named interim CEO, source:Thefly.com, summary: No summary, Headline: Illumina announces CEO transition plan, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has accepted the resignation of Francis deSouza as Illumina's Chief Executive Officer and as a Director, effective Sunday, June 11. Charles Dadswell, Senior Vice President and General Counsel, has been named interim CEO while the Board of Directors conducts a search for a new CEO. Mr. deSouza will stay on in an advisory capacity until July 31, 2023., Headline: Illumina appoints Dadswell as interim CEO, source:Reuters, summary: Illumina said on Sunday that it had appointed Charles Dadswell as interim chief executive officer while the board conducts a search for a new CEO. (Reporting by Lavanya Ahire in Bengaluru; editing by Jason Neely), Headline: Francis deSouza resigns as Illumina boss after proxy battle with Carl Icahn, source:Yahoo, summary: Illumina chief executive Francis deSouza has resigned following a bruising proxy battle with activist investor Carl Icahn over the future of the world’s biggest gene sequencing company.  Illumina said on Sunday that the company’s board of directors had accepted deSouza’s immediate resignation and begun a search for a replacement.  DeSouza will stay on in an advisory capacity at Illumina until July 31, said the company., Headline: UPDATE 1-Illumina CEO Francis DeSouza resigns, source:Yahoo, summary: The CEO of gene-sequencing machine maker Illumina Francis DeSouza has resigned from the group, it said on Sunday, weeks after he survived a challenge to his board seat from activist investor Carl Icahn.  In May Icahn secured a seat for one of his three nominees to Illumina's board, marking a partial victory for him and his months-long proxy battle to remove DeSouza.  The company said on Sunday senior vice president and General Counsel Charles Dadswell will take over as interim CEO while a replacement for DeSouza is found., Headline: Illumina CEO DeSouza Resigns Following Pressure From Icahn, source:Yahoo, summary: (Bloomberg) -- Illumina Inc.’s board accepted the resignation of Chief Executive Officer Francis deSouza, handing a victory to activist investor Carl Icahn who had been seeking his removal.Most Read from BloombergOil Traders Are Daring to Defy Market Kingpin Saudi ArabiaUBS Completes Credit Suisse Takeover to Create Bank TitanAs Fed Signals Rate Pause, Powell Will Have to Placate HawksGoldman’s Low US Recession Odds Get It Wrong, Bond Investors SayJeff Bezos Has Gained $10 on Mystery Purchase of, Headline: Illumina CEO Francis deSouza Resigns, source:Yahoo, summary: Head of gene-sequencing test maker steps aside after regulators challenged deal for a cancer test-developer., Headline: Illumina CEO Francis DeSouza resigns after battle with Icahn, source:Reuters, summary: Illumina Chief Executive Officer Francis DeSouza stepped down on Sunday, the gene-sequencing machine maker said in a statement, ending a battle with activist investor Carl Icahn in which the company's chairman left the company earlier this year., Headline: Illumina CEO Steps Down, source:Yahoo, summary: The gene sequencing company has been in a battle with regulators over its $7 billion deal for cancer test maker Grail., Headline: Illumina CEO resigns amid pressure from activist investor Carl Icahn, source:Yahoo, summary: Gene sequencing test maker Illumina Inc. said Sunday that its board has accepted the resignation of its CEO and director, Francis deSouza, effective immediately.  Charles Dadswell, senior vice president and general counsel, has been named interim CEO, while the board conducts a search for a new CEO.  Illumina said deSouza, who has been with the company since 2013 and was named CEO three years later, will stay on in an advisory capacity until July 31., Headline: Illumina CEO deSouza resigns after battle with Icahn, source:Reuters, summary: Illumina CEO Francis deSouza stepped down on Sunday, the gene-sequencing machine maker said in a statement, ending a battle with activist investor Carl Icahn in which the company's chairman left the company earlier this year., Headline: Tech Sector Powers S&P 500 To 10-Month High, While Oil Stocks Struggle: What's Driving Markets Today, source:Benzinga, summary: No summary, Headline: PRESS DIGEST-Financial Times - June 12, source:Yahoo, summary: Andreessen Horowitz has chosen London for its first office outside the U.S., betting that the UK government will create a more hospitable climate for blockchain start-ups amid a crypto crackdown by the American financial regulator.  - The European Union has offered Tunisia more than 1 billion euros ($1.07 billion) in a bid to help the North African nation overcome a deepening economic crisis that has prompted thousands of migrants to cross the Mediterranean Sea to Italy.  - Illumina CEO Francis deSouza has resigned following a bruising proxy battle with activist investor Carl Icahn over the future of the world's biggest gene-sequencing machine maker., Headline: Tech Sector Powers S&P 500 To 10-Month High While Oil Stocks Struggle: What's Driving Markets Today, source:Benzinga, summary: No summary, Headline: Illumina CEO Francis deSouza resigns amid proxy battle with Carl Icahn, source:Alliance News, summary: No summary, Headline: Illumina CEO deSouza resigns after proxy battle with Icahn, source:Reuters, summary: Illumina CEO Francis deSouza stepped down on Sunday, marking a victory for activist investor Carl Icahn and heightening expectations that it could unwind its controversial $7.1 billion acquisition of Grail., Headline: What You Missed On Wall Street On Monday, source:Thefly.com, summary: No summary",ILMN
211,2023-06-12,"Headline: Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move, source:MarketWatch, summary: No summary, Headline: Illumina CEO change likely to be viewed positively, says Citi, source:Thefly.com, summary: No summary, Headline: Biogen, Carnival and Oracle post solid gains, while Nasdaq and KeyCorp slump, source:MarketWatch, summary: Here are some of the biggest movers on Monday., Headline: Goldman pushes back against bearish Morgan Stanley’s Mike Wilson with new 4,500 S&P 500 target, source:MarketWatch, summary: No summary, Headline: Illumina (NASDAQ:ILMN) CEO Vacates Office;  Path to Victory for Activist Investor Carl Icahn, source:TipRanks, summary: No summary, Headline: Nasdaq, S&P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low, source:Benzinga, summary: No summary, Headline: Illumina gains as Carl Icahn sees positives in CEO transition, source:Seeking Alpha, summary: No summary, Headline: Illumina rises as Carl Icahn sees positives in CEO transition, source:Seeking Alpha, summary: No summary, Headline: Goldman pushes back against bearish Morgan Stanley's Mike Wilson with new 4,500 S&P 500 target, source:MarketWatch, summary: Resilient economic growth and softening inflation will keep stocks supported, says Goldman Sachs, which has a new bullish S&P 500 target., Headline: Canaccord Genuity Reaffirms Their Buy Rating on Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Analysts’ Top Healthcare Picks: Keros Therapeutics (KROS), Biogen (BIIB), source:TipRanks, summary: No summary, Headline: Stocks making the biggest moves before the bell: Nasdaq, Illumina, Oracle, Carnival & more, source:CNBC, summary: These are the stocks posting the largest moves in premarket trading. , Headline: Illumina shares likely to trend up again, says Piper Sandler, source:Thefly.com, summary: No summary, Headline: Illumina rises as Carl Icahn sees positives in CEO transition (update), source:Seeking Alpha, summary: No summary, Headline: Illumina shares rise after CEO resignation, source:MarketWatch, summary: Illumina Inc. stock gained 4.7% premarket on Monday after the company announced Sunday that its board had accepted the resignation of Francis deSouza as CEO,..., Headline: Illumina shares rise after CEO deSouza steps down, source:Yahoo, summary: Investing.com -- Shares in Illumina Inc (NASDAQ:ILMN) rose in premarket U.S. trading on Monday after the gene-sequencing machine maker's Chief Executive Francis deSouza stepped down over the weekend., Headline: A Skip and Pause Aren’t the Same. What’s Next for Fed’s Inflation Fight., source:Yahoo, summary: Glencore bids for Teck’s coal assets, new CEO at Illumina amid Grail battle, and other news to start your day., Headline: What You Missed On Wall Street This Morning, source:Thefly.com, summary: No summary, Headline: Expert Ratings for Illumina, source:Benzinga, summary: No summary, Headline: Is CEO Resignation a Sign That Carl Icahn Can Save Illumina (ILMN) Stock?, source:InvestorPlace, summary: No summary, Headline: Stocks to Watch Monday: Biogen, Illumina, Oracle, source:Yahoo, summary: **↗️** [**Biogen (BIIB)**](https://www.wsj.com/market-data/quotes/BIIB): The biotech company's shares rose 1.3% after an advisory committee [recommended the Food and Drug Administration approve Leqembi](https://investors., Headline: Midday movers: Oracle, Carnival Corp., Illumina and more, source:Yahoo, summary: Investing.com -- Stocks are rising as investors await Tuesday's inflation report and the start of the Federal Reserve's two-day meeting. Here are the market movers for June 12., Headline: Stocks making the biggest moves midday: Carnival, Nasdaq, Oracle, KeyCorp and more, source:CNBC, summary: These are the stocks posting the largest moves midday., Headline: Executive Shakeup at Illumina: CEO Francis deSouza Steps Down Amid Activist Investor Carl Icahn's Pressure, source:Yahoo, summary: Illumina Inc (NASDAQ. ILMN) announced that its Board of Directors accepted the resignation of Francis deSouza as Illumina’s Chief Executive Officer and Director, effective June 11. Charles Dadswell, Senior Vice President and General Counsel, has been named interim CEO while the Board of Directors searches for a new CEO. Mr. deSouza has been with Illumina since 2013 and served as chief executive since 2016. Mr. deSouza will remain in an advisory capacity until July 31, 2023. The resignation comes, Headline: Oracle earnings, Illumina CEO steps down, Nasdaq-Adenza deal: Trending stocks, source:Yahoo, summary: Oracle is set to report Q4 earnings after the bell. Illumina CEO steps down. Nasdaq Inc. is acquiring Adenza in $10.5 billion deal. Yahoo Finance Live breaks down some of the trending stocks this morning., Headline: Pharma: M&A strategy gets dose of bitter medicine, source:Yahoo, summary: Medicines price gouger Martin Shkreli was one of a kind.  Illumina bought cancer test developer Grail for $8bn in 2021, even though US and EU authorities complained the US gene sequencer could deny crucial inputs to Grail’s rivals.  On Monday, its boss Francis deSouza resigned after a proxy fight with activist investor Carl Icahn over Illumina’s decision to proceed., Headline: llumina CEO deSouza resigns after proxy battle with Carl Icahn, source:Yahoo, summary: Illumina CEO Francis deSouza has stepped down after a lengthy proxy battle with activist investor Carl Icahn. Yahoo Finance health care reporter Anjalee Khemlani breaks down the timeline of events, while also commenting on Novartis' $3.5 billion acquisition deal with Chinook Therapeutics., Headline: Broadcom Might Receive European Approval For $61B VMware Deal, UBS Closes Credit Suisse Takeover, Illumina CEO Steps Down Amid Activist Investor Carl Icahn's Pressure: Today's Top Stories, source:Yahoo, summary: Reuters Broadcom Most Likely To Receive EU Approval For $61B VMware Merger In early May, U.S. chipmaker Broadcom Inc's (NASDAQ: AVGO) CEO Hock Tan proposed a pitch to EU antitrust enforcers regarding the pro-competitiveness of the proposed $61 billion bid for cloud computing firm VMware Inc (NASDAQ: VMW). Broadcom is set to gain conditional EU antitrust approval for its proposed acquisition of VMware. The European Commission's approval is linked to Broadcom's interoperability remedies to rivals, Headline: Illumina, Inc. (ILMN) Special Call (2023 ESG Investor Event) Transcript, source:SeekingAlpha, summary: Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Special Call (2023 ESG Investor Event) Transcript June 12, 2023 12:00 PM ETCompany ParticipantsSalli Schwartz - Vice President of Investor..., Headline: Illumina Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. rallied 3.79% to $208.14 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500..., Headline: These Stocks Are Moving the Most Today: Tesla, Carnival, Nasdaq, SoFi, and More, source:Yahoo, summary: Tesla is rising for a 12th consecutive day, Carnival trades higher after Wall Street upgrades the stock, and Nasdaq falls after agreeing to acquire software company Adenza for $10.5 billion in cash and shares., Headline: After Illumina CEO’s Fall, Other Executives Are Expected to Take Hard Look at Deals, source:Yahoo, summary: Francis deSouza resigned from gene-sequencing maker after regulators challenged $7.1 billion deal, triggering proxy battle with Carl Icahn., Headline: Illumina CEO’s Resignation May Restore Stock’s Popularity, source:Yahoo, summary: The gene-sequencing firm's shares were up 3% mid-Monday, to $206, as traders digested the news of Francis deSouza's resignation., Headline: Canaccord Genuity Reiterates Illumina (ILMN) Buy Recommendation, source:Fintel, summary: nan, Headline: Tesla charging wins, Illumina CEO steps down, Nasdaq-Adenza deal: Trending stocks, source:Yahoo, summary: Tesla's charging plug is being used by more EV charging companies, the Nasdaq is acquiring Adenza in $10.5 billion deal, and Illumina shares rise as CEO steps down. Yahoo Finance Live breaks down some of the trending stories of the day.",ILMN
212,2023-06-13,"Headline: Illumina acquisition of Grail wins support from GOP lawmakers, state AGs as FTC tries to block it, source:CNBC, summary: The groups argued in the briefs that the FTC overstepped its authority in trying to unwind Illumina's $7.1 billion acquisition of Grail. , Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. dropped 0.62% to $206.84 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",ILMN
213,2023-06-14,"Headline: GOP lawmakers, state AGs voice support for Illumina's Grail acquisition, source:CNBC, summary: CNBC's Becky Quick reports on the latest news., Headline: Here's Why You Should Retain Illumina (ILMN) Stock for Now, source:Yahoo, summary: Investors are optimistic about Illumina (ILMN) on solid long-term growth potential in the oncology space., Headline: 10 DNA Stocks Billionaires Are Loading Up On, source:Yahoo, summary: In this article, we discuss 10 DNA stocks that billionaires love. If you want to skip our detailed analysis of the DNA market, head over to 5 DNA Stocks Billionaires Are Loading Up On. Genomics is the study of a complete set of DNA within an organism. The global genomics market was worth $28.39 billion […], Headline: Illumina Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. dropped 0.97% to $204.84 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500..., Headline: Illumina's Grail Acquisition Gains Support from GOP Lawmakers and Advocacy Groups Despite FTC Resistance, source:Yahoo, summary: Republican lawmakers, state attorneys general, and several advocacy groups have expressed their support for Illumina Inc's (NASDAQ: ILMN) acquisition of Grail Inc, even as the Federal Trade Commission (FTC) continues challenging the deal. On Monday, these groups filed 14 amicus briefs urging the U.S. 5th Circuit Court of Appeals to reverse the FTC's order, which sought to undo the Grail deal due to concerns about competition suppression. Illumina appealed the agency's ruling last week, CNBC repo, Headline: Illumina Breaks Above 200-Day Moving Average - Bullish for ILMN, source:Market News Video, summary: No summary",ILMN
214,2023-06-15,"Headline: Ominous Death Cross Forms On Illumina's Chart, source:Benzinga, summary: No summary, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rallied 2.49% to $209.94 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...",ILMN
215,2023-06-16,"Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 1.94% to $205.87 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: A Schwab Wealth Survey Reveals a Paradox, source:MarketWatch, summary: Nearly half of the respondents averaging $560,000 in net worth said they were wealthy, when including nonfinancial factors like health and family. But when..., Headline: Illumina CEO Steps Down; Grail Soap Opera Continues, source:Yahoo, summary: In this podcast, Motley Fool senior analyst Jason Moser and host Deidre Woollard discuss:  Whether the departure of Illumina's CEO will impact the company's efforts to keep its Grail acquisition. Carl Icahn's history of activist investing.",ILMN
216,2023-06-17,"Headline: 3 Gene Testing Stocks to Buy Before They Take Off, source:Yahoo, summary: Genes are the foundation of human life. They are the code that gives every instruction to our bodies about how to move, digest and think. So understanding those genes can be critical to understanding our own health. It’s no wonder that the clinical sequencing market is expected to have a compound annual growth rate (CAGR) of 14.6% through 2032. With such growth comes profits, and some of the best biotech stocks to buy right now are already building the future of gene testing. Ever since the huma",ILMN
217,2023-06-18,"Headline: How to Retire Rich: Biotech Stocks Edition, source:Yahoo, summary: Among the most difficult endeavors when it comes to deciphering the best retirement planning stocks is to identify companies that will remain relevant for years, if not decades to come. While no guarantees exist for anything, those who focus on investing in biotech own a clear advantage. Almost surely, the underlying sector – which falls under the broad healthcare industry – is permanently relevant. Further, I submitted a query on ChatGPT to extract key reasons why biotech stocks for retirement",ILMN
218,2023-06-19,"Headline: PBE: Healthcare Dashboard For June, source:SeekingAlpha, summary: Pharma/biotechnology and healthcare providers are slightly undervalued relative to 11-year averages. Click here for the June edition of the Healthcare Dashboard.",ILMN
219,2023-06-20,"Headline: Illumina Ventures to Launch Illumina® Ventures Labs, source:Business Wire, summary: No summary, Headline: Illumina's CEO Was Just Ousted: Should Investors Buy In Now or Steer Clear?, source:Yahoo, summary: On June 11, the gene sequencing giant Illumina (NASDAQ: ILMN) announced that its CEO, Francis deSouza, resigned after a tenure of roughly 10 years and that the company would start looking for a replacement.  In the past five years, its quarterly revenue only rose by 30.9%, reaching nearly $1.1 billion., Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 1.82% to $202.13 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500..., Headline: The Lancet Oncology Publishes Results from SYMPLIFY, The First Prospective Study of a Multi-Cancer Early Detection Test in a Symptomatic Patient Population, source:Business Wire, summary: No summary",ILMN
220,2023-06-21,"Headline: Illumina Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 1.12% to $199.87 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: Red-Hot Quality Opportunities in Genomics, source:GuruFocus, summary: No summary",ILMN
221,2023-06-22,"Headline: If You Invested $1000 In This Stock 20 Years Ago, You Would Have $140 Thousand Today, source:Benzinga, summary: No summary, Headline: ILMN August 4th Options Begin Trading, source:Stock Options Channel, summary: No summary, Headline: Life Sciences Has Lagged; Morningstar Likes These Biotech Stocks, source:Yahoo, summary: Life-science stocks have struggled this year, with the iShares Biotechnology ETF suffering a negative return of 0.64%. The stocks' struggles have put them on average at a discount to Morningstar's fair-value estimate for the first time in five years., Headline: Illumina Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. rallied 1.14% to $202.15 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...",ILMN
222,2023-06-23,"Headline: Goldman adds 25 new stocks with growth potential to its ROE basket, source:Seeking Alpha, summary: No summary, Headline: LGND vs. ILMN: Which Stock Is the Better Value Option?, source:Yahoo, summary: LGND vs. ILMN: Which Stock Is the Better Value Option?, Headline: Illumina Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slumped 0.24% to $201.67 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500..., Headline: UPDATE 1-US House panel critical of Twitter probe to question FTC chair at July 13 hearing, source:Yahoo, summary: U.S. Federal Trade Commission Chair Lina Khan is set to testify on July 13 before the House Judiciary Committee led by Republicans who have sharply criticized her leadership of the antitrust enforcement agency, the committee and commission confirmed on Friday.  This will be her first appearance before the committee since Republicans assumed control.  Republicans have been especially critical of the FTC's privacy investigation into Twitter since it was purchased by billionaire Tesla CEO Elon Musk.",ILMN
223,2023-06-24,"Headline: 10 Personalized Medicine Stocks Billionaires Are Loading Up On, source:Yahoo, summary: In this article, we will take a look at the 10 personalized medicine stocks billionaires are purchasing. If you want to skip our detailed analysis of the industry and its growth prospects, go to the 5 Personalized Medicine Stocks Billionaires Are Loading Up On. According to Allied Market Research, the global personalized medicine industry is set […]",ILMN
224,2023-06-25,"Headline: CEO Shuffle: 7 Stocks That Could Gain Momentum From New Leadership, source:Yahoo, summary: New CEOs can breathe new life into a company by launching new initiatives, hiring more effective managers, and/or entering new markets. One great example is General Electric. (NYSE:GE). When Larry Culp took the helm of that storied firm in 2018, it was losing billions of dollars. However, after cutting GE’s costs and making it far more customer-focused, he was to turn the sinking ship around. Here are seven stocks to gain momentum from leadership changes. Amazon (AMZN) Source: Tada Images / Shut",ILMN
225,2023-06-26,"Headline: Illumina commenced headcount reduction, sees further job cuts in Q3, source:Thefly.com, summary: No summary, Headline: Illumina sees charges of $25M-$35M in connection with job cuts, source:Thefly.com, summary: No summary, Headline: Illumina to reduce global real estate footprint, exit i3 campus in San Diego, source:Thefly.com, summary: No summary, Headline: Illumina announces job cuts, to exit San Diego i3 campus, source:Seeking Alpha, summary: No summary, Headline: Illumina Announces Job Layoffs After CEO Resignation: What's Next?, source:Benzinga, summary: No summary, Headline: Illumina Announces Job Layoffs After CEO Resignation, Icahn's Board Chess Game: What's Next?, source:Benzinga, summary: No summary, Headline: Video: Nasdaq 100 Movers: ILMN, LCID, source:Market News Video, summary: No summary, Headline: Illumina eyes USD100 million worth of annual cost cuts, source:Alliance News, summary: No summary, Headline: Illumina Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slipped 4.85% to $191.88 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500..., Headline: Illumina to Reduce Head Count, Exit Real Estate Amid Cost- Cutting Efforts, source:MarketWatch, summary: By Denny Jacob Illumina on Monday disclosed it plans to reduce its head count further as part of a broader effort to cut its operating expenses. The maker of..., Headline: Illumina to lay off workers as part of cost cuts amid Icahn fight, source:MarketWatch, summary: Illumina Inc. disclosed Monday that it has begun laying off workers, as the DNA-sequencing company looks to cut costs amid a withering fight with activist..., Headline: Illumina starts job cuts, plans office exit to rein in costs, source:Yahoo, summary: The company also intends to further cut workforce in the third quarter and reducing its real estate footprint in California as part of a plan to reduce annualized run rate expenses by more than $100 million in 2023.  Illumina has begun to lay off 10% of its research and development team, health news website STAT reported on Monday, citing internal emails.  Illumina, which had engaged in a proxy battle with activist investor Carl Icahn, earlier this month said CEO Francis deSouza had stepped down., Headline: UPDATE 2-Illumina starts job cuts, plans office exit to rein in costs, source:Yahoo, summary: Illumina Inc has commenced job cuts, the genetic sequencing equipment maker said on Monday, as it looks to cushion the impact of sticky inflation and a strong dollar on its business.  Illumina has begun to lay off 10% of its research and development team, health news website STAT reported on Monday, citing internal emails.  Illumina, which had engaged in a proxy battle with activist investor Carl Icahn, earlier this month said CEO Francis deSouza had stepped down., Headline: Tuesday Sector Laggards: Healthcare, Utilities, source:Market News Video, summary: No summary",ILMN
226,2023-06-27,"Headline: Tesla shares bounce higher after Monday’s decline, Lordstown stock plunges on bankruptcy filing, and other stocks on the move, source:MarketWatch, summary: No summary, Headline: Illumina (NASDAQ:ILMN) Downsizes Workforce, Exits Office Space, source:TipRanks, summary: No summary, Headline: Delta Air Lines, Generac stocks rally, Walgreens and Lordstown Motors shares tumble, and other stocks on the move, source:MarketWatch, summary: No summary, Headline: Stocks Rebound, Tech Rallies As Dip Buyers Return: What's Driving Markets Tuesday?, source:Benzinga, summary: No summary, Headline: Illumina Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slid 4.40% to $183.43 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500..., Headline: Illumina Unusual Options Activity For June 28, source:Benzinga, summary: No summary",ILMN
227,2023-06-28,"Headline: How a big biotech’s start-up gamble went wrong, source:Yahoo, summary: Gene sequencer Illumina took a bet on start-up Grail during the height of the biotech boom. What happened next was not part of the plan, Headline: Citi screens for most crowded short stocks with new model, source:Seeking Alpha, summary: No summary, Headline: SVB Securities Remains a Buy on Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Illumina Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.59% higher to $184.51 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P..., Headline: Looking Into Illumina's Recent Short Interest, source:Benzinga, summary: No summary",ILMN
228,2023-06-29,"Headline: Illumina Inc. stock underperforms Thursday when compared to competitors despite daily gains, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.53% higher to $185.49 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the..., Headline: What Does Illumina's Debt Look Like?, source:Benzinga, summary: No summary, Headline: PacBio initiated with a Buy at Goldman Sachs, source:Thefly.com, summary: No summary",ILMN
229,2023-06-30,"Headline: PacBio initiated at buy at Goldman on sequencing system, source:Seeking Alpha, summary: No summary, Headline: Nvidia upgraded, Apple initiated: Wall Street's top analyst calls, source:Yahoo, summary: Nvidia upgraded, Apple initiated: Wall Street's top analyst calls, Headline: Illumina Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. advanced 1.08% to $187.49 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",ILMN
230,2023-07-01,"Headline: Wall Street Breakfast: What Moved Markets, source:SeekingAlpha, summary: Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.",ILMN
231,2023-07-04,"Headline: Illumina faces record fine over purchase of Grail without EU approval, source:Yahoo, summary: World’s biggest gene sequencing group closed deal with cancer screening start-up despite ongoing investigation, Headline: Illumina faces record European Union fine over Grail deal  next week - report, source:Seeking Alpha, summary: No summary, Headline: Illumina assumed with a Neutral at JPMorgan, source:Thefly.com, summary: No summary",ILMN
232,2023-07-05,"Headline: Inside a media mogul’s 60th birthday bash, source:Yahoo, summary: Plus, the FT digs into Nigel Farage’s bank blacklisting claims and Illumina faces a record fine for jumping the EU antitrust gun, Headline: Wall Street Breakfast Podcast: Instagram's Threads, source:SeekingAlpha, summary: Instagram puts Threads on App Store with launch imminent. Illumina faces record European Union fine over Grail deal next week-report. GTCR in advanced talks to buy Worldpay stake., Headline: FTC Vs. Microsoft: FTC Wins, source:SeekingAlpha, summary: Microsoft Corporation has already won in its acquisition of Activision Blizzard, Inc. See whatâs next in the process for MSFT and ATVI and my strategy., Headline: Illumina Stock (NASDAQ:ILMN): Regulators Come Knocking on the Door, source:TipRanks, summary: No summary, Headline: Illumina Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. sank 0.58% to $187.03 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index..., Headline: Analyst Expectations for Illumina's Future, source:Benzinga, summary: No summary",ILMN
233,2023-07-06,"Headline: August 25th Options Now Available For Illumina (ILMN), source:Stock Options Channel, summary: No summary, Headline: Canaccord Genuity Reiterates Illumina (ILMN) Buy Recommendation, source:Fintel, summary: nan, Headline: Illumina Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slipped 2.43% to $182.48 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",ILMN
234,2023-07-07,"Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.46% higher to $183.32 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",ILMN
235,2023-07-09,"Headline: Goldman Sachs sees rays of hope in underperforming health sector, source:Seeking Alpha, summary: No summary",ILMN
236,2023-07-10,"Headline: Citi opens 'negative catalyst watch' on Illumina into earnings, source:Thefly.com, summary: No summary, Headline: Did Carl Icahn Just Save IEP Stock?, source:InvestorPlace, summary: No summary, Headline: RBC Capital Reaffirms Their Buy Rating on Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Illumina Or Pacific Biosciences? The Upstart Vs. The 800-Pound Gorilla, source:SeekingAlpha, summary: Illumina and Pacific Biosciences are two of the best-known next-generation DNA sequencing companies. Read what stock is a better short-term buy and the other is a good long-term investment., Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.34% higher to $183.94 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...",ILMN
237,2023-07-11,"Headline: Illumina to receive record EU fine related to Grail Inc. merger, Bloomberg says, source:Thefly.com, summary: No summary, Headline: Illumina DRAGEN&trade; 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discovery, source:Finnhub, summary: 2023 marks five years of industry-leading DRAGEN software offered by Illumina
SAN DIEGO, July 11, 2023 /PRNewswire/ -- Illumina Inc. , a global leader in DNA sequencing and array-based technologies,..., Headline: Illumina DRAGEN™ 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discovery, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of the latest version of DRAGEN™ software for analysis of next-generation sequencing data. DRAGEN 4.2 expands award-winning accuracy combined with its renowned flexibility and scalability to enable efficient workflows and extract meaningful insights from genomic data., Headline: Illumina to face record EU antitrust fine on Wednesday for Grail deal, source says, source:Finnhub, summary: U.S. life sciences company
Illumina will face a record EU antitrust fine on
Wednesday for closing its takeover of Grail before it
secured EU antitrust approval, a person familiar with the matter
said..., Headline: LGND or ILMN: Which Is the Better Value Stock Right Now?, source:Yahoo, summary: LGND vs. ILMN: Which Stock Is the Better Value Option?, Headline: Illumina Inc. stock rises Tuesday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.48% higher to $184.82 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the..., Headline: UPDATE 2-Illumina to face record EU antitrust fine for Grail deal, source says, source:Yahoo, summary: U.S. genetic testing company Illumina will face a record EU antitrust fine on Wednesday for closing its takeover of Grail before it secured approval from EU regulators, a person familiar with the matter said on Tuesday.  Reuters reported in January that the European Commission is set to hand out a fine of up to 10% of Illumina's global revenue, the maximum allowed under EU merger rules.  Illumina has set aside $458 million, representing 10% of its consolidated annual revenue for fiscal year 2022, as of Jan. 1 for a potential fine, according to a regulatory filing.",ILMN
238,2023-07-12,"Headline: Illumina, GRAIL fined by EU for implementing deal without approval, source:Thefly.com, summary: No summary, Headline: Illumina fined $475M in EU for closing GRAIL acquisition, source:Seeking Alpha, summary: No summary, Headline: Illumina hit with record $476 million fine for closing Grail deal without EU approval , source:CNBC, summary: The European Commission last year blocked Illumina's $7.1 billion acquisition of Grail over concerns it would stifle innovation and consumer choice. , Headline: Illumina Fined $475M in Europe Over Grail Acquisition, source:TipRanks, summary: No summary, Headline: 5 things to know before the stock market opens Wednesday, source:CNBC, summary: Here are the most important news items that investors need to start their trading day., Headline: Illumina Fined $475 Million in Europe Over Grail Acquisition, source:TipRanks, summary: No summary, Headline: Illumina Slapped With €400M In Fines: European Commission Penalizes Company For Hasty Grail Deal, source:Benzinga, summary: No summary, Headline: Illumina DRAGEN 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discovery, source:Finnhub, summary: SAN DIEGO - Illumina Inc. , a global leader in DNA sequencing and array-based technologies, today announced the launch of the latest version of DRAGEN software for analysis of next-generation..., Headline: EU regulator fines Illumina EUR432 million for breach of merger rules, source:Alliance News, summary: No summary, Headline: Nvidia, Microsoft, Netflix and Domino's rise premarket; Illumina falls, source:Yahoo, summary: Investing.com -- U.S. futures traded lower, with investors cautious ahead of the release of Federal Reserve meeting minutes from the June policy gathering., Headline: Disney Considers Different Strategies For Star India, Broadcom Wins Conditional European Approval For VMware Deal, Google Deprioritizes Gen Z Chatbot App: Today's Top Stories, source:Benzinga, summary: No summary, Headline: EU regulators fine Illumina $476 mln for closing Grail deal without green light, source:Yahoo, summary: EU antitrust regualators on Wednesday fined Illumina a record 432 million euros ($476.19 million) for closing its takeover of Grail before securing EU antitrust approval.  ""This is a very serious infringement, which requires the imposition of a proportionate fine, with the aim of deterring such conduct,"" the European Commission said.  The fine, 10% of Illumina's global turnover, was the maximum allowed under EU merger rules for such infringements., Headline: EU fines US firm Illumina $475 million for jumping gun on buying cancer-screening company Grail, source:Yahoo, summary: The European Union on Wednesday slapped a $475 million fine on U.S. biotech giant Illumina for buying cancer-screening company Grail without regulators' approval, the latest setback for the deal.  Illumina announced an $7.1 billion acquisition of Grail in 2020, but the European Commission, the EU's executive arm and top antitrust enforcer, said the company broke EU merger rules by completing the deal without its consent., Headline: Illumina fined a record $476 million by EU over Grail deal, source:Yahoo, summary: BRUSSELS (Reuters) -U.S. genetic testing company Illumina was fined a record 432-million-euro ($476 million) by the EU on Wednesday for closing its takeover of cancer test maker Grail before securing EU antitrust approval.  Illumina has been fighting the EU competition watchdog on several fronts since it was forced to seek its approval in 2021 despite the deal falling short of the EU turnover threshold for scrutiny.  The deal was eventually blocked last September, with regulators concerned that Illumina, once it had acquired Grail, would have an incentive to cut off Grail's rivals from accessing its technology to develop blood-based early cancer detection tests to compete with Grail., Headline: UPDATE 2-Illumina fined a record $476 mln by EU over Grail deal, source:Yahoo, summary: U.S. genetic testing company Illumina was fined a record 432-million-euro ($476 million) by the EU on Wednesday for closing its takeover of cancer test maker Grail before securing EU antitrust approval.  Illumina has been fighting the EU competition watchdog on several fronts since it was forced to seek its approval in 2021 despite the deal falling short of the EU turnover threshold for scrutiny.  The deal was eventually blocked last September, with regulators concerned that Illumina, once it had acquired Grail, would have an incentive to cut off Grail's rivals from accessing its technology to develop blood-based early cancer detection tests to compete with Grail., Headline: Illumina Fined More Than $400 Million in Europe for Closing Grail Deal Early, source:Yahoo, summary: The European Union’s antitrust watchdog called the move to wrap up the acquisition during an in-depth probe an unprecedented infringement. Illumina said it would appeal the fine., Headline: Illumina hit with record €432mn fine for ignoring EU concerns over Grail deal, source:Yahoo, summary: US gene sequencing company proceeded with acquisition of cancer test developer even as regulators were probing deal, Headline: Illumina to Appeal $476 Million EU Fine for Closing Grail Acquisition Early, source:Yahoo, summary: The European Commission says the gene-sequencing company completed its acquisition of Grail, a cancer test developer, before receiving the appropriate approvals., Headline: 10 Health Care Stocks With Whale Alerts In Today's Session, source:Benzinga, summary: No summary, Headline: EU Fines Illumina Record $476 Million for Closing Grail Deal Without Approval, source:Yahoo, summary: The European Commission fined biotech firm Illumina 432 million euros ($476 million) for closing its acquisition of Grail without the commission's approval, in the Commission's largest merger regulation fine yet.﻿﻿, Headline: Illumina's (ILMN) Latest Launch to Boost Genomics Analysis, source:Yahoo, summary: Illumina's (ILMN) DRAGEN v4.2 is expected to improve the identification of genetic disease causes, drug discovery and population genomics., Headline: NEW YORK MARKET CLOSE: Stocks up, dollar down as CPI hits two-year low, source:Alliance News, summary: No summary, Headline: Illumina Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. rose 3.86% to $191.95 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",ILMN
239,2023-07-13,"Headline: Illumina Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slipped 1.63% to $188.83 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500..., Headline: Grail sued by three female ex-employees over ‘toxic work culture’, source:Yahoo, summary: Illumina-owned cancer testing group allegedly failed to deal with accusations of inappropriate behaviour and racism",ILMN
240,2023-07-14,"Headline: Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years, source:Benzinga, summary: No summary, Headline: SVB Securities Sticks to Its Buy Rating for Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Mettler-Toledo International: Shares Still Expensive Heading Into Q2 Earnings, source:SeekingAlpha, summary: Mettler-Toledo International Inc. stock was hit hard despite MTD's improvement in revenue, profits, and cash flows. Click for our MTD Q2 earnings preview., Headline: Illumina Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slid 0.89% to $187.15 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",ILMN
241,2023-07-16,"Headline: Looking Into Illumina's Recent Short Interest, source:Benzinga, summary: No summary",ILMN
242,2023-07-17,"Headline: Illumina Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: No summary, Headline: Shady Business: 3 Well-Known Stocks That Deserve to Be on Your Blacklist, source:Yahoo, summary: Bank of America (NYSE:BAC) is one of the country’s largest banks. It’s also one of America’s most well-known stocks thanks to Warren Buffett’s 13% ownership stake. While the bank has found itself in a bit of hot water recently, I’ve learned over the years that the Oracle of Omaha isn’t afraid to own controversial stocks that get into trouble with regulators and consumers. One that comes to mind is Wells Fargo (NYSE:WFC). Berkshire Hathaway (NYSE:BRK-B) held on to shares for several years after i",ILMN
243,2023-07-18,"Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: No summary, Headline: RBC Capital Reaffirms Their Buy Rating on Illumina (ILMN), source:TipRanks, summary: No summary, Headline: The Alliance for Genomic Discovery announces founding biopharma members : AbbVie, Amgen, AstraZeneca, Bayer, and Merck, source:Finnhub, summary: Alliance aims to accelerate therapeutic development and expand the diversity of genomic data through inclusion of more samples from currently underrepresented ancestries 
SAN DIEGO, July 18, 2023..., Headline: Illumina put volume heavy and directionally bearish, source:Thefly.com, summary: No summary, Headline: The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced the five founding members of the Alliance for Genomic Discovery (AGD). The multiyear agreement aims to accelerate development of therapeutics through large-scale genomics and the establishment of a preeminent clinical ge, Headline: Bridging the Diagnosis Gap for Canada’s Indigenous Children, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / July 18, 2023 / Illumina Originally published on Illumina News Center The United Nations Declaration on the Rights of Indigenous Peoples asserts ""the right to access, without any discrimination, to all social and ..., Headline: Illumina to Announce Second Quarter 2023 Financial Results on Wednesday, August 9, 2023, source:Yahoo, summary: Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the second quarter 2023 following the close of market on Wednesday, August 9, 2023.",ILMN
244,2023-07-19,"Headline: Illumina Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: No summary, Headline: Illumina Inc. - The Alliance for Genomic Discovery announces founding biopharma members, AbbVie, Amgen, AstraZeneca, Bayer, and Merck, source:Finnhub, summary: SAN DIEGO - Illumina Inc. , a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC, a leading clinical and genomic data company and wholly..., Headline: Illumina, Inc.: Collapsing Margins, Rising Debt, Legal Setbacks, And Downward Momentum, source:SeekingAlpha, summary: Illuminaâs financials are deteriorating; its customers are tightening up purchases due to persistent macro headwinds. Find out why I'm bearish on ILMN stock.",ILMN
245,2023-07-20,"Headline: Illumina Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: No summary, Headline: Cramer's Lightning Round: KeyCorp is a buy, source:CNBC, summary: ""Mad Money"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed., Headline: Lightning Round: It's time to buy KeyCorp, says Jim Cramer, source:CNBC, summary: 'Mad Money' host Jim Cramer weighs in on stocks including: Illumina, Compass Pathways, KeyCorp, Eaton, Verve Theraputics, Informatica and ASML., Headline: Polen Focus Growth Q2 2023 Portfolio Manager Commentary, source:SeekingAlpha, summary: The Focus Growth Composite Portfolio returned 10.51% gross fees and 10.36% net fees in the second quarter of 2023. Click here to read the full fund letter.",ILMN
246,2023-07-21,"Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary, Headline: Is Illumina Inc (ILMN) a Value Trap? An In-depth Analysis, source:GuruFocus, summary: No summary, Headline: FTC and DOJ reveal new merger guidelines, source:Yahoo, summary: The Federal Trade Commission and the Department of Justice have released new draft guidelines for how they will evaluate mergers. There is a public will have until September 18 to comment on the proposals. Jonathan Kanter, Assistant Attorney General for the Justice Department's Antitrust Division, tells Yahoo Finance Live that the ""guidelines help provide transparency"" about how the law is applied. Addressing criticism that the guidelines may impact some industries more than others, Kanter says the guidelines ""are business-model agnostic, they don't focus on any specific companies or any specific businesses. It simply says we want to protect and preserve competition.""",ILMN
247,2023-07-22,"Headline: Assessing the GF Value of Illumina Inc (ILMN): A Potential Value Trap?, source:GuruFocus, summary: No summary, Headline: Ensemble Capital Second Quarter 2023 Investor Letter, source:SeekingAlpha, summary: On a year-to-date basis, Ensemble Fund is now up 11.61% vs the S&P 500 up 16.89%. Click here to read the full fund letter., Headline: Is It Too Late To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?, source:Yahoo, summary: Today we're going to take a look at the well-established Illumina, Inc. ( NASDAQ:ILMN ). The company's stock received a..., Headline: 20 Countries With Highest Rate Of Down Syndrome, source:Yahoo, summary: In this detailed article, we’ll talk about 20 countries with the highest rate of down syndrome. You can skip our analysis on progress in corporate healthcare sector on this front and go to 8 Countries With Highest Rate Of Down Syndrome. Each year, around 6,000 babies are born with Down syndrome across the globe, which […]",ILMN
248,2023-07-23,"Headline: Is Illumina Inc (ILMN) a Value Trap? An In-depth Look at the GF Value, source:GuruFocus, summary: No summary",ILMN
249,2023-07-24,"Headline: Illumina (ILMN) Soars 3.4%: Is Further Upside Left in the Stock?, source:Yahoo, summary: Illumina (ILMN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term., Headline: Illumina Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. slipped 1.27% to $188.07 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",ILMN
250,2023-07-25,"Headline: Illumina, Pillar Biosciences announce partnership, source:Thefly.com, summary: No summary, Headline: Illumina and Pillar Biosciences partner to improve access to personalized cancer treatment options, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of Decision Medicine™, today announced a strategic partnership to make Pillar's suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products. The agreement will result in an unprecedented offering of complementary next-generation sequencing solutions that will enhance the efficiency, accuracy, and cost-effective, Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.68% higher to $189.35 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the...",ILMN
251,2023-07-26,"Headline: IN BRIEF: Yourgene Health inks five-year, Illumina contract extension, source:Alliance News, summary: No summary, Headline: Yourgene Health inks five-year, Illumina contract extension, source:Finnhub, summary: Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Signs five-year contract extension with Illumina Inc. The contract is a restated licence and supply agreement for..., Headline: New Research Shows CGP Is Most Effective as a Standalone Test, source:Yahoo, summary: Comprehensive genomic profiling (CGP) assesses hundreds of tumor genes to find actionable mutations and is becoming the standard of care for many cancers., Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.97% higher to $191.19 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",ILMN
252,2023-07-27,"Headline: September 8th Options Now Available For Illumina (ILMN), source:Stock Options Channel, summary: No summary, Headline: Budi Hermawan’s Long Fight Against Tuberculosis, source:Yahoo, summary: NORTHAMPTON, MA / ACCESSWIRE / July 27, 2023 / Illumina: Originally published on Illumina News Center Nothing about Budi Hermawan's experience with tuberculosis (TB) has been easy. In 2003, he had a cough. He didn't think much of it, but as his ..., Headline: Illumina Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. slid 0.78% to $189.70 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index..., Headline: Inside Illumina’s $8 billion deal that spurred a proxy fight with Carl Icahn and the ouster of 2 prominent Black Silicon Valley executives, source:Yahoo, summary: Illumina’s contentious acquisition of cancer test maker Grail brought billionaire Carl Icahn to the company’s doorstep.",ILMN
253,2023-07-28,"Headline: Here’s Why Illumina (ILMN) Declined -19.4% in Q2, source:Yahoo, summary: Ensemble Capital Management, an investment management company, released its second quarter 2023 investor letter. A copy of the same can be downloaded here. During the quarter, the strategy slightly outperformed with a gain of 8.76% compared to the S&P 500’s 8.74% gain. The strategy’s performance in the quarter was driven by big gains generated by small […], Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rose 1.44% to $192.44 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",ILMN
254,2023-07-29,"Headline: Week In Review: Pyrotech Closes $97 Million Series A Round For Immunomodulator Drugs, source:TalkMarkets, summary: No summary, Headline: Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil, source:Yahoo, summary: As biotech stock prices have fallen, Wall Street and biotech boards have grown increasingly unfriendly. Amid the turmoil, key biotech stocks have become the targets of activist investors demanding new executives, new boards and new strategies. The specifics of each case vary, but the biotech stocks in sharpest focus have been those whose earnings and revenue have disappointed investors. Of course, it’s no accident this happens. Investors want to protect their investments. And if the company isn’",ILMN
255,2023-07-30,"Headline: Baron Opportunity Fund Q2 2023 Shareholder Letter, source:SeekingAlpha, summary: During Q2 2023, Baron Opportunity FundÂ® climbed 16.31% (Institutional Shares), outperforming the broader market. Click here to read the full fund letter., Headline: This Illumina Insider Reduced Their Stake By 12%, source:Yahoo, summary: Insiders were net sellers of Illumina, Inc.'s ( NASDAQ:ILMN ) stock during the past year. That is, insiders sold more...",ILMN
256,2023-07-31,"Headline: Illumina Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: No summary, Headline: Illumina and Pillar Biosciences Partner To Improve Access to Personalized Cancer Treatment Options, source:Finnhub, summary: SAN DIEGO -- Illumina Inc. , a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of Decision Medicine, announced a strategic partnership to make..., Headline: Tracking Baillie Gifford's 13F Portfolio - Q2 2023 Update, source:SeekingAlpha, summary: Baillie Gifford's 13F portfolio value increased from ~$111B to ~$118B this quarter. Top three holdings make up ~17% of the portfolio. Click here to read more., Headline: Guardant Health resolves pending litigation with Illumina, source:Thefly.com, summary: No summary",ILMN
257,2023-08-01,"Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: No summary, Headline: Guardant resolves lllumina litigation, will share cancer research specimens, source:Seeking Alpha, summary: No summary, Headline: Hologic CEO Steve MacMillan says he's not leaving after taking on Illumina chair role, source:Seeking Alpha, summary: No summary, Headline: Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research, source:Business Wire, summary: No summary",ILMN
258,2023-08-02,"Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary",ILMN
259,2023-08-03,"Headline: Illumina Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: No summary",ILMN
260,2023-08-04,"Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary, Headline: Carl Icahn’s company stock drops 30% after IEP slashes quarterly dividend in half, source:CNBC, summary: Carl Icahn's conglomerate Icahn Enterprises slashed quarterly dividend in half amid notable short seller Hindenburg Research's campaign., Headline: Icahn Enterprises’ bonds see buying after bond-friendly halving of distribution, source:MarketWatch, summary: No summary",ILMN
261,2023-08-05,"Headline: 2023 shaping up to be biggest year for biopharma M&A since pandemic, source:Seeking Alpha, summary: No summary",ILMN
262,2023-08-06,"Headline: Earnings week ahead: Disney, Palantir, Plug Power, Roblox, Rivian and more, source:Seeking Alpha, summary: No summary",ILMN
263,2023-08-07,"Headline: Illumina Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: No summary, Headline: BNGO Stock Alert: Bionano Just Reverse Split Its Stock, source:InvestorPlace, summary: No summary",ILMN
264,2023-08-08,"Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: No summary, Headline: Acquisition of Grail Pressured Illumina (ILMN)’s Stock Price, source:Yahoo, summary: Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” second-quarter 2023 investor letter. A copy of the same can be downloaded here. The fund returned 10.51% gross of fees and 10.36% net of fees in the second quarter compared to a 12.81% return for the Russell 1000 Growth Index and an 8.74% return […], Headline: The Final Peak Week For Q2 Starts As Earnings Hit Their Stride, source:SeekingAlpha, summary: S&P 500 EPS growth for Q2 2023 is set to come in at -5.2%, the lowest rate in nearly 3 years and the third consecutive quarter of negative earnings growth., Headline: GLOBAL BRIEFING: China slips into deflation as domestic spending slows, source:Alliance News, summary: No summary, Headline: Illumina reports Q2 adjusted EPS 32c, consensus 2c, source:Thefly.com, summary: No summary, Headline: Illumina cuts FY23 adjusted EPS view to 75c-90c from  $1.25-$1.50, source:Thefly.com, summary: No summary, Headline: Illumina Non-GAAP EPS of $0.32 beats by $0.30, revenue of $1.18B beats by $20M, source:Seeking Alpha, summary: No summary, Headline: Illumina sees customers 'more cautious in their purchasing' in 2H23, source:Thefly.com, summary: No summary, Headline: Illumina names Dr. Steven Barnard as Chief Technology Officer, source:Thefly.com, summary: No summary, Headline: Illumina cuts full year top and bottom line guidance, shares fall nearly 6% after hours, source:Seeking Alpha, summary: No summary",ILMN
265,2023-08-09,"Headline: Illumina Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: No summary, Headline: Fly Intel: After-Hours Movers, source:Thefly.com, summary: No summary, Headline: US Stocks Walk Inflation Tightrope As Futures Point To Cautious Recovery: Why This Analyst Downplays Fed Rate Worries, source:Benzinga, summary: No summary, Headline: Notable companies reporting after market close, source:Thefly.com, summary: No summary, Headline: Stocks Retreat, Nasdaq Hits 4-Week Low, Energy Sector Rallies: What's Driving Markets Wednesday, source:Benzinga, summary: No summary, Headline: How Genetic Technologies Can Empower More People With Information, source:Yahoo, summary: After earning a graduate degree in genetic counseling, Zoë Milgrom's first job immediately exposed her to the difficult reality of putting her education into practice., Headline: Illumina Reports Financial Results for Second Quarter of Fiscal Year 2023, source:Finnhub, summary: $
Amortization of acquired intangible assets
1.23
Legal contingency and settlement 
0.09
Acquisition-related expenses 
0.30
Strategic investment related loss, net 
0.10
Gain on Helix contingent value..., Headline: Illumina cuts annual profit forecast, source:Finnhub, summary: Illumina Inc lowered annual
profit forecast on Wednesday, signaling weak demand for its
sequencing and diagnostic services, sending the life sciences
firm's shares down 7.5% after the bell.
          ..., Headline: Illumina: Q2 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: Illumina : Q2 Earnings Snapshot, source:Finnhub, summary: SAN DIEGO  — SAN DIEGO  — Illumina Inc.  on Wednesday reported a loss of $234 million in its second quarter.
  The San Diego-based company said it had a loss of $1.48 per share. Earnings,..., Headline: Illumina narrows quarter losses but expects tricky second half, source:Alliance News, summary: No summary, Headline: Illumina Reduces Guidance On Cautious Consumers, source:MarketWatch, summary: By Ben Glickman Illumina lowered its full-year revenue guidance, anticipating more cautious consumers. The San Diego-based gene-sequencing company now..., Headline: Illumina 2Q Loss Narrows on Higher Sales of NovaSeq X Instruments, source:MarketWatch, summary: By Ben Glickman Illumina's loss narrowed in the second quarter as the gene-sequencing company posted higher-than-expected sales of its new NovaSeq X product...., Headline: Stocks making the biggest moves after hours: Disney, Wynn Resorts, AppLovin and more, source:CNBC, summary: See which stocks are posting big moves after the bell., Headline: Illumina Medical Chief Phil Febbo, Chief Technology Officer Aravanis Exit, source:MarketWatch, summary: By Ben Glickman Illumina said Wednesday that Chief Medical Officer Phil Febbo had departed the company. The San Diego-based gene-sequencing company didn't..., Headline: Illumina stock falls, as ‘cautious consumer backdrop’ tempers outlook, source:MarketWatch, summary: Shares of Illumina Inc. slid 6.6% after hours on Wednesday after the DNA-sequencing company tempered its full-year sales outlook, amid a cautious consumer..., Headline: Dr. Steven Barnard Appointed Chief Technology Officer, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Dr. Steven Barnard, Illumina's Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer (CTO), effective immediately. Dr. Alex Aravanis, who held the position of CTO, will be departing Illumina to pursue another opportunity outside of the company., Headline: Illumina cuts annual profit forecast as biotech funding woes linger, source:Yahoo, summary: The funding crunch has been exacerbated by the collapse of U.S. lender Silicon Valley Bank, a key investment banker in the biotech sector.  ""We expect our second-half revenue to be negatively impacted by customers remaining more cautious in their purchasing, a more protracted recovery in China, and a larger-than-expected temporary decline in high throughput consumables as customers transition to NovaSeq X,"" said Interim CEO Charles Dadswell.  Higher-than-estimated demand for the production-scale sequencer, NovaSeq X, however, helped the U.S. genetic testing company surpass Wall Street estimates for second-quarter profit., Headline: Illumina Slides After Slashing Full-Year Forecast, source:Yahoo, summary: (Bloomberg) -- Shares of Illumina Inc. dropped as much as 7% in late trading after the company cut its sales and profit outlook and said a pair of top executives are departing.Most Read from BloombergFirst American City to Tame Inflation Owes Its Success to Affordable HousingEveryone Wants to Work at UPS After Teamsters DealRetirees Face $17,400 Cut to Social Security Benefits in 2033Stock Traders Shun Risk in Run-Up to Key CPI Test: Markets WrapTycoon Who Gave Away $750 Million Sees Profit in L, Headline: Illumina Stock Crumbles As Earnings Outlook Completely Misses Forecasts, source:Yahoo, summary: Illumina's earnings outlook completely missed Wall Street's expectations late Wednesday, causing ILMN stock to dive in late action., Headline: UPDATE 1-Illumina cuts annual profit forecast as biotech funding woes linger, source:Yahoo, summary: Illumina Inc cut annual profit forecast, in a sign that a funding crunch among its biotech and pharmaceutical clients is expected to weigh on sales for its genetic testing tools and diagnostics products.  The funding crunch has been exacerbated by the collapse of U.S. lender Silicon Valley Bank, a key investment banker in the biotech sector.  Higher-than-estimated demand for the production-scale sequencer, NovaSeq X, however, helped the U.S. genetic testing company surpass Wall Street estimates for second-quarter profit., Headline: Illumina (ILMN) Tops Q2 Earnings and Revenue Estimates, source:Yahoo, summary: Illumina (ILMN) delivered earnings and revenue surprises of 1,500% and 1.11%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?, Headline: Illumina (ILMN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates, source:Yahoo, summary: While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values., Headline: Illumina, Inc. (ILMN) Q2 2023 Earnings Call Transcript, source:SeekingAlpha, summary: Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Q2 2023 Results Earnings Conference Call August 9, 2023 5:00 PM ETCompany ParticipantsSalli Schwartz - Vice President of Investor RelationsCharles..., Headline: Illumina, Inc. 2023 Q2 - Results - Earnings Call Presentation, source:SeekingAlpha, summary: The following slide deck was published by Illumina, Inc., Headline: Analysts Have Conflicting Sentiments on These Healthcare Companies: Iovance Biotherapeutics (IOVA), Insulet (PODD) and Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Disney, Alibaba And 3 Stocks To Watch Heading Into Thursday, source:Benzinga, summary: No summary, Headline: What You Missed On Wall Street On Thursday, source:Thefly.com, summary: No summary",ILMN
266,2023-08-10,"Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary, Headline: Illumina price target lowered to $180 from $229 at Baird, source:Thefly.com, summary: No summary, Headline: Illumina price target lowered to $200 from $225 at Credit Suisse, source:Thefly.com, summary: No summary, Headline: Illumina price target lowered to $150 from $180 at Citi, source:Thefly.com, summary: No summary, Headline: Analysts Conflicted on These Healthcare Names: Deciphera Pharmaceuticals (DCPH), Illumina (ILMN) and Ionis Pharmaceuticals (IONS), source:TipRanks, summary: No summary, Headline: Nasdaq, S&P 500 Futures Rally Ahead Of Inflation Data; Why This Analyst Sounds Out Caution About Stock Valuations, source:Benzinga, summary: No summary, Headline: Bank of America Securities Reaffirms Their Hold Rating on Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Illumina price target lowered to $210 from $230 at BofA, source:Thefly.com, summary: No summary, Headline: Illumina price target lowered to $225 from $265 at Stifel, source:Thefly.com, summary: No summary, Headline: Illumina price target raised to $240 from $235 at Evercore ISI, source:Thefly.com, summary: No summary, Headline: Stocks making the biggest moves premarket: Capri, Tapestry, AppLovin, Disney and more, source:CNBC, summary: These are the stocks posting the largest moves in early trading. , Headline: Piper Sandler Sticks to Their Buy Rating for Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday, source:Benzinga, summary: No summary, Headline: What You Missed On Wall Street This Morning, source:Thefly.com, summary: No summary, Headline: Illumina Takes Over #260 Spot From Aptiv, source:The Online Investor, summary: No summary, Headline: AppLovin, Wynn Resorts rise; Tapestry, Plug Power fall, Thursday, 8/10/2023, source:Associated Press, The, summary: No summary, Headline: Illumina Unusual Options Activity, source:Benzinga, summary: No summary, Headline: Stocks Trim Gains On Inflation Data, NVIDIA Faces Worst Week Of 2023: What's Driving Markets Thursday?, source:Benzinga, summary: No summary, Headline: Stocks Trim Gains Following Inflation Data, NVIDIA Faces Worst Week Of 2023: What's Driving Markets Thursday?, source:Benzinga, summary: No summary, Headline: Illumina To Bear The Brunt Of Slowdown In Consumables Purchasing Amid Lower Demand In China: Analyst, source:Benzinga, summary: No summary, Headline: Novo Nordisk reports earnings miss, sees profit and sales growth, source:Yahoo, summary: Novo Nordisk (NVO) earnings came in lower than expected while reporting profits rose by 43 percent and sales are up by as much as 30 percent. Novo Nordisk is lifting its full-year outlook in accordance with the overwhelming success of its weight-loss and diabetes drugs while reducing their supply of lower doses. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down Novo Nordisk's earnings, also turning her attention to biotech company Illumina's (ILMN) slashed annual profits and the latest COVID-19 variant, ""Eris"", which the World Health Organization is calling a ""variant of interest."", Headline: Illumina Slashes Guidance Amid ‘Cautious’ Consumer. What Wall Street Thinks., source:Yahoo, summary: Illumina  stock was rising Thursday, following an initial drop in the premarket session, after the gene-sequencing company cut its full-year outlook as it faces a hesitant consumer and growing competition.  Illumina  (ticker: ILMN) said after the close of trading Wednesday that it now expects to report full-year earnings between 75 cents a share to 90 cents a share and revenue growth of about 1%.  “Many of our customers are remaining more cautious in their purchasing behaviors,” Interim Chief Executive Charles Dadswell said on the earnings conference call., Headline: Illumina Recovers After Torching Its 2023 Outlook; Announces A 'Huge Accomplishment', source:Yahoo, summary: Illumina stock recovered Thursday after the company torched its guidance on continuing headwinds. ILMN stock retook its 50-day line., Headline: Illumina (ILMN) Q2 Earnings Beat Estimates, Margins Contract, source:Yahoo, summary: Illumina (ILMN) shipped 109 NovaSeq X instruments in the second quarter, boosting its supply capacity to more than 390 instruments for fiscal 2023., Headline: NEW YORK MARKET CLOSE: S&P gains evaporate despite inflation surprise, source:Alliance News, summary: No summary, Headline: Q2 2023 Singular Genomics Systems Inc Earnings Call, source:Yahoo, summary: Q2 2023 Singular Genomics Systems Inc Earnings Call, Headline: Is Illumina (ILMN) a Potential Value Trap? Think Twice Before Investing, source:Yahoo, summary: An in-depth analysis of Illumina Inc's intrinsic value, financial strength, profitability, and growth, Headline: Credit Suisse Maintains Illumina (ILMN) Neutral Recommendation, source:Fintel, summary: nan, Headline: Evercore ISI Group Maintains Illumina (ILMN) Outperform Recommendation, source:Fintel, summary: nan, Headline: Citigroup Maintains Illumina (ILMN) Sell Recommendation, source:Fintel, summary: nan, Headline: Stifel Maintains Illumina (ILMN) Buy Recommendation, source:Fintel, summary: nan, Headline: JP Morgan Maintains Illumina (ILMN) Neutral Recommendation, source:Fintel, summary: nan, Headline: Is Illumina Inc (ILMN) a Potential Value Trap? A Comprehensive Valuation Analysis, source:GuruFocus, summary: No summary",ILMN
267,2023-08-11,"Headline: Illumina Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: No summary, Headline: Illumina under SEC investigation over GRAIL acquisition, source:Seeking Alpha, summary: No summary, Headline: SEC investigating Illumina over acquisition of cancer test developer Grail, source:CNBC, summary: Illumina's acquisition of cancer test developer Grail has also faced heavy scrutiny from antitrust regulators in the U.S. and European Union. , Headline: Illumina Shares Fall After Disclosing SEC Investigation Into Grail Deal, source:Finnhub, summary: By Will Feuer Shares of Illumina slid more than 4% after the gene-sequencing company disclosed that the Securities and Exchange Commission is investigating the company's $7 billion takeover..., Headline: Icahn Enterprises LP: An Update On Its Ballooning Unit Count, source:SeekingAlpha, summary: IEP continues to trade at a multiple of its underlying NAV, and even its newly announced lower distribution surely looks unsustainable. Click here to read more., Headline: Company News for Aug 11, 2023, source:Yahoo, summary: Companies in The News Are: DDS,MFC,ILMN,G, Headline: US securities regulator probes Illumina over Grail deal, source:Yahoo, summary: The regulator has requested documents and communications related to the acquisition along with certain statements and disclosures about the ""conduct and compensation"" of certain members of the companies' management, according to Illumina.  Illumina said it is cooperating with the SEC.  An SEC spokesperson said the agency ""does not comment on the existence or nonexistence of a possible investigation""., Headline: UPDATE 1-US securities regulator probes Illumina over Grail deal, source:Yahoo, summary: The U.S. Securities and Exchange Commission (SEC) has begun an investigation into Illumina's $7.1 billion acquisition of cancer detection test maker Grail, the gene sequencing company said in a regulatory filing.  Shares of the California-based company fell 3.6% in afternoon trading on Friday.  Illumina said it is cooperating with the SEC., Headline: Illumina, Inc. (NASDAQ:ILMN) Q2 2023 Earnings Call Transcript, source:Yahoo, summary: Illumina, Inc. (NASDAQ:ILMN) Q2 2023 Earnings Call Transcript August 10, 2023 Operator: Good day, ladies and gentlemen, and welcome to the Second Quarter 2023 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Please be advised that today’s conference is […]",ILMN
268,2023-08-12,"Headline: RBC Capital Sticks to Their Buy Rating for Illumina (ILMN), source:TipRanks, summary: No summary",ILMN
269,2023-08-13,"Headline: Illumina price target lowered to $235 from $270 at HSBC, source:Thefly.com, summary: No summary",ILMN
270,2023-08-14,"Headline: Illumina Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: No summary, Headline: Wall Street Breakfast: AI Generation, source:Seeking Alpha, summary: No summary, Headline: The Latest Analyst Ratings for Illumina, source:Benzinga, summary: No summary, Headline: Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Illumina (ILMN) and Tonix Pharma (TNXP), source:TipRanks, summary: No summary, Headline: Illumina to Webcast Upcoming Investor Conference, source:Finnhub, summary: SAN DIEGO - Illumina, Inc. today announced that its vice president of investor relations will be speaking at the following investor conference: UBS MedTech, Tools and Genomics Summit 2023 on August..., Headline: HSBC Maintains Illumina (ILMN) Buy Recommendation, source:Fintel, summary: nan, Headline: Is Illumina Inc (ILMN) a Hidden Value Trap? A Comprehensive Analysis, source:Yahoo, summary: Uncovering the Risks and Potential Rewards of Investing in Illumina Inc (ILMN), Headline: Is Illumina Inc. (ILMN) a Hidden Value Trap? An In-Depth Analysis, source:GuruFocus, summary: No summary",ILMN
271,2023-08-15,"Headline: Elliott Wave Technical Analysis: Illumina Inc., source:TalkMarkets, summary: No summary, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: No summary, Headline: Illumina price target lowered to $275 from $290 at Piper Sandler, source:Thefly.com, summary: No summary, Headline: Why Shares of SomaLogic Are Up Tuesday, source:Yahoo, summary: What happened Shares of SomaLogic (NASDAQ: SLGC) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock is down more than 9% this year., Headline: Piper Sandler Maintains Illumina (ILMN) Overweight Recommendation, source:Fintel, summary: nan",ILMN
272,2023-08-16,"Headline: Illumina Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: No summary, Headline: Illumina price target lowered to $285 from $300 at Canaccord, source:Thefly.com, summary: No summary, Headline: Is Illumina Inc (ILMN) a Hidden Value Trap? A Comprehensive Analysis, source:GuruFocus, summary: No summary, Headline: Baron Global Advantage Fund Q2 2023 Shareholder Letter, source:SeekingAlpha, summary: Baron Global Advantage Fund gained 6.4% (Institutional Shares) in the second quarter of 2023. Click here to read the full fund letter., Headline: Baron Fifth Avenue Growth Fund Q2 2023 Quarterly Letter, source:SeekingAlpha, summary: Baron Fifth Avenue Growth Fund gained 16.0% during Q2, which compares to gains of 12.8% for the Russell 1000 Growth Index (R1KG) and 8.7% for S&P 500 Index (SPX)., Headline: S&P 500 2023 Q2 Earnings Review: Revenues Miss Analyst Expectations, source:Seeking Alpha, summary: No summary, Headline: Canaccord Genuity Maintains Illumina (ILMN) Buy Recommendation, source:Fintel, summary: nan, Headline: Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years, source:Benzinga, summary: No summary",ILMN
273,2023-08-17,"Headline: Illumina Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary, Headline: Illumina opens Solutions Center in India, source:Thefly.com, summary: No summary, Headline: Down 15% in 2023, Should You Buy the Dip With Illumina Stock?, source:Yahoo, summary: Illumina's (NASDAQ: ILMN) stock is down by 15% this year so far, and it's no surprise why.  With the new disclosure of a Securities and Exchange Commission (SEC) investigation into its bedraggled acquisition of Grail, a genetic-testing company it originally founded, and a $476 million fine from regulators in the E.U. just one month ago on account of the purchase in advance of regulatory permission, things look fraught.  The bull thesis for Illumina stock has nothing at all to do with its most visible struggles resulting from the Grail acquisition., Headline: Illumina expands genomics capabilities in India with opening of Solutions Center, source:Yahoo, summary: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the opening of a new office and state-of-the-art Illumina Solutions Center in Bengaluru, India., Headline: Illumina, Inc. (ILMN) Management Presents at UBS MedTech, Tools and Genomics Summit 2023 Conference (Transcript), source:SeekingAlpha, summary: Illumina, Inc. (NASDAQ:NASDAQ:ILMN) UBS MedTech, Tools and Genomics Summit 2023 Conference Transcript August 17, 2023 12:00 PM ETExecutivesSalli Schwartz - Vice President, Investor...",ILMN
274,2023-08-18,"Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: No summary, Headline: Here’s Why Illumina (ILMN) Declined in Q2, source:Yahoo, summary: Baron Funds, an investment management company, released its “Baron Fifth Avenue Growth Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here. The second quarter saw a continuation of the trends seen earlier in the year. The fund was up 16% (Institutional Shares) in the second quarter compared to a 12.8% […], Headline: EXEL or ILMN: Which Is the Better Value Stock Right Now?, source:Yahoo, summary: EXEL vs. ILMN: Which Stock Is the Better Value Option?",ILMN
275,2023-08-21,"Headline: Illumina (ILMN) Expands Presence in India With New Facility, source:Yahoo, summary: Illumina (ILMN) boosts genomic capabilities in India with a new state-of-the-art Solutions Center., Headline: Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen., source:Yahoo, summary: Wall Street analysts are upbeat on California-based biotech Illumina (NASDAQ: ILMN) these days, estimating on average that the stock could climb by up to 27% over the next year.  The most important reason why Illumina's shares are unlikely to rise that much in the near term is that nobody is anticipating an uptick in sales of the gene sequencers that Illumina makes -- or the consumable reagents that those sequencers need in perpetuity if they're to be usable by customers.  To make matters worse, its sales of consumables, which totaled $739 million in the second quarter, actually dropped by 1% year over year., Headline: Illumina Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.11% higher to $167.41 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...",ILMN
276,2023-08-22,"Headline: Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor, source:Benzinga, summary: No summary, Headline: Illumina Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. shed 2.67% to $162.94 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",ILMN
277,2023-08-23,"Headline: Illumina Inc. stock rises Wednesday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.61% higher to $163.94 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...",ILMN
278,2023-08-24,"Headline: Whitman-Walker Institute, Cancer Support Community and GRAIL Collaborate On Research Aimed at Advancing Health Equity in Cancer Screening and Care through Multi-Cancer Early Detection, source:Finnhub, summary: WASHINGTON - Whitman-Walker Institute, a leader in LGBTQ health, research, education and policy with special expertise in HIV care; Cancer Support Community , a global nonprofit that works to ease..., Headline: Illumina Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. shed 2.65% to $159.60 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",ILMN
279,2023-08-25,"Headline: Illumina Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of Illumina Inc. slid 0.95% to $158.08 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",ILMN
280,2023-08-27,"Headline: 18 Best 52-Week Low Stocks To Buy Now, source:Yahoo, summary: In this article, we will take a look at the 18 best 52-week low stocks to buy now. To see more such companies, go directly to 5 Best 52-Week Low Stocks To Buy Now. US stock markets are jittery after Fed Chair Jerome Powell made it clear that inflation is still high and needs further […]",ILMN
281,2023-08-28,"Headline: Illumina Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of Illumina Inc. inched 0.08% higher to $158.20 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P..., Headline: Illumina To Webcast Upcoming Investor Conference, source:Yahoo, summary: Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:",ILMN
282,2023-08-29,"Headline: RBC Capital Remains a Buy on Illumina (ILMN), source:TipRanks, summary: No summary, Headline: Illumina Inc. stock rises Tuesday, outperforms market, source:MarketWatch, summary: Shares of Illumina Inc. rallied 2.36% to $161.93 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",ILMN
283,2023-08-30,"Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rallied 2.55% to $166.06 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P..., Headline: Unusual Put Option Trade in Illumina (ILMN)  Worth $4,743.00K, source:Fintel, summary: nan",ILMN
284,2023-08-31,"Headline: Interesting ILMN Put And Call Options For October 13th, source:Stock Options Channel, summary: No summary, Headline: Illumina Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of Illumina Inc. shed 0.51% to $165.22 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",ILMN
285,2023-09-01,"Headline: Illumina added to 'Tactical Outperform' list at Evercore ISI, source:Thefly.com, summary: No summary, Headline: Illumina added to Evercore’s Tactical Outperform list on a potential CEO hire, source:Seeking Alpha, summary: No summary, Headline: At Illumina, new leadership could fuel turnaround, analysts say, source:MarketWatch, summary: Illumina Inc. shares may be poised for a turnaround as the company hunts for a new CEO, Evercore ISI analysts wrote in a research note Friday. The analysts..., Headline: Early notable gainers among liquid option names on September 1st, source:Thefly.com, summary: No summary, Headline: Is Illumina (ILMN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap, source:Yahoo, summary: Navigating the Thin Line Between Value and Trap in Illumina (ILMN) Stock, Headline: Illumina Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of Illumina Inc. rose 1.96% to $168.46 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",ILMN
